| Use of Multiple Urinary Biomarkers for the Early Detection of Chronic Kidney Disease in Sickle Cell Anemia. | Castro Sesquen Y, Saraf SL, Gordeuk VR, Nekhai S, Jerebtsova M | Blood Adv | 2023 |
| Is CBD ready for prime time in sickle cell disease? | Curtis SA, Novelli EM | Blood | 2023 |
| Ups and downs in the treatment of sickle cell disease. | Brousse V | Blood | 2023 |
| (De)ironing out sickle cell disease. | Das NK, Shah YM | Blood | 2023 |
| Cognitive Function in Children With β-thalassemia Major. | Kurian AK, Sharma M, Varughese PV, Aggarwal N | Indian Pediatr | 2023 |
| Membrane bending and sphingomyelinase associated sulfatide dependent hypoxic adhesion of sickle mature erythrocytes. | Goreke U, Kucukal E, Wang F, An R, Arnold N, Quinn E, Yuan C, Bode A, Hill A, Man Y, Hambley BC, Schilz R, Ginwalla M, Little J, Gurkan UA | Blood Adv | 2023 |
| Sickle Cell Disease Gene Therapy Trial Paused. | Larkin HD | JAMA | 2023 |
| Associations of the serum albumin concentration and Sequential Organ Failure Assessment score at discharge with 1-year mortality in sepsis survivors: A retrospective cohort study. | Lee SM, Jo YH, Lee JH, Hwang JE, Park I, Baek S, Jeong H, Um YW, Kim HE | Shock | 2023 |
| Comment on: Impact of telehealth visits on hydroxyurea response in sickle cell anemia. | Cheema MRS | Pediatr Blood Cancer | 2023 |
| Social inequalities in the temporal trend of mortality from sickle cell disease in Brazil, 1996-2019. | Cordovil K, Tassinari W, Oliveira RVC, Hökerberg Y | Cad Saude Publica | 2023 |
| Sickle cell Trevor Thompson transition project (ST3P-UP) protocol for managing care transitions: Methods and rationale. | Osunkwo I, Lawrence R, Robinson M, Patterson C, Symanowski J, Minniti C, Bryant P, Williams J, Eckman J, Desai P | Contemp Clin Trials | 2023 |
| Understanding the Association between Red Blood Cell Transfusion Utilization and Humanistic and Economic Burden in Patients with β-Thalassemia from the Patients' Perspective. | Knoth RL, Gupta S, Perkowski K, Costantino H, Inyart B, Ashka L, Clapp K | J Clin Med | 2023 |
| Therapeutic adenine base editing of human hematopoietic stem cells. | Liao J, Chen S, Hsiao S, Jiang Y, Yang Y, Zhang Y, Wang X, Lai Y, Bauer DE, Wu Y | Nat Commun | 2023 |
| Classification of red cell dynamics with convolutional and recurrent neural networks: a sickle cell disease case study. | Darrin M, Samudre A, Sahun M, Atwell S, Badens C, Charrier A, Helfer E, Viallat A, Cohen-Addad V, Giffard-Roisin S | Sci Rep | 2023 |
| Optical coherence tomography angiography findings in transfusion-dependent beta-thalassemia patients with and without splenectomy. | Koctekin B, Karakus V, Dogan B, Erdem R, Dogan U, Buber H, Kurtoglu E | Photodiagnosis Photodyn Ther | 2023 |
| Electrophysiological properties and heart rate variability of patients with thalassemia major in Jakarta, Indonesia. | Sukardi R, Wahidiyat PA, Gultom PA, Ikhsan M, Yamin M, Salim S, Djer MM | PLoS One | 2023 |
| Left ventricular global function index is associated with myocardial iron overload and heart failure in thalassemia major patients. | Meloni A, Positano V, Pistoia L, Righi R, Missere M, Grassedonio E, Schicchi N, Vallone A, Gamberini MR, Cuccia L, Lisi R, Cecinati V, Spasiano A, Cademartiri F | Int J Cardiovasc Imaging | 2023 |
| Transfusion-transmitted babesiosis in a patient with sickle cell disease undergoing chronic red cell exchange. | Costa V, Mercure-Corriveau N, Gourneau J, Tobian AAR, Jones JM, Lauriello A, Lanzkron S, Crowe EP, Bloch EM | Transfusion | 2023 |
| Foetal haemoglobin inducers for reducing blood transfusion in non-transfusion-dependent beta-thalassaemias. | Foong WC, Loh CK, Ho JJ, Lau DS | Cochrane Database Syst Rev | 2023 |
| Impact of Hemin on Interleukin-21 Levels and Plasma Cells in Transfusion-Dependent Thalassemia with Positive and Negative Allo-Autoantibody. | Tambunan BA, Ugrasena IDG, Aryati A | Int J Gen Med | 2023 |
| Patient and Caregiver Perspectives on Care-Seeking During a Vaso-Occlusive Crisis in Sickle Cell Disease: Results from Qualitative Interviews in Canada. | Durgam N, Brion T, Lewis HB, Tinga B, Sanon W, Lundie M, Cadieux C | Patient Prefer Adherence | 2023 |
| Dual diagnosis of autosomal dominant polycystic kidney disease and sickle cell disease in a teenage male. | Stein Q, Herman K, Deyo J, McDonough C, Bloom MS, Mansuri A | Pediatr Nephrol | 2023 |
| Prevalence and Risk Factors for Pulmonary Embolism in Pediatric Sickle Cell Disease: A National Administrative Database Study. | Bala N, Stanek J, Rodriguez V, Villella A | Pediatr Hematol Oncol | 2023 |
| Labile plasma iron and echocardiographic parameters are associated to cardiac events in β-thalassemic patients. | Ferrara F, Coppi F, Riva R, Ventura P, Ricci A, Mattioli AV, Talarico M, Garuti C, Bevini M, Rochira V, Buzzetti E, Pietrangelo A, Corradini E | Eur J Clin Invest | 2023 |
| A reliable and high throughput HPLC-HRMS method for the rapid screening of β-thalassemia and hemoglobinopathy in dried blood spots. | Li Z, Chen D, Shu Y, Yang J, Zhang J, Ming Wang , Wan K, Zhou Y, He X, Zou L, Yu C | Clin Chem Lab Med | 2023 |
| Sleep disordered breathing and its relation to stroke and pulmonary hypertension in children with sickle cell disease: a single-center cross-sectional study. | Tantawy A, El-Sherif N, Makkeyah S, Eldeen NS, Farghal NBE, Soliman N, Ebeid FSE | Ann Hematol | 2023 |
| Oxidants and Antioxidants in the Redox Biochemistry of Human Red Blood Cells. | Möller MN, Orrico F, Villar SF, López AC, Silva N, Donzé M, Thomson L, Denicola A | ACS Omega | 2023 |
| Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies. | Ureña-Bailén G, Block M, Grandi T, Aivazidou F, Quednau J, Krenz D, Daniel-Moreno A, Lamsfus-Calle A, Epting T, Handgretinger R, Wild S, Mezger M | CRISPR J | 2023 |
| Enuresis and overactive bladder in sickle cell patients: a narrative review of the literature. | Gaye O, Seck M, Thiam NM, Ndong A, Fall PA | World J Urol | 2023 |
| Factors Associated with Leg Ulcers in Adults with Sickle Cell Disease in Brazil. | Reis de Souza V, Kelly S, Cerdeira Sabino E, Mendes de Oliveira F, Silva T, Miranda Teixeira C, Máximo C, Loureiro P, Barbara de Freitas Carneiro-Proietti A, Gomes I, Custer B, de Almeida-Neto C | Adv Skin Wound Care | 2023 |
| Epidemiological Surveillance of SARSCov2 in β-Thalassemia Patients in the Last Two Years: Reinfection Rate, Insights and Future Challenges. | Torti L, Sorrentino F, Maffei L, De Fabritiis P, Abruzzese E | Mediterr J Hematol Infect Dis | 2023 |
| Glucose Homeostasis and Assessment of β-Cell Function by 3-hour Oral Glucose Tolerance (OGTT) in Patients with β-Thalassemia Major with Serum Ferritin below 1,000 ng/dL: Results from a Single ICET-A Centre. | de Sanctis V, Soliman AT, Daar S, Tzoulis P, Di Maio S, Kattamis C | Mediterr J Hematol Infect Dis | 2023 |
| Adverse Pregnancy Outcomes in Sickle Cell Trait: a Prospective Cohort Study Evaluating Clinical and Haematological Parameters in Postpartum Mothers and Newborns. | Ali EH, Alkindi S, Mohamed AO, Awadalla KE, Abdlgadir O, Adam G, Magdi M, Ibrahim AK, Ghebremeskel K | Mediterr J Hematol Infect Dis | 2023 |
| The Burden of Sickle Cell Disease in Saudi Arabia: A Single-Institution Large Retrospective Study. | Bin Zuair A, Aldossari S, Alhumaidi R, Alrabiah M, Alshabanat A | Int J Gen Med | 2023 |
| A specific G9a inhibitor unveils BGLT3 lncRNA as a universal mediator of chemically induced fetal globin gene expression. | Takase S, Hiroyama T, Shirai F, Maemoto Y, Nakata A, Arata M, Matsuoka S, Sonoda T, Niwa H, Sato S, Umehara T, Shirouzu M, Nishigaya Y, Sumiya T, Hashimoto N, Namie R, Usui M, Ohishi T, Ohba SI, Kawada M, Hayashi Y, Harada H, Yamaguchi T, Shinkai Y, Nakamura Y, Yoshida M, Ito A | Nat Commun | 2023 |
| CRISPR-Cas9 base editors and their current role in human therapeutics. | Lahr WS, Sipe CJ, Skeate JG, Webber BR, Moriarity BS | Cytotherapy | 2023 |
| Early recognition of pulmonary complications of sickle cell disease. | Almusally RM | Saudi Med J | 2023 |
| Physical, Mental, and Social Health of Adult Patients with Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Mixed-Methods Study. | Dovern E, Nijland SJAM, van Muilekom MM, Suijk EMJ, Hoogendoorn GM, Mekelenkamp H, Biemond BJ, Haverman L, Nur E | Transplant Cell Ther | 2023 |
| Clinical Utility of Neutrophil to Lymphocyte Ratio in Sickle Cell Disease With Vaso-Occlusive Crisis. | Maharaj S, Chang S | Hematol Oncol Stem Cell Ther | 2023 |
| Breaking the Cycle: Care Coordination Interventions and Sickle Cell Readmissions. | No authors listed | Prof Case Manag | 2022 |
| Breaking the Cycle: Care Coordination Interventions and Sickle Cell Readmissions. | Edge NB | Prof Case Manag | 2022 |
| Nano-sized zeolite-like metal-organic frameworks induced hematological effects on red blood cell. | Hao F, Yan XP | J Hazard Mater | 2022 |
| Homing in on haemoglobinopathies. | The Lancet Global Health | Lancet Glob Health | 2022 |
| Bloodstream Infections in Children With Sickle Cell Disease: 2010-2019. | Yee ME, Lai KW, Bakshi N, Grossman JK, Jaggi P, Mallis A, Wang YF, Jerris RC, Lane PA, Yildirim I | Pediatrics | 2022 |
| Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization. | Pinto VM, Musallam KM, Derchi GE, Graziadei G, Giuditta M, Origa R, Barella S, Casu G, Pasanisi A, Longo F, Casale M, Miceli R, Merella P, Tartaglione I, Piga A, Cappellini MD, Gianesin B, Forni GL | Blood | 2022 |
| Efficacy and Safety of Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Thalassemia Patients: A Retrospective Observational Study. | Kupesiz FT, Sivrice C, Akinel A, Kintrup GT, Guler E, Kupesiz A | J Pediatr Hematol Oncol | 2022 |
| Telehealth Use Before and During the COVID-19 Pandemic Among Children with Sickle Cell Anemia. | Reeves SL, Patel PN, Madden B, Ng S, Creary SE, Smith D, Ellimoottil C | Telemed J E Health | 2022 |
| Modern management of iron overload in thalassemia major patients guided by MRI techniques: real-world data from a long-term cohort study. | Bayraktaroglu S, Karadas N, Onen S, Karapinar DY, Aydinok Y | Ann Hematol | 2022 |
| Up-regulation of miR-130a is related to leg ulcers in sickle cell anaemia. | Batista THC, Santana RM, Sobreira MJ, Arcanjo GS, Domingos IF, Pereira-Martins DA, Falcão DA, Oliveira JMF, Batista JVGF, Weinhӓuser I, Hatzlhofer BL, Júnior WLB, Araujo AS, Dos Anjos AC, Costa FF, Saad MJA, Carvalho BM, Vasconcelos LRS, Lucena-Araujo AR, Bezerra MA | Br J Haematol | 2022 |
| Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease: A Case Series. | Alwaheed AJ, Alqatari SG, AlSulaiman AS, AlSulaiman RS | Am J Case Rep | 2022 |
| Translating research to usual care of children with sickle cell disease in Northern Nigeria: lessons learned from the SPRING Trial Team. | Bello-Manga H, Haliru L, Tabari AM, Farouk B, Suleiman A, Bahago GY, Sani AM, Bauman AA, DeBaun MR, King AA | BMC Res Notes | 2022 |
| A rare case of adrenal extramedullary haematopoiesis in a Cypriot woman with β-thalassaemia. | Georgiou AC, Lisacek-Kiosoglous AB, Mariannis D, Christou S, Hadjianastassiou VG | Ann R Coll Surg Engl | 2022 |
| Liver Transplant in Hemoglobin SC Disease and Autoimmune Hepatitis: A Case Report. | Kim A, Assarzadegan N, Anders RA, Oshima K, Chaturvedi S, Weeks S, Kohli R, Lanzkron S, Gurakar A, Garonzik-Wang J, Chen PH | Exp Clin Transplant | 2022 |
| The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease. | Soulières D, Mercier-Ross J, Fradette C, Rozova A, Tsang YC, Tricta F | Ann Hematol | 2022 |
| Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trial. | Boulad F, Maggio A, Wang X, Moi P, Acuto S, Kogel F, Takpradit C, Prockop S, Mansilla-Soto J, Cabriolu A, Odak A, Qu J, Thummar K, Du F, Shen L, Raso S, Barone R, Di Maggio R, Pitrolo L, Giambona A, Mingoia M, Everett JK, Hokama P, Roche AM, Cantu VA, Adhikari H, Reddy S, Bouhassira E, Mohandas N, Bushman FD, Rivière I, Sadelain M | Nat Med | 2022 |
| Perforated Duodenal Ulcer Associated with Deferasirox in a Child with β-Thalassemia Major. | Zahra A, Ragab A, Al-Abboh H, Ismaiel A, Adekile AD | Hemoglobin | 2022 |
| Anti-inflammatory cytokines in sickle cell disease. | Alagbe AE, Domingos IF, Adekile AD, Blotta MHSL, Santos MNN | Mol Biol Rep | 2022 |
| Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia major. | Lüftinger R, Zubarovskaya N, Galimard JE, Cseh A, Salzer E, Locatelli F, Algeri M, Yesilipek A, de la Fuente J, Isgrò A, Alseraihy A, Angelucci E, Smiers FJ, La La Nasa G, Zecca M, Fisgin T, Unal E, Kleinschmidt K, Peters C, Lankester A, Corbacioglu S, | Ann Hematol | 2022 |
| Quality of life and challenges experienced by the surviving adults with transfusion dependent thalassaemia in Malaysia: a cross sectional study. | Foong WC, Chean KY, Rahim FF, Goh AS, Yeoh SL, Yeoh AAC | Health Qual Life Outcomes | 2022 |
| Cost analysis of acute care resource utilization among individuals with sickle cell disease in a middle-income country. | Lobo C, Moura P, Fidlarczyk D, Duran J, Barbosa R, Oliveira T, do Nascimento EM, Bhakta N, Hankins JS | BMC Health Serv Res | 2022 |
| Biopsychosocial Factors Associated with Parenting Stress in Pediatric Sickle Cell Disease. | Johnson YL, Woodward K, Dampier C, Cohen L, Sil S | J Clin Psychol Med Settings | 2022 |
| Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case Report. | Leyde S, Suen L, Pratt L, DeFries T | J Gen Intern Med | 2022 |
| l-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: Hype or hope? | Leibovitch JN, Tambe AV, Cimpeanu E, Poplawska M, Jafri F, Dutta D, Lim SH | Blood Rev | 2022 |
| Clonal hematopoiesis in sickle cell disease. | Liggett LA, Cato LD, Weinstock JS, Zhang Y, Nouraie SM, Gladwin MT, Garrett ME, Ashley-Koch A, Telen M, Custer B, Kelly S, Dinardo C, Sabino EC, Loureiro P, Carneiro-Proietti A, Maximo C, Reiner AP, Abecasis GR, Williams DA, Natarajan P, Bick AG, Sankaran VG | J Clin Invest | 2022 |
| Venous cerebral blood flow quantification and cognition in patients with sickle cell anemia. | Stotesbury H, Hales PW, Koelbel M, Hood AM, Kawadler JM, Saunders DE, Sahota S, Rees DC, Wilkey O, Layton M, Pelidis M, Inusa BP, Howard J, Chakravorty S, Clark CA, Kirkham FJ | J Cereb Blood Flow Metab | 2022 |
| Evolving Strategies in the Management of Sickle Cell Disease in the 21st Century and the Role of the Pediatrician. | Hardit V, Alvarez O, Ziga E, Alperstein W | Pediatr Ann | 2022 |
| Assessing and managing people with sickle cell disease presenting with vaso-occlusive crisis in the emergency department. | De D, Thakur I | Emerg Nurse | 2022 |
| Prevalence of Depression among Iranian Patients with Beta-Thalassemia Major: A Systematic Review and Meta-analysis. | Jaafari Z, Sadidi N, Abdolahinia Z, Shahesmaeili A | Iran J Med Sci | 2022 |
| A Novel Association of HbQ India Trait with Sickle Cell Anemia: a New Insight in Hemoglobinopathies. | Gupta RK, Verma KK, Singh G | SN Compr Clin Med | 2022 |
| Navigating Hemostasis of Bleeding Among Children With β-Thalassemia. | El-Beshlawy A, Rabah F, Hamed HM, Mahmoud AA, Al-Wakeel HA, Abdelhamid EM, El-Sonbaty MM, El Sissy M | J Pediatr Hematol Oncol | 2022 |
| Hydroxyurea and fetal hemoglobin effect on leg ulcers in patients with sickle cell disease. | Tolu SS, Crouch A, Choi J, Gao Q, Reyes-Gil M, Ogu UO, Vinces G, Minniti CP | Ann Hematol | 2022 |
| Extensive porto-splenic venous thrombosis postsplenectomy in a sickle cell disease: a rare complication. | Al Barhi T, Wali Y, Al Sibai S, Al Balushi Z | BMJ Case Rep | 2022 |
| Effect of Sickle Cell Trait on Total Hip Arthroplasty in a Matched Cohort. | Waters TL, Wilder JH, Ross BJ, Salas Z, Sherman WF | J Arthroplasty | 2022 |
| Gastrointestinal vaso-occlusive crisis in a woman with hemoglobin SC disease. | Clement JM, Li AY, Berg BW, Law JY, Baer MR | Am J Med | 2022 |
| Native cardiac magnetic resonance T1 mapping and cardiac mechanics as assessed by speckle tracking echocardiography in patients with beta-thalassaemia major. | See WS, So EK, Hwang GY, Chin L, Ip L, Lam WW, Ha SY, Cheung YF | Int J Cardiol Heart Vasc | 2022 |
| Spectrum of HBB gene mutations among 696 β-thalassemia patients and carriers in Southern Vietnam. | Xinh PT, Chuong HQ, Ha NTT, Tram HDB, Van Dong C, Thanh LVH, Hoa NTH, Nghia H, Binh NT, Dung PC, Vu HA | Mol Biol Rep | 2022 |
| Feasibility of early sirolimus cessation post non-myeloablative transplantation in adult patients with severe sickle cell disease. | Damlaj M, Alahmari B, Alaskar A, Alhejazi A, Alsadi H, Shehab-Eddine I, Alghamdi A, Almashaqbeh W, Alshobaki H, Mahasneh I, Alotaibi A, Alanazi T, Balili M, Quarshi M, Ahmed M, Alzahrani M | Bone Marrow Transplant | 2022 |
| Effects of corticosteroids in patients with sickle cell disease and acute complications: a systematic review and meta-analysis. | Lopinto J, Gendreau S, Berti E, Bartolucci P, Habibi A, Mekontso Dessap A | Haematologica | 2022 |
| Correction to: Modern management of iron overload in thalassemia major patients guided by MRI techniques: real‑world data from a long‑term cohort study. | Bayraktaroglu S, Karadas N, Onen S, Karapinar DY, Aydinok Y | Ann Hematol | 2022 |
| Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease. | Schroeder P, Fulzele K, Forsyth S, Ribadeneira MD, Guichard S, Wilker E, Marshall CG, Drake A, Fessler R, Konstantinidis DG, Seu KG, Kalfa TA | J Pharmacol Exp Ther | 2022 |
| De novo mutation rates at the single-mutation resolution in a human gene-region associated with adaptation and genetic disease. | Melamed D, Nov Y, Malik A, Yakass MB, Bolotin E, Shemer R, Hiadzi EK, Skorecki KL, Livnat A | Genome Res | 2022 |
| Annual decline in lung function in adults with sickle cell disease is similar to that observed in adults with cystic fibrosis. | Hodges B, Ivy ZK, Cronin RM, Rodeghier M, DeBaun MR, Willen S | Blood Adv | 2022 |
| Correction to: Macular microvascular changes in children with transfusion-dependent beta-thalassemia. | AttaAllah HR, Mousa SO, Omar IAN | Graefes Arch Clin Exp Ophthalmol | 2022 |
| Newborn Screening and Clinical Profile of Children with Sickle Cell Disease in a Tribal Area of Gujarat. | Dave KK, Desai S, Italia Y, Mukherjee MB, Mehta P, Desai G | Indian Pediatr | 2022 |
| Effects of dual chelation therapy with deferasirox and deferoxamine in patients with beta thalassaemia major. | Zargari A, Wu S, Greenway A, Cheng K, Kaplan Z | Vox Sang | 2022 |
| Epigenomic analysis of KLF1 haploinsufficiency in primary human erythroblasts. | Heshusius S, Grech L, Gillemans N, Brouwer RWW, den Dekker XT, van IJcken WFJ, Nota B, Felice AE, van Dijk TB, von Lindern M, Borg J, van den Akker E, Philipsen S | Sci Rep | 2022 |
| COVID-19 and Sickle Cell Disease-Related Deaths Reported in the United States. | Payne AB, Schieve LA, Abe K, Hulihan M, Hooper WC, Hsu LL | Public Health Rep | 2022 |
| Incorporation of novel therapies for the management of sickle cell disease: A pharmacist's perspective. | Dela-Pena JC, King MA, Brown J, Nachar VR | J Oncol Pharm Pract | 2022 |
| Possible effects of sirolimus treatment on the long‑term efficacy of COVID‑19 vaccination in patients with β‑thalassemia: A theoretical perspective. | Zurlo M, Nicoli F, Borgatti M, Finotti A, Gambari R | Int J Mol Med | 2022 |
| A case of α-chain variant hemoglobin (Hb Chad) with falsely high HbA1c levels measured by immunoassay. | Yoshino K, Hirota Y, Ogawa W, Sugawara K, Kawaguchi A, Yoshino H, Ishibashi M, Yoshino G, Koga M | Diabetol Int | 2022 |
| COVID -19 Precipitating Vaso-Occlusive Crisis in a Patient of Sickle Cell Anemia with Avascular Necrosis of Femur. | Khandual SP, Mallick R, Jhankar SK, Tudu K, Bariha PK, Mohapatra MK | J Assoc Physicians India | 2022 |
| Atrial Fibrillation in β-Thalassemia: Overview of Mechanism, Significance and Clinical Management. | Malagù M, Marchini F, Fiorio A, Sirugo P, Clò S, Mari E, Gamberini MR, Rapezzi C, Bertini M | Biology (Basel) | 2022 |
| Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients. | Saad HKM, Abd Rahman AA, Ab Ghani AS, Taib WRW, Ismail I, Johan MF, Al-Wajeeh AS, Al-Jamal HAN | Biomedicines | 2022 |
| Redox-Regulation of α-Globin in Vascular Physiology. | Kiger L, Keith J, Freiwan A, Fernandez AG, Tillman H, Isakson BE, Weiss MJ, Lechauve C | Antioxidants (Basel) | 2022 |
| Influence of Haptoglobin Polymorphism on Stroke in Sickle Cell Disease Patients. | Edwards O, Burris A, Lua J, Wilkie DJ, Ezenwa MO, Doré S | Genes (Basel) | 2022 |
| Importance of Sequencing , and Genes to Confirm the Diagnosis of High Oxygen Affinity Hemoglobin. | Filser M, Gardie B, Wemeau M, Aguilar-Martinez P, Giansily-Blaizot M, Girodon F | Genes (Basel) | 2022 |
| Clinical phenotypes of three children with sickle cell disease caused by HbS/Sicilian (δβ) -thalassemia deletion. | Aygun B, Bello A, Thompson AA, Davis L, Sun Y, Luo HY, Cui S, Chui DHK | Am J Hematol | 2022 |
| Glucose-6-phosphate dehydrogenase deficiency is more prevalent in Duffy-null red blood cell transfusion in sickle cell disease. | Yee ME, Francis RO, Luban NLC, Easley KA, Lough CM, Roback JD, Josephson CD, Fasano RM | Transfusion | 2022 |
| Acoustic radiation force impulse elastography for liver iron overload in β-thalassemia major: Is it going to cut it? | Alessandrino F, Cantisani V | J Clin Ultrasound | 2022 |
| Ultra-rare Hb Regina (:c.289C>G) with coinherited β-thalassaemia trait: solving the puzzle for extreme erythrocytosis. | Mallik N, Jamwal M, Sharma R, Singh N, Sharma P, Bansal D, Trehan A, Chhabra S, Das R | J Clin Pathol | 2022 |
| Successful use of veno-venous extracorporeal membrane oxygenation for acute chest syndrome in a child with sickle cell disease and SARS-CoV-2. | Koh W, Malik P, Whitehead J, Morales DLS, Hayes D | Pediatr Pulmonol | 2022 |
| Procedural adverse events in pediatric patients with sickle cell disease undergoing chronic automated red cell exchange. | Wade J, Yee MEM, Easley KA, Pahz S, Butler H, Zerra PE, Josephson CD, Fasano RM | Transfusion | 2022 |
| A Case Study in Process Improvement to Minimize Delays from Obtaining Blood for Red Cell Exchange for a Patient with Sickle Cell Disease and Multiple Red Blood Cell Alloantibodies. | Narayanan D, Hogan NB, Schaser KA, Ruegsegger P, Rose WN | Case Rep Hematol | 2022 |
| Transfusion Practice, Post-Transfusion Complications and Risk Factors in Sickle Cell Disease in Senegal, West Africa. | Seck M, Senghor AB, Loum M, Touré SA, Faye BF, Diallo AB, Keita M, Bousso SE, Guèye SM, Gadji M, Sall A, Touré AO, Diop S | Mediterr J Hematol Infect Dis | 2022 |
| The Effect of Alpha Thalassemia, HbF and HbC on Haematological Parameters of Sickle Cell Disease Patients in Ibadan, Nigeria. | Fasola FA, Babalola OA, Brown BJ, Odetunde A, Falusi AG, Olopade O | Mediterr J Hematol Infect Dis | 2022 |
| Benefit of Pulmonary Subspecialty Care for Children with Sickle Cell Disease and Asthma. | Saxena S, Afolabi-Brown O, Ballester L, Schmucker N, Smith-Whitley K, Allen J, Bhandari A | Pediatr Pulmonol | 2022 |
| Rare co-inherited alpha-thalassemia minor and beta-thalassemia minor with heterozygous H63D mutation mistaken as iron deficiency anemia: a case report. | Chaudhry AF, Malik Z, Shegos CJ | AME Case Rep | 2022 |
| Endothelial Activation Markers in Polytransfused Children with Beta Thalassemia: Study from a Tertiary Care Centre in India. | Pallewar TS, Sharma K, Sharma S, Chandra J, Nangia A | Indian J Hematol Blood Transfus | 2022 |
| Impact of HFE-2 and HAMP Gene Variations on Iron Overload in Pediatric Patients with Non-Transfusion Dependent Thalassemia: A Pilot Study. | Bharadwaj N, Peyam S, Bhatia P, Bhatia A, Das R, Singh M, Bansal D, Trehan A, Jain R | Indian J Hematol Blood Transfus | 2022 |
| [Study on Thalassemia in Han Population in Sanya of Hainan Province]. | Xu YY, Li M, Guan LX, Xiang SH, Cheng LC, Yang YH, Gao XN, Ning HM | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| [Genetic Analysis and Prenatal Diagnosis of Thalassemia in Couples of Childbearing Age in Quanzhou Region Fujian Province, China]. | Zhuang JL, Zhang N, Wang YB, Jiang YY | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| [Hematological Characteristics of Different Genotypes of Thalassemia among Reproductive Population in Chongqing]. | Li SY, Li QH, Yi SW, Li CL | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| [Genetic Analysis of Thalassemia in 22 940 Pregnant Women in Xiangxi Tujia and Miao Autonomous Prefecture]. | Yu H, Yang QX, Liu C, Peng LY, Zhou XB, Shao L, Huang N | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| Revascularization Is Associated With a Reduced Stroke Risk in Patients With Sickle Cell-Associated Moyamoya Syndrome. | Newman S, McMahon JT, Boulter JH, Malcolm JG, Revuelta Barbero JM, Chern JJ, Barrow DL, Pradilla G | Neurosurgery | 2022 |
| Thrombospondin-1, Platelet Factor 4, and Galectin-1 are Associated with Engraftment in Patients with Sickle Cell Disease Who Underwent Haploidentical HSCT. | Shaikh A, Olkhanud PB, Gangaplara A, Kone A, Patel S, Gucek M, Fitzhugh CD | Transplant Cell Ther | 2022 |
| Therapeutic plasma exchange in the management of acute complications of sickle cell disease: A single centre experience. | Tsitsikas DA, Mihalca D, Hibbs S, Freeman T, Bello-Sanyaolu O, Orebayo F, Lewis N, Green L | Transfus Apher Sci | 2022 |
| The Importance of Functional and Feature-Tracking Cardiac MRI Parameters in Prediction of Adverse Cardiac Events and Cardiac Mortality in Thalassemia Patients. | Asadian S, Hosseini L, Rezaeian N | Acad Radiol | 2022 |
| Main Complications during Pregnancy and Recommendations for Adequate Antenatal Care in Sickle Cell Disease: A Literature Review. | Figueira CO, Surita FG, Fertrin K, Nobrega GM, Costa ML | Rev Bras Ginecol Obstet | 2022 |
| Omega 3 fatty acids - Potential modulators for oxidative stress and inflammation in the management of sickle cell disease. | Khan SA, Damanhouri GA, Ahmed TJ, Halawani SH, Ali A, Makki A, Khan SA | J Pediatr (Rio J) | 2022 |
| Hybrid bone SPECT/CT reveals spleen calcification in sickle cell mutation and beta-thalassemia. | Sakellariou K, Charalampidou S, Fotopoulos A, Sioka C | Nucl Med Rev Cent East Eur | 2022 |
| Challenges in the Diagnosis of Beta-thalassemia Syndrome: The Importance of Molecular Diagnosis. | Rameli N, Ramli M, Zulkafli Z, Hassan MN, Yusoff SM, Noor NHM, Hussin S, Kamarudin NKM, Yusoff YM, Bahar R | Oman Med J | 2022 |
| Sudden Death in Diabetic Ketoacidosis Complicated by Sickle Cell Trait. | Dau GE, Shah JJ, Walsh JC, Berran PJ | Am J Forensic Med Pathol | 2022 |
| Sideroblastic anaemia in a patient with sickle cell disease. | Vobugari N, Chaturvedi M, Schlam-Camhi IM, Smith HP | BMJ Case Rep | 2022 |
| GRNDaD: big data and sickle cell disease. | Lanzkron S, Manwani D, Desai P, Kanter J, Little J | Blood Adv | 2022 |
| Pharmacologic induction of PGC-1α stimulates fetal haemoglobin gene expression. | Sun Y, Habara A, Le CQ, Nguyen N, Chen R, Murphy GJ, Chui DHK, Steinberg MH, Cui S | Br J Haematol | 2022 |
| Neurocognitive risk in sickle cell disease: Utilizing neuropsychology services to manage cognitive symptoms and functional limitations. | Longoria JN, Heitzer AM, Hankins JS, Trpchevska A, Porter JS | Br J Haematol | 2022 |
| Description of Hb Évora (: c.106T>C) on an Unexpected Allele in a Swiss Family. | Truttmann R, Schmidt A, Hartmann B, Rusch S, Mendez A | Hemoglobin | 2022 |
| Reduced blood pressure in sickle cell disease is associated with decreased angiotensin converting enzyme (ACE) activity and is not modulated by ACE inhibition. | Brito PL, Dos Santos AF, Chweih H, Favero ME, Gotardo EMF, Silva JAF, Leonardo FC, Franco-Penteado CF, de Oliveira MG, Ferreira WA, Zaidan BC, Billis A, Baldanzi G, Mashima DA, Antunes E, Saad STO, Costa FF, Conran N | PLoS One | 2022 |
| From H1N1 to COVID-19: What we have seen in children with hemoglobinopathies. | Oliveira CM, Soares VJ, Rechenmacher C, Daudt LE, Michalowski MB | Clinics (Sao Paulo) | 2022 |
| Cerebral oxygen metabolic stress is increased in children with sickle cell anemia compared to anemic controls. | Fields ME, Mirro AE, Binkley MM, Guilliams KP, Lewis JB, Fellah S, Chen Y, Hulbert ML, An H, Ford AL, Lee JM | Am J Hematol | 2022 |
| Efficacy and Safety of Gene Therapy for β-Thalassemia. | Payen E | N Engl J Med | 2022 |
| Determinants of the point of sickling measured by oxygen gradient ektacytometry in sickle cell anaemia. | Joly P, Boisson C, Renoux C, Caillat N, Robert M, Gauthier-Vasserot A, Poutrel S, Cibiel A, Nader E, Connes P | Br J Haematol | 2022 |
| Opioid Use in Patients With Sickle Cell Disease During a Vaso-Occlusive Crisis: A Systematic Review. | Arzoun H, Srinivasan M, Sahib I, Fondeur J, Escudero Mendez L, Hamouda RK, Mohammed L | Cureus | 2022 |
| Sickle cell nephropathy: A review of novel biomarkers and their potential roles in early detection of renal involvement. | Safdar OY, Baghdadi RM, Alahmadi SA, Fakieh BE, Algaydi AM | World J Clin Pediatr | 2022 |
| Health State Utilities for Sickle Cell Disease: A Catalog Prepared From a Systematic Review. | Jiao B, Basu A, Ramsey S, Roth J, Bender MA, Quach D, Devine B | Value Health | 2022 |
| Experiences of African Americans Living With Sickle Cell Disease. | Wickersham KE, Dawson RM, Becker KP, Everhart KC, Miles HS, Schultz BE, Tucker CM, Wright PJ, Jenerette CM | J Transcult Nurs | 2022 |
| Size and density measurements of single sickle red blood cells using microfluidic magnetic levitation. | Goreke U, Bode A, Yaman S, Gurkan UA, Durmus NG | Lab Chip | 2022 |
| Sickle cell disease and COVID-19 in pregnant women. | Kolanska K, Vasileva R, Lionnet F, Santin A, Jaudi S, Dabi Y, Chabbert-Buffet N, Daraï E, Bornes M | J Gynecol Obstet Hum Reprod | 2022 |
| CRISPR/Cas9-based multiplex genome editing of BCL11A and HBG efficiently induces fetal hemoglobin expression. | Han Y, Tan X, Jin T, Zhao S, Hu L, Zhang W, Kurita R, Nakamura Y, Liu J, Li D, Zhang Z, Fang X, Huang S | Eur J Pharmacol | 2022 |
| Process and strategies for patient engagement and outreach in the Sickle Cell Disease (SCD) community to promote clinical trial participation. | Byrnes C, Botello-Harbaum M, Clemons T, Bailey L, Valdes KM, Coleman-Cowger VH | J Natl Med Assoc | 2022 |
| Nrf2 expands the intracellular pool of the chaperone AHSP in a cellular model of β-thalassemia. | Han G, Cao C, Yang X, Zhao GW, Hu XJ, Yu DL, Yang RF, Yang K, Zhang YY, Wang WT, Liu XZ, Xu P, Liu XH, Chen P, Xue Z, Liu DP, Lv X | Redox Biol | 2022 |
| Tocilizumab in the management of posttransfusion hyperhemolysis syndrome in sickle cell disease: The experience so far. | Meenan J, Hall R, Badle S, Chatterjee B, Win N, Tsitsikas DA | Transfusion | 2022 |
| Documented Viral Illness at the Time of Splenic Sequestration Does Not Affect the Odds of Recurrence in Children With Sickle Cell Disease. | Clement O, Fishbein J, Appiah-Kubi A, Aygun B | J Pediatr Hematol Oncol | 2022 |
| Haemoglobin Bristol-Alesha in a child with non-spherocytic severe haemolytic anaemia and marked anisochromic poikilocytosis with basophilic stippling and amorphous intracellular content. | Corrons JV, Bain BJ | Blood Cells Mol Dis | 2022 |
| [Associations, key players in the sickle cell patient's journey]. | Mbebi-Liégeois C | Rev Infirm | 2022 |
| [Pregnancy planning and follow-up of a pregnant woman with sickle cell disease]. | Bornes M | Rev Infirm | 2022 |
| [The place of therapeutic education in the care of the sickle cell patient]. | Doumdo L, Bibrac A, Italique C, Petras M, Bernit E | Rev Infirm | 2022 |
| [Long-term nursing care of the adult sickle cell patient]. | Vasseur V, Barbin C | Rev Infirm | 2022 |
| [Psychology and culture in sickle cell disease]. | Faure J | Rev Infirm | 2022 |
| [Management of the adult with sickle cell disease]. | Mattioni S, Santin A | Rev Infirm | 2022 |
| [Care pathway for the sickle cell child]. | Holvoet L, Keohavong A, Traore K | Rev Infirm | 2022 |
| [Sickle cell disease, a genetic haemoglobin disease]. | Girot R | Rev Infirm | 2022 |
| Disrupting the adult-globin promoter alleviates promoter competition and reactivates foetal-globin gene expression. | Topfer S, Feng R, Huang P, Ly L, Martyn G, Blobel GA, Weiss MJ, Quinlan K, Crossley M | Blood | 2022 |
| The ektacytometric elongation Index (EI) of erythrocytes, validation of a prognostic, rheological biomarker for patients with sickle cell disease. | Franck P, Buijs P, Meenhuis A, Dane M, Postma C, Spaans A, Gijsbertha N, Kuypers FA, Hudig C, Kerkhoffs JL | Eur J Haematol | 2022 |
| Action on sickle cell retinopathy: the time is now. | Dinah C, Greystoke B, Mueller I, Talks J | Eye (Lond) | 2022 |
| Efficiency and management factors: finding the balance in Thalassaemia care centres. | Shafie AA, Mohammed NS, See KF, Ibrahim HM, Wong JHY, Chhabra IK | Health Econ Rev | 2022 |
| Rare unstable and low oxygen affinity haemoglobin variant, Hb Hazebrouck, detected on Sysmex XN-9000. | Adam AS, Benyaich S, Colard M, Benghiat FS, Cotton F, Gulbis B | Clin Chem Lab Med | 2022 |
| Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial. | Magrin E, Semeraro M, Hebert N, Joseph L, Magnani A, Chalumeau A, Gabrion A, Roudaut C, Marouene J, Lefrere F, Diana JS, Denis A, Neven B, Funck-Brentano I, Negre O, Renolleau S, Brousse V, Kiger L, Touzot F, Poirot C, Bourget P, El Nemer W, Blanche S, Tréluyer JM, Asmal M, Walls C, Beuzard Y, Schmidt M, Hacein-Bey-Abina S, Asnafi V, Guichard I, Poirée M, Monpoux F, Touraine P, Brouzes C, de Montalembert M, Payen E, Six E, Ribeil JA, Miccio A, Bartolucci P, Leboulch P, Cavazzana M | Nat Med | 2022 |
| Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin. | Ravi NS, Wienert B, Wyman SK, Bell HW, George A, Mahalingam G, Vu JT, Prasad K, Bandlamudi BP, Devaraju N, Rajendiran V, Syedbasha N, Pai AA, Nakamura Y, Kurita R, Narayanasamy M, Balasubramanian P, Thangavel S, Marepally S, Velayudhan SR, Srivastava A, DeWitt MA, Crossley M, Corn JE, Mohankumar KM | Elife | 2022 |
| Post-transplant CD34+ selected stem cell boost as an intervention for declining mixed chimerism following reduced intensity conditioning allogeneic stem cell transplant in children and young adults with sickle cell disease: A case series. | Ngwube A, Franay C, Shah N | Pediatr Hematol Oncol | 2022 |
| Prevalence of neuropathic pain in adolescents with sickle cell disease: A single-center experience. | Cregan M, Puri L, Kang G, Anghelescu D | Pediatr Blood Cancer | 2022 |
| A predictive algorithm for identifying children with sickle cell anemia among children admitted to hospital with severe anemia in Africa. | Olupot-Olupot P, Connon R, Kiguli S, Opoka RO, Alaroker F, Uyoga S, Nakuya M, Okiror W, Nteziyaremye J, Ssenyondo T, Nabawanuka E, Kayaga J, Williams Mukisa C, Amorut D, Muhindo R, Frost G, Walsh K, Macharia AW, Gibb DM, Walker AS, George EC, Maitland K, Williams TN | Am J Hematol | 2022 |
| Diagnostic value of fetal hemoglobin Bart's for evaluation of fetal α-thalassemia syndromes: application to prenatal characterization of fetal anemia caused by undiagnosed α-hemoglobinopathy. | Singha K, Yamsri S, Chaibunruang A, Srivorakun H, Sanchaisuriya K, Fucharoen G, Fucharoen S | Orphanet J Rare Dis | 2022 |
| Hb Mizuho (: c.206T>C): Pitfalls of Screening Tests in an Unstable Hemoglobin Variant Diagnosed after Targeted Next-Generation Sequencing. | Yadav DD, Jamwal M, Singh N, Sharma R, Das R, Trehan A, Bansal D, Chhabra S, Sharma P | Hemoglobin | 2022 |
| Voxelotor and albuminuria in adults with sickle cell anaemia. | Han J, Molokie RE, Hussain F, Njoku F, Gordeuk VR, Saraf SL | Br J Haematol | 2022 |
| COVID-19 Vaccine Perception and Hesitancy Among Patients With Sickle Cell Disease in the Western Region of Saudi Arabia. | Jan H, Waheeb A, AlAhwal H, Almohammadi A, Al-Marzouki A, Barefah A, Bahashawan S, Radhwi O | Cureus | 2022 |
| Awareness and Acceptance of Hematopoietic Stem Cell Transplantation for Sickle Cell Disease in Jazan Province, Saudi Arabia. | Hurissi E, Hakami A, Homadi J, Kariri F, Abu-Jabir E, Alamer R, Mobarki R, Jaly AA, Alamer E, Alhazmi AH | Cureus | 2022 |
| Neonatal Screening for Sickle Cell Disease in Congo. | Dokekias AE, Ocko Gokaba LT, Louokdom JS, Ocini LN, Galiba Atipo Tsiba FO, Ondzotto Ibatta CI, Kouandzi QN, Tamekue ST, Bango JC, Nziengui Mboumba JV, Kobawila SC | Anemia | 2022 |
| Pas-de-deux: African Plasmodium falciparum adaptations to sickle hemoglobin. | Matuschewski K, Maier AG | Trends Parasitol | 2022 |
| Genes modulating intestinal permeability and microbial community are dysregulated in sickle cell disease. | Poplawska M, Dutta D, Jayaram M, Chong NS, Salifu M, Lim SH | Ann Hematol | 2022 |
| Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and Ghana. | Zempsky WT, Yanaros M, Sayeem M, Boruchov D, Piccone CM, Manwani D, Strunk C, Tartaglione I, Colombatti R, Akatue S, Oteng B, Owda A, Bamfo R, Wilson S, Rivers A, Farooq F, Urbonya R, Boatemaa GD, Rao S, Inusa B, Antwi-Boasiako C, Segbefia C, Sey F, Andemariam B, Asare EV, Campbell AD | Pain Med | 2022 |
| A Systematic Review on the Management of Transfusion-Related Acute Lung Injury in Transfusion-Dependent Sickle Cell Disease. | Arzoun H, Srinivasan M, Adam M, Thomas SS, Lee B, Yarema A | Cureus | 2022 |
| Circulating Small Extracellular Vesicles May Contribute to Vaso-Occlusive Crises in Sickle Cell Disease. | Gemel J, Zhang J, Mao Y, Lapping-Carr G, Beyer EC | J Clin Med | 2022 |
| Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence. | Gentinetta T, Belcher JD, Brügger-Verdon V, Adam J, Ruthsatz T, Bain J, Schu D, Ventrici L, Edler M, Lioe H, Patel K, Chen C, Nguyen J, Abdulla F, Zhang P, Wassmer A, Jain M, Mischnik M, Pelzing M, Martin K, Davis R, Didichenko S, Schaub A, Brinkman N, Herzog E, Zürcher A, Vercellotti GM, Kato GJ, Höbarth G | J Clin Med | 2022 |
| MicroRNAs miR-451a and Let-7i-5p Profiles in Circulating Exosomes Vary among Individuals with Different Sickle Hemoglobin Genotypes and Malaria. | Oxendine Harp K, Bashi A, Botchway F, Dei-Adomakoh Y, Iqbal SA, Wilson MD, Adjei AA, Stiles JK, Driss A | J Clin Med | 2022 |
| Shear-Stress-Gradient and Oxygen-Gradient Ektacytometry in Sickle Cell Patients at Steady State and during Vaso-Occlusive Crises. | Boisson C, Nader E, Renoux C, Gauthier A, Poutrel S, Bertrand Y, Stauffer E, Virot E, Hot A, Fort R, Cannas G, Joly P, Connes P | Cells | 2022 |
| Reactivation of γ-globin expression using a minicircle DNA system to treat β-thalassemia. | Ma SP, Gao XX, Zhou GQ, Zhang HK, Yang JM, Wang WJ, Song XM, Chen HY, Lu DR | Gene | 2022 |
| Evolutionary race: Malaria evolves to evade sickle cell protection. | Gómez-Díaz E, Ranford-Cartwright L | Cell Host Microbe | 2022 |
| Acute chest syndrome of sickle cell disease: genetics, risk factors, prognosis, and management. | Klings ES, Steinberg MH | Expert Rev Hematol | 2022 |
| Phenotypic variation in sickle cell disease: the role of beta globin haplotype, alpha thalassaemia and fetal haemoglobin in HbSS. | Serjeant GR | Expert Rev Hematol | 2022 |
| Pregnancy outcomes with hydroxyurea use in women with sickle cell disease. | Kroner BL, Hankins JS, Pugh N, Kutlar A, King AA, Shah NR, Kanter J, Glassberg J, Treadwell M, Gordeuk VR, | Am J Hematol | 2022 |
| Comment on: Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia. | Sheehan VA, van Beers EJ, Connes P, van Wijk R, Rab MAE | Br J Haematol | 2022 |
| Long-read sequencing on the SMRT platform enables efficient haplotype linkage analysis in preimplantation genetic testing for β-thalassemia. | Wu H, Chen D, Zhao Q, Shen X, Liao Y, Li P, Chiu PCN, Zhou C | J Assist Reprod Genet | 2022 |
| Association and Risk Factors of Osteonecrosis of Femoral Head in Sickle Cell Disease: A Systematic Review. | Leandro MP, De Sá CKC, Filho DPS, De Souza LAA, Salles C, Tenório MCC, Paz CLDSL, Matos MAA | Indian J Orthop | 2022 |
| Multiplex Quantitative Real-Time Polymerase Chain Reaction and High-Resolution Melting Analysis for Identification of a Couple At-Risk of Having a Newborn with Severe Thalassemia. | Ruengdit C, Punyamung M, Khamphikham P, Pongpunyayuen P, Intasai N, Pornprasert S | Hemoglobin | 2022 |
| Fetal-like Hemoglobin in Sickle Cell Anemia. | Steinberg MH | N Engl J Med | 2022 |
| Scalable manufacturing platform for the production of methemoglobin as a non-oxygen carrying control material in studies of cell-free hemoglobin solutions. | Gu X, Hickey R, Rath A, Palmer AF | PLoS One | 2022 |
| The distinct longitudinal impact of pain catastrophizing on pain interference among youth living with sickle cell disease and chronic pain. | Schneider MB, Manikowski A, Cohen L, Dampier C, Sil S | J Behav Med | 2022 |
| Purinergic signaling is essential for full Psickle activation by hypoxia and by normoxic acid pH in mature human sickle red cells and in vitro-differentiated cultured human sickle reticulocytes. | Vandorpe DH, Rivera A, Ganter M, Dankwa S, Wohlgemuth JG, Dlott JS, Snyder LM, Brugnara C, Duraisingh M, Alper SL | Pflugers Arch | 2022 |
| An Evaluation for the Causes of Reduced Hb A and the Molecular Characterization of Variants in Hong Kong. | Chan NCN, Wong THY, Cheng KCK, Chan NPH, Ng MHL | Hemoglobin | 2022 |
| Direct antiglobulin test-negative autoimmune hemolytic anemia in a patient with β-thalassemia minor during pregnancy: A case report. | Zhou Y, Ding YL, Zhang LJ, Peng M, Huang J | World J Clin Cases | 2022 |
| Anaesthetic management of patients with sickle cell disease in obstetrics. | Stoddard K, Sohal M, Bedson R | BJA Educ | 2022 |
| Thalassemia-free and graft-versus-host-free survival: outcomes of hematopoietic stem cell transplantation for thalassemia major, Turkish experience. | Yesilipek MA, Uygun V, Kupesiz A, Karasu G, Ozturk G, Ertem M, Şaşmaz İ, Daloğlu H, Güler E, Hazar V, Fisgin T, Sezgin G, Kansoy S, Kuşkonmaz B, Akıncı B, Özbek N, İnce EÜ, Öztürkmen S, Küpesiz FT, Yalçın K, Anak S, Bozkurt C, Karakükçü M, Küpeli S, Albayrak D, Öniz H, Aksoylar S, Okur FV, Albayrak C, Yenigürbüz FD, Bozkaya İO, İleri T, Gürsel O, Karagün BŞ, Kintrup GT, Çelen S, Elli M, Aksoy BA, Yılmaz E, Tanyeli A, Akyol ŞT, Siviş ZÖ, Özek G, Uçkan D, Kartal İ, Atay D, Akyay A, Bilir ÖA, Çakmaklı HF, Kürekçi E, Malbora B, Akbayram S, Demir HA, Kılıç SÇ, Güneş AM, Zengin E, Özmen S, Antmen AB | Bone Marrow Transplant | 2022 |
| Factors associated with blood pressure variation in sickle cell disease patients: a systematic review and meta-analyses. | Nguweneza A, Oosterwyk C, Banda K, Nembaware V, Mazandu G, Kengne AP, Wonkam A | Expert Rev Hematol | 2022 |
| Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center. | Varelas C, Gavriilaki E, Sakellari I, Klonizakis P, Koravou EE, Christodoulou I, Mavrikou I, Kourelis A, Chatzopoulou F, Chatzidimitriou D, Touloumenidou T, Papalexandri A, Anagnostopoulos A, Vlachaki E | J Clin Med | 2022 |
| Comparison of Ultra-Wide Field Photography to Ultra-Wide Field Angiography for the Staging of Sickle Cell Retinopathy. | Torres-Villaros H, Fajnkuchen F, Amari F, Janicot L, Giocanti-Aurégan A | J Clin Med | 2022 |
| Conditioning Regimens in Patients with β-Thalassemia Who Underwent Hematopoietic Stem Cell Transplantation: A Scoping Review. | Mulas O, Mola B, Caocci G, La Nasa G | J Clin Med | 2022 |
| Use of Deferasirox Film-Coated Tablets in Pediatric Patients with Transfusion Dependent Thalassemia: A Single Center Experience. | Adramerina A, Printza N, Hatzipantelis E, Symeonidis S, Tarazi L, Teli A, Economou M | Biology (Basel) | 2022 |
| Health-Related Quality of Life Assessments by Children and Adolescents with Sickle Cell Disease and Their Parents in Portugal. | Abadesso C, Pacheco S, Machado MC, Finley GA | Children (Basel) | 2022 |
| A Description of the Hemolytic Component in Sickle Leg Ulcer: The Role of Circulating miR-199a-5p, miR-144, and miR-126. | Santos EDC, Melo GIV, Santana PVB, Quadros IGS, Yahouédéhou SCMA, Guarda CCD, Santiago RP, Fiuza LM, Carvalho SP, Adorno EV, Kaneto CM, Fonseca TCC, Goncalves MS, Aleluia MM | Biomolecules | 2022 |
| Optimizing transfusion therapy for survivors of Haemoglobin Bart's hydrops fetalis syndrome: Defining the targets for haemoglobin-H fraction and | Amid A, Barrowman N, Odame I, Kirby-Allen M | Br J Haematol | 2022 |
| The hematopoietic saga of clonality in sickle cell disease. | Stonestrom AJ, Levine RL | J Clin Invest | 2022 |
| A microfluidic-informatics assay for quantitative physical occlusion measurement in sickle cell disease. | Zhang X, Chan T, Carbonella J, Gong X, Ahmed N, Liu C, Demandel I, Zhang J, Pashankar F, Mak M | Lab Chip | 2022 |
| GBT1118, a voxelotor analog, protects red blood cells from damage during severe hypoxia. | Tarasev M, Ferranti M, Herppich A, Hines P | Am J Transl Res | 2022 |
| Sickle cell disease as an accelerated aging syndrome. | Idris IM, Botchwey EA, Hyacinth HI | Exp Biol Med (Maywood) | 2022 |
| Expanded eligibility for emerging therapies in sickle cell disease in the UK - crizanlizumab and voxelotor. | Vora SM, Boyd S, Denny N, Jackson E, Roy NBA, Howard J, Lugthart S | Br J Haematol | 2022 |
| Coinheritance of HbO Arab/β0-thalassemia with Severe Manifestation in Newborn. | Kalai M, Moumni I, Ouragini H, Chaouechi D, Boudriga I, Menif S | Am J Perinatol | 2022 |
| Black Americans' willingness to participate in pediatric sickle cell clinical trials: A retrospective, systematic review. | Zanfardino S, Mazziotto V, Bodas P | Pediatr Blood Cancer | 2022 |
| Diagnosis of α-thalassemia Chiang Rai (--) deletion by melt curve analysis in Northern Thailand. | Ruengdit C, Khamphikham P, Punyamung M, Pongpunyayuen P, Pornprasert S | Scand J Clin Lab Invest | 2022 |
| An impact evaluation of two modes of care for sickle cell disease crises. | Skinner R, Breck A, Esposito D | J Comp Eff Res | 2022 |
| Extra-Medullary Hematopoiesis in Sickle Cell Disease Presenting as a Right Adrenal Mass. | Ajayi F, Nali MS, Ali R, Patel A, Shaaban H | Cureus | 2022 |
| The clinical and radiological effectiveness of autologous bone marrow derived osteoblasts (ABMDO) in the management of avascular necrosis of femoral head (ANFH) in sickle cell disease (SCD). | Sadat-Ali M, Al-Omran AS, AlTabash K, Acharya S, Hegazi TM, Al Muhaish MI | J Exp Orthop | 2022 |
| Two trade names of deferasirox (Osveral® and Exjade®) in reduction of iron overload parameters in major beta-thalassemia patients: A randomized open labeled clinical trial. | Rafati M, Karami H, Lashtoo-Aghaee B, Lashtoo-Aghaee B, Dabirian M, Avan R | Caspian J Intern Med | 2022 |
| A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia. | Yasara N, Wickramarathne N, Mettananda C, Silva I, Hameed N, Attanayaka K, Rodrigo R, Wickramasinghe N, Perera L, Manamperi A, Premawardhena A, Mettananda S | Sci Rep | 2022 |
| Effect of age, cerebral infarcts, vasculopathy and haemoglobin on cognitive function, in Tanzanian children with sickle cell anaemia. | Jacob M, Stotesbury H, Kija E, Saunders D, Mtei RJ, Tutuba H, Masanu U, Kilonzo M, Kazema R, Hood AM, Kirkham F, Dimitriou D, Makani J | Eur J Paediatr Neurol | 2022 |
| Reduction in Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Transplantation. | Patel A, Wilkerson K, Chen H, Sharma D, Byrne M, Green J, Sengsayadeth S, Dholaria B, Savani B, Chinratanalab W, Jayani R, Gatwood K, Engelhardt BG, Kitko C, Connelly J, Kassim A | Transplant Cell Ther | 2022 |
| Third-generation sequencing: A novel tool detects complex variants in the α-thalassemia gene. | Long J, Sun L, Gong F, Zhang C, Mao A, Lu Y, Li J, Liu E | Gene | 2022 |
| Correlation of Asymmetric Dimethyl Arginine Level to Sickle Retinopathy in Children With Sickle Cell Disease. | Elhawary EE, Khedr SF, Nagy HM, El-Bradey MH, Elshanshory MR | J Pediatr Hematol Oncol | 2022 |
| Assessment of Liver Fibrosis by Transient Elastography in Children and Young Adults With Sickle Cell Disease With and Without Iron Overload. | Alvarez O, Cumming V, Fifi AC | J Pediatr Hematol Oncol | 2022 |
| Introduction of Hydroxyurea Therapy to a Cohort of Sickle Cell Patients in Northern Haiti. | Paul-Hanna M, Joseph W, Mondesir W, Faustino EVS, Canarie MF | J Pediatr Hematol Oncol | 2022 |
| Peripheral Blood Smear Detection of Asymptomatic Central Line Infection in a Patient With Sickle Cell Disease. | Carll TC, Mariani R, Schafernak K, Snowberger T, Jacobsen J, Gomez E, Su L | J Pediatr Hematol Oncol | 2022 |
| Enuresis and Hyperfiltration in Children With Sickle Cell Disease. | Zahr RS, Ding J, Kang G, Wang WC, Hankins JS, Ataga KI, Lebensburger JD, Porter JS | J Pediatr Hematol Oncol | 2022 |
| Whole blood versus red cell concentrates for children with severe anaemia: a secondary analysis of the Transfusion and Treatment of African Children (TRACT) trial. | George EC, Uyoga S, M'baya B, Kyeyune Byabazair D, Kiguli S, Olupot-Olupot P, Opoka RO, Chagaluka G, Alaroker F, Williams TN, Bates I, Mbanya D, Gibb DM, Walker AS, Maitland K, | Lancet Glob Health | 2022 |
| Globin vector regulatory elements are active in early hematopoietic progenitor cells. | Cabriolu A, Odak A, Zamparo L, Yuan H, Leslie C, Sadelain M | Mol Ther | 2022 |
| The unexpected impact of cabozantinib on red blood cells consumption in patients with transfusion-dependent thalassemia. | Costantini S, Meloni A, Spasiano A, Cinque P, Ricchi P | Ann Hematol | 2022 |
| Retinal and choroidal thickness in pediatric patients with sickle cell disease: a cross-sectional cohort study. | Prazeres J, Lucatto LF, Ferreira A, Moraes N, Braga JAP, Lima LH, Regatieri C, Maia M | Int J Retina Vitreous | 2022 |
| The Sickle Cell Disease Functional Assessment (SCD-FA) tool: a feasibility pilot study. | Oyedeji CI, Hall K, Luciano A, Morey MC, Strouse JJ | Pilot Feasibility Stud | 2022 |
| Healthcare resource utilization and direct costs of transfusion-dependent thalassemia patients in Dubai, United Arab Emirates: a retrospective cost-of-illness study. | Alshamsi S, Hamidi S, Narci HO | BMC Health Serv Res | 2022 |
| Accuracy of transcranial Doppler in detecting intracranial stenosis in patients with sickle cell anemia when compared to magnetic resonance angiography. | Krementz NA, Gardener HE, Torres L, Alkhalifah M, Campo-Bustillo I, Campo N, Koch S, Alvarez O, Rundek T, Romano JG | J Clin Ultrasound | 2022 |
| Nursing Education for the Acute Care Nurse on Pain Mechanisms of Sickle Cell Disease. | Evelyn AE, Kittelson S, Mandernach MW, Black V, Duckworth L, Wilkie DJ | J Contin Educ Nurs | 2022 |
| Autoimmune disease and sickle cell anaemia: 'Intersecting pathways and differential diagnosis'. | Piccin A, O'Connor-Byrne N, Daves M, Lynch K, Farshbaf AD, Martin-Loeches I | Br J Haematol | 2022 |
| Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience. | Gagliardi I, Celico M, Gamberini MR, Pontrelli M, Fortini M, Carnevale A, Napoli N, Zatelli MC, Ambrosio MR | Calcif Tissue Int | 2022 |
| Erythrocyte (red blood cell) dataset in thalassemia case. | Tyas DA, Ratnaningsih T, Harjoko A, Hartati S | Data Brief | 2022 |
| Advances in the diagnosis and treatment of sickle cell disease. | Brandow AM, Liem RI | J Hematol Oncol | 2022 |
| Growth Hormone/Insulin-Like Growth Factor 1 Axis Associated with Modifiers Factors in Children with Sickle Cell Anemia. | Costa-Júnior DAD, Santos APP, da Silva CM, Velloso-Rodrigues C | Endocr Metab Immune Disord Drug Targets | 2022 |
| Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a retrospective, multicentre, case-control study. | Ranque B, Kitenge R, Ndiaye DD, Ba MD, Adjoumani L, Traore H, Coulibaly C, Guindo A, Boidy K, Mbuyi D, Ly ID, Offredo L, Diallo DA, Tolo A, Kafando E, Tshilolo L, Diagne I | Lancet Haematol | 2022 |
| Filling the data gaps on sickle cell anaemia in sub-Saharan Africa. | Williams TN | Lancet Haematol | 2022 |
| Assessment of serum endocan levels in patients with beta-thalassemia minor. | Khanmammadov N, Zorlu M, Ozer OF, Karatoprak C, Kıskaç M, Çakırca M | Rev Assoc Med Bras (1992) | 2022 |
| A Rare Hemoglobin Variant (β51Pro → His) Causing Misleading Measurements of Hemoglobin A. | Mackley MP, Morgenthau A, Elnenaei M, MacKenzie H | J Endocr Soc | 2022 |
| Hair-on-End Sign in a 9-Year-Old Girl Presenting with Acute Stroke in Sickle Cell Disease. | Ogwang E, Odongo CN, Namusisi J, Okello PA, Acan M | Int Med Case Rep J | 2022 |
| Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-Thalassemia. | Derchi G, Musallam KM, Pinto VM, Graziadei G, Giuditta M, Barella S, Origa R, Casu G, Pasanisi A, Longo F, Casale M, Miceli R, Merella P, Gianesin B, Ameri P, Tartaglione I, Perrotta S, Piga A, Cappellini MD, Forni GL | Haematologica | 2022 |
| Prevalence and risk factors of hepatitis E virus infection among patients with β-thalassemia major in South of Iran. | Farshadpour F, Taherkhani R, Shaeri M | J Immunoassay Immunochem | 2022 |
| Relation between haptoglobin polymorphism and oxidative stress status, lipid profile, and cardiovascular risk in sickle cell anemia patients. | Kengne Fotsing CB, Pieme CA, Biapa Nya PC, Chedjou JP, Dabou S, Nguemeni C, Teto G, Mbacham WF, Gatsing D | Health Sci Rep | 2022 |
| Healthcare professionals' perceptions of implementing a decision support intervention for cascade screening for beta-thalassemia in Pakistan. | Ahmed S, Jafri H, Ahmed WN, Faran M, Rashid Y, Ehsan Y, Ahmed M | Eur J Hum Genet | 2022 |
| ETV6 Regulates Hemin-Induced Erythroid Differentiation of K562 Cells through Mediating the Raf/MEK/ERK Pathway. | Li Z, Sun MZ, Lv X, Guo C, Liu S | Biol Pharm Bull | 2022 |
| Outcomes of kidney donors with sickle cell trait: A preliminary analysis. | Hebert SA, Gandhi NV, Al-Amin S, Edwards AR, Murad DN, Nguyen DT, Graviss EA, Ibrahim HN | Clin Transplant | 2022 |
| Two co-inherited hemoglobin variants revealed by capillary electrophoresis during quantification of glycated hemoglobin. | Antonello G, Lo Monaco C, Napoli P, Solimando D, Curcio C, Barberio G, Maoggi S, Ivaldi G, Nigra M | Clin Chem Lab Med | 2022 |
| Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies. | Radhwi OO, Jan H, Waheeb A, Alamri SS, Alahwal HM, Denetiu I, Almanzlawey A, Al-Marzouki AF, Almohammadi AT, Bahashwan SM, Barefah AS, Qari MH, Abuzenadah AM, Hashem AM | Vaccines (Basel) | 2022 |
| Fetal Hemoglobin in β Hemoglobinopathies: Is Enough Too Much? | Steinberg MH | Am J Hematol | 2022 |
| High Frequency of Post-Transfusion Microchimerism Among Multi-Transfused Beta-Thalassemic Patients. | Matsagos S, Verigou E, Kourakli A, Alexis S, Vrakas S, Argyropoulou C, Lazaris V, Spyropoulou P, Labropoulou V, Georgara N, Lykouresi M, Karakantza M, Alepi C, Symeonidis A | Front Med (Lausanne) | 2022 |
| Editorial: Red Blood Cell Vascular Adhesion and Deformability, Volume II. | Guizouarn H, Barshtein G | Front Physiol | 2022 |
| Magnetic Resonance Imaging Quantification of the Liver Iron Burden and Volume Changes Following Treatment With Thalidomide in Patients With Transfusion-Dependent -Thalassemia. | Che J, Luo T, Huang L, Lu Q, Yan D, Meng Y, Xie J, Chen W, Chen J, Long L | Front Pharmacol | 2022 |
| Comparison of the programmed freezer method and deep freezer method in the manufacturing of frozen red blood cell products. | Fuchizaki A, Yasui K, Tanaka M, Mitsuhashi H, Shimogaki K, Kimura T, Takihara Y, Hirayama F | Vox Sang | 2022 |
| Extramedullary haematopoiesis in patients with transfusion dependent β-thalassaemia (TDT): a systematic review. | A Subahi E, Ata F, Choudry H, Iqbal P, A AlHiyari M, T Soliman A, De Sanctis V, A Yassin M | Ann Med | 2022 |
| Risk and protective factors for severe COVID-19 infection in a cohort of patients with sickle cell disease. | Cai J, Chen-Goodspeed A, Idowu M | J Investig Med | 2022 |
| Lower Muscle and Blood Lactate Accumulation in Sickle Cell Trait Carriers in Response to Short High-Intensity Exercise. | Messonnier LA, Oyono-Enguéllé S, Vincent L, Dubouchaud H, Chatel B, Sanchez H, Malgoyre A, Martin C, Galactéros F, Bartolucci P, Thiriet P, Féasson L | Nutrients | 2022 |
| Endothelial superoxide dismutase 2 is decreased in sickle cell disease and regulates fibronectin processing. | Dosunmu-Ogunbi A, Yuan S, Shiwarski DJ, Tashman JW, Reynolds M, Feinberg A, Novelli EM, Shiva S, Straub AC | Function (Oxf) | 2022 |
| α-thalassemia in affected fetuses with hemoglobin E-β-thalassemia disease in a high-risk population in Thailand. | Yamsri S, Prommetta S, Srivorakun H, Taweenan W, Sanchaisuriya K, Chaibunruang A, Fucharoen G, Fucharoen S | Am J Transl Res | 2022 |
| Acute complications in children with sickle cell disease: Prevention and management. | Beck CE, Trottier ED, Kirby-Allen M, Pastore Y | Paediatr Child Health | 2022 |
| Reflex single-gene non-invasive prenatal testing is associated with markedly better detection of fetuses affected with single-gene recessive disorders at lower cost. | Riku S, Hedriana H, Carozza JA, Hoskovec J | J Med Econ | 2022 |
| Rheological Abnormalities in Human Erythrocytes Subjected to Oxidative Inflammation. | Maruyama T, Hieda M, Mawatari S, Fujino T | Front Physiol | 2022 |
| Letter to the Editor: Role of Ketamine in Vaso-Occlusive Crisis of Sickle Cell Disease. | Raghuraman MS | Saudi J Med Med Sci | 2022 |
| Adiponectin and Disease Severity in Sickle Cell Anemia Patients Attending a Tertiary Health Institution in Nnewi, Southeast Nigeria. | Okocha CE, Manafa PO, Igwe CN, Okite UP, Onah CE, Efobi C | Front Genet | 2022 |
| Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana. | Paintsil V, Amuzu EX, Nyanor I, Asafo-Adjei E, Mohammed AR, Yawnumah SA, Oppong-Mensah YG, Nguah SB, Obeng P, Dogbe EE, Jonas M, Nembaware V, Mazandu G, Ohene-Frempong K, Wonkam A, Makani J, Ansong D, Osei-Akoto A, | Front Genet | 2022 |
| Moyamoya syndrome in a child with HbEβ-thalassemia. | Zahra A, Al-Abboh H, Habeeb Y, Adekile A | Clin Case Rep | 2022 |
| A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders. | Tucci F, Galimberti S, Naldini L, Valsecchi MG, Aiuti A | Nat Commun | 2022 |
| XMN polymorphism along with HU administration renders alterations to RBC membrane lipidome in β-thalassemia patients. | Khan MBN, Iftikhar F, Ali M, Danish A, Shamsi T, Musharraf SG, Siddiqui AJ | Chem Phys Lipids | 2022 |
| Noninvasive prenatal testing of beta-thalassemia for common Pakistani mutations: a comparative study using cell-free fetal DNA from maternal plasma and chorionic villus sampling. | Afzal M, Naeem MA, Ahmed S, Amin N, Rahim A, Munawar M, Ishaq M, Rathore A, Maria K | Hematology | 2022 |
| Web Exclusive. Annals for Hospitalists Inpatient Notes - Clinical Pearls-Acute Pain Episodes in Sickle Cell Disease. | Strouse JJ, Brandow AM | Ann Intern Med | 2022 |
| The role of immature granulocyte percentage in predicting acute chest syndrome and the severity of the vaso-occlusive crisis in sickle cell disease. | Karahan F, Ünal S, Topçu DB, Öztaş Y, Bozlu G | Turk J Pediatr | 2022 |
| 50 Years Ago in TheJournalofPediatrics: Newborn Screening for Sickle Cell Disease: A Promise (Un)Fulfilled. | Strumph K, Manwani D | J Pediatr | 2022 |
| In Memoriam: Haig H. Kazazian, Jr. (1937-2022). | Cutting GR | Hum Mutat | 2022 |
| Early prenatal diagnosis of Hb Lepore Boston-Washington and β-thalassemia on fetal celomatic DNA. | Giambona A, Leto F, Cassarà F, Tartaglia V, Marchese G, Orlandi E, Cigna V, Picciotto F, Maggio A, Vinciguerra M | Int J Lab Hematol | 2022 |
| Heterozygosity of the Complex Corfu δβ Thalassemic Allele ( Deletion and HBB:c.92+5G>A) Revisited. | Kattamis C, Skafida M, Delaporta P, Vrettou C, Traeger-Synodinos J, Sofocleous C, Kattamis A | Biology (Basel) | 2022 |
| Elevated tricuspid regurgitation velocity is associated with increased adverse haematologic events during pregnancy in women with sickle cell disease. | Marshall WH, Cleary EM, Della-Moretta S, Li R, Samuels P, Desai PC, Rajpal S | Br J Haematol | 2022 |
| Epigenetic and Transcriptional Control of Erythropoiesis. | Wells M, Steiner L | Front Genet | 2022 |
| Link between Genotype and Multi-Organ Iron and Complications in Children with Transfusion-Dependent Thalassemia. | Meloni A, Pistoia L, Ricchi P, Putti MC, Gamberini MR, Cuccia L, Messina G, Massei F, Facchini E, Righi R, Renne S, Peritore G, Positano V, Cademartiri F | J Pers Med | 2022 |
| Vulnerability of β-Thalassemia Heterozygotes to COVID-19: Results from a Cohort Study. | Sotiriou S, Samara AA, Lachanas KE, Vamvakopoulou D, Vamvakopoulos KO, Vamvakopoulos N, Janho MB, Perivoliotis K, Donoudis C, Daponte A, Gourgoulianis KI, Boutlas S | J Pers Med | 2022 |
| Disseminated spp. Endocarditis in a Beta-Thalassemia Patient after Asymptomatic COVID-19 Infection. | Cinteza E, Nicolescu A, Ciomartan T, Gavriliu LC, Voicu C, Carabas A, Popescu M, Margarint I | Diagnostics (Basel) | 2022 |
| Hsp90 in Human Diseases: Molecular Mechanisms to Therapeutic Approaches. | Sumi MP, Ghosh A | Cells | 2022 |
| Neuroimaging Findings in Pediatric Patients with Thalassemia Major. | Akbaş Y, Aydın S, Tunçer GÖ, Köker A, Çoban Y, Oktay G, Yeral H | Hematol Rep | 2022 |
| COVID-19 in Patients with Transfusion Dependent Thalassemia (TDT) in Indonesia: Characteristics of the Disease and Patients, and Comparison between Epidemiological Data for COVID-19 and Thalassemia in Indonesia and Southeast Asia. | Atmakusuma TD | Hematol Rep | 2022 |
| HIV-1 infection in sickle cell disease and sickle cell trait: role of iron and innate response. | Nekhai S, Kumari N | Expert Rev Hematol | 2022 |
| A Novel Hemoglobin Variant Hb Liaobu [α107(G14)Val→Leu, : c.322G>C] Detected by Matrix-Assisted Laser Desorption Ionization-Time-of-Flight Mass Spectrometry. | Tan XM, Liu YH, Shang X, Ye YH, Xu XM | Hemoglobin | 2022 |
| Cognitive Impairment in Thalassemia and Associated Factors. | Limpawattana P, Juntararuangtong T, Teawtrakul N, Wanitpongpun C, Lanamtieng T, Phiphitaporn P, Chansung K | Dement Geriatr Cogn Disord | 2022 |
| Perspectives of individuals with sickle cell disease on barriers to care. | Phillips S, Chen Y, Masese R, Noisette L, Jordan K, Jacobs S, Hsu LL, Melvin CL, Treadwell M, Shah N, Tanabe P, Kanter J | PLoS One | 2022 |
| Perspective on newborn screening (NBS): Evidence sharing on conditions to be included in NBS in Pakistan. | Majid H, Jafri L, Ahmed S, Humayun K, Kirmani S, Ali N, Moiz B, Khan AH, Afroze B | J Pak Med Assoc | 2022 |
| Association of early donor chimerism status with survival outcomes in post allogeneic haematopoietic stem cell transplant patients of nonmalignant diseases. | Sial N, Ahmed P, Wattoo FH, Ali N | J Pak Med Assoc | 2022 |
| Can We Perform the Maximal Treadmill Test on Individuals with Sickle Cell Disease? | Ahner MM, Motta SBD, Franzoni L | Arq Bras Cardiol | 2022 |
| Exercise Testing In Patients with Sickle Cell Disease: Safety, Feasibility and Potential Prognostic Implication. | Araújo CG, Resende MBS, Tupinambás JT, Dias RCTM, Barros FC, Vasconcelos MCM, Januário JN, Ribeiro ALP, Nunes MCP | Arq Bras Cardiol | 2022 |
| An Immersive Virtual Reality Curriculum for Pediatric Hematology Clinicians on Shared Decision-making for Hydroxyurea in Sickle Cell Anemia. | Real FJ, Hood AM, Davis D, Cruse B, Klein M, Johnson Y, McTate E, Brinkman WB, Hackworth R, Hackworth K, Quinn CT, Crosby LE | J Pediatr Hematol Oncol | 2022 |
| Transition Preparation and Satisfaction of Care Among Adolescents and Young Adults With Sickle Cell Disease at the Ghana Institute of Clinical Genetics. | Kwarteng-Siaw M, Benneh-Akwasi Kuma A, Green NS | J Pediatr Hematol Oncol | 2022 |
| Genotype-phenotype correlation in patients with deletional and nondeletional mutations of Hb H disease in Southwest of Iran. | Hamid M, Keikhaei B, Galehdari H, Saberi A, Sedaghat A, Shariati G, Mohammadi-Anaei M | Sci Rep | 2022 |
| An unusual left atrial Rosai-Dorfman involvement in sickle cell disease patient. | Hritani R, Ramsey Z, Lee R, Bates WB, Williams H, Garcia D, Kutlar A, Aljaroudi W | J Nucl Cardiol | 2022 |
| Bloodstream Infections in Children With Sickle Cell Disease: 2010-2019. | Yee ME, Lai KW, Bakshi N, et al. | Pediatr Infect Dis J | 2022 |
| Feature tracking microfluidic analysis reveals differential roles of viscosity and friction in sickle cell blood. | Szafraniec HM, Valdez JM, Iffrig E, Lam WA, Higgins JM, Pearce P, Wood DK | Lab Chip | 2022 |
| Screening for glucose dysregulation in β-thalassemia major (β-TM): An update of current evidences and personal experience. | De Sanctis V, Daar S, Soliman AT, Tzoulis P, Karimi M, Di Maio S, Kattamis C | Acta Biomed | 2022 |
| Long-term Survival after Hematopoietic Cell Transplant for Sickle Cell Disease Compared to the United States Population. | StMartin A, Hebert KM, Serret-Larmande A, Jouhet V, Hughes E, Stedman J, DeSain T, Pillion D, Lyons JC, Steinert P, Avillach P, Eapen M | Transplant Cell Ther | 2022 |
| GH/IGF-1 axis in a large cohort of ß-thalassemia major adult patients: a cross-sectional study. | Gagliardi I, Mungari R, Gamberini MR, Fortini M, Dassie F, Putti MC, Maffei P, Aliberti L, Bondanelli M, Zatelli MC, Ambrosio MR | J Endocrinol Invest | 2022 |
| Acute kidney injury in hospitalized children with sickle cell anemia. | Batte A, Menon S, Ssenkusu J, Kiguli S, Kalyesubula R, Lubega J, Mutebi EI, Opoka RO, John CC, Starr MC, Conroy AL | BMC Nephrol | 2022 |
| Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia. | Heitzer AM, Longoria J, Rampersaud E, Rashkin SR, Estepp JH, Okhomina VI, Wang WC, Raches D, Potter B, Steinberg MH, King AA, Kang G, Hankins JS | Curr Res Transl Med | 2022 |
| Mitochondrial function in sickle cell disease. | Messonnier LA | Blood | 2022 |
| Hemogen /BRG1 cooperativity modulates promoter and enhancer activation during erythropoiesis. | Guo X, Dean A, Zhao Y, Kim J | Blood | 2022 |
| Gonadal Status and Sexual Function at Long-Term Follow-up after Allogeneic Stem Cell Transplantation in Adult Patients with Sickle Cell Disease. | Boga C, Asma S, Ozer C, Bulgan Kilicdag E, Kozanoglu I, Yeral M, Korur A, Gereklioglu C, Ozdogu H | Exp Clin Transplant | 2022 |
| Sickle Cell Intrahepatic Cholestasis: Extremely Rare but Fatal Complication of Sickle Cell Disease. | Khan A, Nashed B, Issa M, Khan MZ | Cureus | 2022 |
| Demand-only patient-controlled analgesia for treatment of acute vaso-occlusive pain in sickle cell disease. | Carullo V, Morrone K, Weiss M, Choi J, Gao Q, Pisharoty S, Moody K, Manwani D | Pediatr Blood Cancer | 2022 |
| Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol. | Lobitz S, Frömmel C, Brose A, Blankenstein O, Turner C, Dalton RN, Daniel Y, Klein J | Ann Hematol | 2022 |
| Difficulties in the diagnosis of HbS/beta thalassemia: Really a mild disease? | Uçucu S, Karabıyık T, Azik F | J Med Biochem | 2022 |
| Doppler US and Leg Ulcer Prevention in Children with Sickle Cell Disease. | Paltiel HJ | Radiology | 2022 |
| Abnormal Lower Extremity Hemodynamics at Doppler US in Children with Sickle Cell Anemia. | Komolafe OO, Adetiloye VA, Ayoola OO, Adefehinti O, Onwuka C | Radiology | 2022 |
| Alpha- and Beta-thalassemia: Rapid Evidence Review. | Baird DC, Batten SH, Sparks SK | Am Fam Physician | 2022 |
| Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model. | Quezado ZMN, Kamimura S, Smith M, Wang X, Heaven MR, Jana S, Vogel S, Zerfas P, Combs CA, Almeida LEF, Li Q, Quezado M, Horkayne-Szakaly I, Kosinski PA, Yu S, Kapadnis U, Kung C, Dang L, Wakim P, Eaton WA, Alayash AI, Thein SL | Blood Cells Mol Dis | 2022 |
| Characteristics and Prevalence of Antibiotic Allergies in Patients with Sickle Cell Disease: A Single Center Retrospective Study. | Wong KH, Soffer GK | Am J Hematol | 2022 |
| Pulmonary hypertension in thalassemia: a call to action. | Wood JC | Blood | 2022 |
| A landscape analysis and discussion of value of gene therapies for sickle cell disease. | Quach D, Jiao B, Basu A, Bender MA, Hankins JS, Ramsey SD, Devine B | Expert Rev Pharmacoecon Outcomes Res | 2022 |
| The Sickle Cell Disease Ontology: recent development and expansion of the universal sickle cell knowledge representation. | Mazandu GK, Hotchkiss J, Nembaware V, Wonkam A, Mulder N | Database (Oxford) | 2022 |
| β-thalassemia, and the advent of new Interventions beyond Transfusion and Iron chelation. | Chauhan W, Shoaib S, Fatma R, Zaka-Ur-Rab Z, Afzal M | Br J Clin Pharmacol | 2022 |
| Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy. | Graziadei G, De Franceschi L, Sainati L, Venturelli D, Masera N, Bonomo P, Vassanelli A, Casale M, Lodi G, Voi V, Rigano P, Pinto VM, Quota A, Notarangelo LD, Russo G, Allò M, Rosso R, D'Ascola D, Facchini E, Macchi S, Arcioni F, Bonetti F, Rossi E, Sau A, Campisi S, Colarusso G, Giona F, Lisi R, Giordano P, Boscarol G, Filosa A, Marktel S, Maroni P, Murgia M, Origa R, Longo F, Bortolotti M, Colombatti R, Di Maggio R, Mariani R, Piperno A, Corti P, Fidone C, Palazzi G, Badalamenti L, Gianesin B, Piel FB, Forni GL | Front Med (Lausanne) | 2022 |
| Case Report: Clinical and Hematological Characteristics of ε Thalassemia in an Italian Patient. | Fotzi I, Pegoraro F, Chiocca E, Casini T, Mogni M, Veltroni M, Favre C | Front Pediatr | 2022 |
| Plasma Interleukin-33 Cannot Predict Hip Osteonecrosis in Patients With Sickle Cell Disease: A Case-Control Study. | Agrawal AC, Mohapatra E, Nanda R, Bodhey NK, Sakale H, Garg AK | Cureus | 2022 |
| A Huge Subcapsular Splenic Cyst Like Hematoma in Sickle Cell Anemia. | Odeh AM, Boumarah KA, Alsumaien WA, Al-Abbad MT, Al-Ali AH, Alammar ZA, Alsuqair H, Albeladi AM, Alsuwaigh A, Omrani A, Almuhanna MM, Busbaih Z, Al-Shaban HR, Aldhameen AA | Cureus | 2022 |
| An Interesting and Rare Case of Hemoglobin D-Punjab Variant in Tamil Nadu. | Spandana R, Panneerselvam K, Mani S, Krishnamoorthy N | Cureus | 2022 |
| Transcranial Doppler sonography and the effect of haematopoietic stem cell transplantation in sickle cell disease. | Thurn S, Kleinschmidt K, Kovacic I, Wendl C, Linker RA, Corbacioglu S, Schlachetzki F | Neurol Res Pract | 2022 |
| Spinal cord compression: An unusual sequela of sickle cell disease. | Shekar M, Casini G, Donoho D, Mohila C, Kim TO, Fasipe T, Porea T | Pediatr Blood Cancer | 2022 |
| Regional anesthesia for sickle cell disease vaso-occlusive crisis: A single-center case series. | Karsenty C, Tubman VN, Liu CJ, Fasipe T, Wyatt KEK | Pediatr Blood Cancer | 2022 |
| Healthcare utilization and the quality of life of children and adolescents with sickle cell disease. | Moody KL | Pediatr Blood Cancer | 2022 |
| Impact of hydroxyurea dose and adherence on hematologic outcomes for children with sickle cell anemia. | Creary SE, Beeman C, Stanek J, King K, McGann PT, O'Brien SH, Liem RI, Holl J, Badawy SM | Pediatr Blood Cancer | 2022 |
| Essential thrombocythemia complicating hemoglobin SC disease and presenting with priapism. | Nwogbo OV, Loghavi S | Blood | 2022 |
| β-Thalassemia Intermedia: Interaction of α-Globin Gene Triplication With β-thalassemia Heterozygous in Spain. | Ropero P, González Fernández FA, Nieto JM, Torres-Jiménez WM, Benavente C | Front Med (Lausanne) | 2022 |
| Bacteraemia and Septic Arthritis in a Sickle Cell Disease Patient. | Alqurashi M, Madani B, Mursi M, Eltayeb N | Eur J Case Rep Intern Med | 2022 |
| Favorable outcomes of patients with sickle cell disease hospitalized due to COVID-19: A report of three cases. | Tentolouris A, Stafylidis C, Siafarikas C, Dimopoulou MN, Makrodimitri S, Bousi S, Papalexis P, Damaskos C, Trakas N, Sklapani P, Spandidos DA, Epameinondas Georgakopoulou V | Exp Ther Med | 2022 |
| Outcome of Hydroxyurea Use in SCD and Evaluation of Patients' Perception and Experience in Nigeria. | Chianumba RI, Ofakunrin AOD, Morrice J, Olanrewaju O, Oniyangi O, Kuliya-Gwarzo A, Nnebe-Agumadu U, Isa HA, Nnodu OE | Front Genet | 2022 |
| Strategies to increase access to basic sickle cell disease care in low- and middle-income countries. | Dua M, Bello-Manga H, Carroll YM, Galadanci AA, Ibrahim UA, King AA, Olanrewaju A, Estepp JH | Expert Rev Hematol | 2022 |
| Molecular spectrum of thalassemia in tropical Hainan Island of southern China：high allele frequency with low health burden. | Lai Y, Tao F, Zou Y, Huang M, Lin K, Li Y, Huang W, Zhou W | J Genet Genomics | 2022 |
| Unstable hemoglobin Montreal II uncovered in an adult with unexplained hemolysis exacerbated by a presumed viral infection: a case report. | Medri C, Méndez A, Hammerer-Lercher A, Rovó A, Angelillo-Scherrer A | J Med Case Rep | 2022 |
| Successful haploidentical hematopoietic stem cell transplantation (HSCT) and durable engraftment by repeated donor lymphocyte infusions for a Chinese patient with transfusion-dependent hemoglobin (Hb) Hammersmith and massive splenomegaly. | Chan WYK, Chan NCN, So JCC, Lee PPW, Cheuk DKL, Ha SY, Chan GCF, Leung W | Pediatr Transplant | 2022 |
| Adjuvant low-dose ketamine for paediatric and young adult sickle cell vaso-occlusive episodes in the emergency department. | Cooper-Sood JB, Hagar W, Marsh A, Hoppe C, Agrawal AK | Br J Haematol | 2022 |
| [Thalassemia Gene Detection Results and Application Value of Hematological Indexes Among Pregnant Women in Xindu District of Chengdu City]. | Zhou XP, Liu T, Huang YS | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| [Comparision of Allogeneic Hematopoietic Stem Cell Transplantation between Children with Thalassemia of Different Ages]. | Kang DL, Tan YH, Chen YM, Lu JY, Shi J, Yan XZ, Lu QY | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| [The Clinical Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation by Using Parental Donors in Patients with Thalassemia]. | Ou HB, Lin JZ, Hong XL, Lu JY, Lu QY | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| [Clinical Diagnosis and Prenatal Screening of Hb Lepore-BW Associated with IVS-II-654 Heterozygous Mutation]. | Bai HL, Cheng W, Cui J, Li R, Li Y, Xiao J, Zhang YH | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| Zinc in sickle cell disease: A narrative review. | Miranda CTOF, Vermeulen-Serpa KM, Pedro ACC, Brandão-Neto J, Vale SHL, Figueiredo MS | J Trace Elem Med Biol | 2022 |
| Assessing Cerebrovascular Resistance in Patients With Sickle Cell Disease. | Sayin ES, Sobczyk O, Poublanc J, Mikulis DJ, Fisher JA, Kuo KHM, Duffin J | Front Physiol | 2022 |
| and Studies for the Investigation of γ-Globin Gene Induction by : A Pre-Clinical Study of HbF Inducers for β-Thalassemia. | Iftikhar F, Rahman S, Khan MBN, Khan K, Khan MN, Uddin R, Musharraf SG | Front Pharmacol | 2022 |
| Blood Component Requirements and Erythrocyte Transfusion and Mortality Related to Hemoglobin Deficit in Phase III Trial of Hemoglobin-Based Oxygen Carrier: HBOC-201. | Jahr JS, Williams JP | Am J Ther | 2022 |
| DNA testing for sickle cell anemia in Africa: Implementation choices for the Democratic Republic of Congo. | Ngole M, Race V, Mbayabo G, Lumbala P, Songo C, Lukusa PT, Devriendt K, Matthijs G, Lumaka A | J Clin Lab Anal | 2022 |
| How Would You Treat This Patient With Acute and Chronic Pain From Sickle Cell Disease? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center. | Kanjee Z, Achebe MO, Smith WR, Burns RB | Ann Intern Med | 2022 |
| Hb New York, preliminary results concerning the hematologic characteristics and the effects on thalassemia. | Cheng Z, Zhu X, Zeng D, Feng Q, Tian B, Zheng H, Tan S, Zhu C | Mol Biol Rep | 2022 |
| Arginine Therapy and Cardiopulmonary Hemodynamics in Hospitalized Children with Sickle Cell Anemia: A Prospective Double-Blinded Randomized Placebo-Controlled Trial. | Onalo R, Cilliers A, Cooper P, Morris CR | Am J Respir Crit Care Med | 2022 |
| Validation of single-gene noninvasive prenatal testing for sickle cell disease. | Westin ER, Tsao DS, Atay O, Landry BP, Ye PP, Chandler-Brown D, Alford B, Hoskovec J, Subramaniam A, Pawlik KM, Kuper SG, Goldman FD, Townes TM, Sheehan VA | Am J Hematol | 2022 |
| A decade of molecular preimplantation genetic diagnosis of 350 blastomeres for beta-thalassemia combined with HLA typing, aneuploidy screening and sex selection in Iran. | Keshvar Y, Sabeghi S, Sharifi Z, Fatemi KS, Fouladi P, Younesi Khah S, Rahiminejad F, Joudaki A, Amini M, Bagherian H, Ghaffari Novin M, Movahedin M, Mojbafan M, Zeinali S | BMC Pregnancy Childbirth | 2022 |
| Attitudes and practices of unmarried adults towards sickle cell disease: emergent factors from a cross sectional study in Nigeria's capital. | Adigwe OP, Onavbavba G, Onoja SO | Hematology | 2022 |
| Hemoglobinopathies and preimplantation diagnostics. | Mamas T, Kakourou G, Vrettou C, Traeger-Synodinos J | Int J Lab Hematol | 2022 |
| Translational control by heme-regulated elF2α kinase during erythropoiesis. | Chen JJ, Zhang S | Curr Opin Hematol | 2022 |
| Clinical profile of sickle cell disease in children treated at | Bianga VF, Nangunia M, Oponjo FM, Itongwa JM, Mushubusha JI, Colombe MM, Walemba CM, Wembonyama O | Pan Afr Med J | 2022 |
| Distribution of HbS Allele and Haplotypes in a Multi-Ethnic Population of Guinea Bissau, West Africa: Implications for Public Health Screening. | Martella M, Campeggio M, Pulè G, Wonkam A, Menzato F, Munaretto V, Viola G, Da Costa SP, Reggiani G, Araujo A, Cumbà D, Liotta G, Sainati L, Riccardi F, Colombatti R | Front Pediatr | 2022 |
| Incidental Detection of Hemoglobin Variants During Evaluation of HbA1c. | Kulkarni JD, Shivashanker S | Indian J Clin Biochem | 2022 |
| Evaluation of Paper-Based Point of Care Screening Test for Sickle Cell Disease. | Kumar R, Mishra S, Gwal A, Shanmugam R | Indian J Clin Biochem | 2022 |
| Sickle Cell Trait and Risks for Common Diseases: Evidence from the UK Biobank. | Hulsizer J, Resurreccion WK, Shi Z, Wei J, Ladson-Gary S, Zheng SL, Helfand BT, Billings L, Caplan MS, Xu J | Am J Med | 2022 |
| Real-World Data On Voxelotor To Treat Patients With Sickle Cell Disease. | Muschick K, Fuqua T, Stoker-Postier C, Anderson AR | Eur J Haematol | 2022 |
| Left atrial deformation indices in β-thalassemia major patients. | Patsourakos D, Aggeli C, Gatzoulis KA, Delicou S, Dimitroglou Y, Xydaki K, Fragodimitri C, Androulakis A, Tsioufis K | Ann Hematol | 2022 |
| Hepatitis C virus (HCV) infection among patients with sickle cell disease at the Korle-Bu teaching hospital. | Mawuli G, Dzudzor B, Tachi K, Kuma AAB, Odame-Aboagye J, Obeng BM, Boateng AT, Edu-Quansah EP, Attiku KO, Agbosu E, Arjarquah A, Bonney JHK | Virol J | 2022 |
| Isolation and Characterisation of Quercitrin as a Potent Anti-Sickle Cell Anaemia Agent from . | Adeniyi O, Baptista R, Bhowmick S, Cookson A, Nash RJ, Winters A, Shen J, Mur LAJ | J Clin Med | 2022 |
| Global Globin Network Consensus Paper: Classification and Stratified Roadmaps for Improved Thalassaemia Care and Prevention in 32 Countries. | Halim-Fikri BH, Lederer CW, Baig AA, Mat-Ghani SNA, Syed-Hassan SR, Yusof W, Abdul Rashid D, Azman NF, Fucharoen S, Panigoro R, Silao CLT, Viprakasit V, Jalil N, Mohd Yasin N, Bahar R, Selvaratnam V, Mohamad N, Nik Hassan NN, Esa E, Krause A, Robinson H, Hasler J, Stephanou C, Raja-Sabudin RZ, Elion J, El-Kamah G, Coviello D, Yusoff N, Abdul Latiff Z, Arnold C, Burn J, Kountouris P, Kleanthous M, Ramesar R, Zilfalil BA, On Behalf Of The Global Globin Network Ggn | J Pers Med | 2022 |
| Motivators and Barriers to Physical Activity among Youth with Sickle Cell Disease: Brief Review. | Olorunyomi OO, Liem RI, Hsu LL | Children (Basel) | 2022 |
| Hemoglobin Oxidation Reactions in Stored Blood. | Alayash AI | Antioxidants (Basel) | 2022 |
| Prevalence of transfusion-transmitted infections in multiple blood transfusion-dependent thalassemic patients in Asia: A systemic review. | Riaz M, Abbas M, Rasool G, Baig IS, Mahmood Z, Munir N, Mahmood Tahir I, Ali Shah SM, Akram M | Int J Immunopathol Pharmacol | 2022 |
| Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years. | Estepp JH, Kalpatthi R, Woods G, Trompeter S, Liem RI, Sims K, Inati A, Inusa BPD, Campbell A, Piccone C, Abboud MR, Smith-Whitley K, Dixon S, Tonda M, Washington C, Griffin NM, Brown C | Pediatr Blood Cancer | 2022 |
| Sickle cell disease and fat embolism: a rare complication of vaso-occlusive crisis. | Filippatou AG, Naveed M, Barry DP, Deboer SR, Haas CJ | Pract Neurol | 2022 |
| Red Cell Alloimmunization and Autoimmunization Among Sickle Cell Disease and Thalassemia Patients in Jazan Province, Saudi Arabia. | Halawani AJ, Mobarki AA, Arjan AH, Saboor M, Hamali HA, Dobie G, Alsharif KF | Int J Gen Med | 2022 |
| Microcytic Anemia: An Insidious Presentation of Sickle Cell Beta+ Thalassemia, a Rare Sickle Cell Variant. | Shankar M, Gousy N, Chowdhury T | Cureus | 2022 |
| Outcomes of Patients With Sickle Cell Disease and Trait After Congenital Heart Disease Surgery. | Misra A, Halas R, Kobayashi D, Walters HL, Bondarenko I, Thomas R, Vener DF, Aggarwal S, Safa R | Ann Thorac Surg | 2022 |
| Loop-mediated isothermal amplification (LAMP) colorimetric phenol red assay for rapid identification of α0-thalassemia: Application to population screening and prenatal diagnosis. | Jomoui W, Srivorakun H, Chansai S, Fucharoen S | PLoS One | 2022 |
| Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease. | Johnson KM, Jiao B, Bender MA, Ramsey SD, Devine B, Basu A | PLoS One | 2022 |
| Extinguishing the fire in sickle cell anemia. | Novelli EM | Blood | 2022 |
| Pulmonary Dysfunction in Transfusion-Dependent Thalassemia and Response to Intensive Chelation Therapy. | Panwar N, Gomber S, Dewan P, Kumar R | Indian Pediatr | 2022 |
| Pulmonary Function in Children with Transfusion-Dependent Thalassemia and Its Correlation with Iron Overload. | Baruah A, Bhattacharjee J | Indian Pediatr | 2022 |
| Prevalence of Hemoglobin-S and Baseline Level of Knowledge on Sickle Cell Disease Among Pregnant Women Attending Antenatal Clinics in Dar-Es-Salaam, Tanzania. | Tutuba HJ, Jonathan A, Lloyd W, Luoga F, Marco E, Ndunguru J, Kidenya BR, Makani J, Ruggajo P, Minja IK, Balandya E | Front Genet | 2022 |
| Automating Pitted Red Blood Cell Counts Using Deep Neural Network Analysis: A New Method for Measuring Splenic Function in Sickle Cell Anaemia. | Nardo-Marino A, Braunstein TH, Petersen J, Brewin JN, Mottelson MN, Williams TN, Kurtzhals JAL, Rees DC, Glenthøj A | Front Physiol | 2022 |
| Human Hemoglobin S Erythrocyte-Stabilizing and Antisickling Potential of Extract of Wood Ear Mushroom, Auricularia auricula (Agaricomycetes). | Ohiri RC, Odey OP | Int J Med Mushrooms | 2022 |
| Does size matter? Two new deletions in the HBB gene cause β-thalassemia. | Ropero P, González Fernández FA, Nieto JM, Recasens V, Montañés Á, Murúzabal MJ, Sarasa M, Fernández C, Villegas A, Benavente CC | Ann Hematol | 2022 |
| Out Of Pocket Expenditure On Thalassemia Major And Its Implications On The Household Economics. | Qamar MK, Shaikh BT | J Ayub Med Coll Abbottabad | 2022 |
| Knowledge and attitude of Engaged and Recently Married Couples Toward Premarital Screening: A Cross-Sectional Study. | Almoliky MA, Abdulrhman H, Safe SH, Galal M, Abdu H, Towfiq B, Abdullah S, Waleed M, Sultan MA | Inquiry | 2022 |
| Modifying priming techniques in cardiopulmonary bypass circuit in known case of sickle-cell trait undergoing open heart surgery. | Bishnoi S, Yadav P, Shah P | Perfusion | 2022 |
| Structural origin of cooperativity in human hemoglobin: a view from different roles of α and β subunits in the αβ tetramer. | Nagatomo S, Nagai M, Kitagawa T | Biophys Rev | 2022 |
| Development of a double shmiR lentivirus effectively targeting both BCL11A and ZNF410 for enhanced induction of fetal hemoglobin to treat β-hemoglobinopathies. | Liu B, Brendel C, Vinjamur DS, Zhou Y, Harris C, McGuinness M, Manis JP, Bauer DE, Xu H, Williams DA | Mol Ther | 2022 |
| Impact of Ketamine in the Management of Painful Sickle Cell Disease Vaso-Occlusive Crisis. | Froomkin J, Knoebel RW, Dickerson D, Soni H, Szwak J | Hosp Pharm | 2022 |
| [HemoTypeSC screening for sickle cell disease in the Democratic Republic of Congo (DRC): a case from the city of Kindu]. | Aimé AK, Etienne SM, Mbongi D, Nsonso D, Serrao E, Léon TMM, Oscar LN, Stanis WO | Pan Afr Med J | 2022 |
| Genome Engineering of Hematopoietic Stem Cells Using CRISPR/Cas9 System. | Devaraju N, Rajendiran V, Ravi NS, Mohankumar KM | Methods Mol Biol | 2022 |
| [Sickle cell retinopathy]. | Budnikova V, Rougier MB, Korobelnik JF, Delyfer MN, Gattoussi S | J Fr Ophtalmol | 2022 |
| Sickle cell disease prevention: How prepared are the senior secondary school students in Surulere Local Government Area, Lagos, Nigeria? | Kanma-Okafor OJ, Abolarinwa AO, Ojo OY, Ekanem EE | Afr J Prim Health Care Fam Med | 2022 |
| The Diagnosis and Management of Recurrent Ischemic Priapism, Priapism in Sickle Cell Patients, and Non-ischemic Priapism: An AUA/SMSNA Guideline. | Bivalacqua TJ, Allen BK, Brock GB, Broderick GA, Chou R, Kohler TS, Mulhall JP, Oristaglio J, Rahimi LL, Rogers ZR, Terlecki RP, Trost L, Yafi FA, Bennett NE | J Urol | 2022 |
| Mutations in Thalassemia Carrier Couples: The Importance of Prenatal Diagnostic Tests. | Kiani AA, Mohamadinejad M, Shokrgozar N, Abbasian S | Clin Lab | 2022 |
| Understanding the roots of mistrust in medicine: Learning from the example of sickle cell disease. | LaMotte JE, Hills GD, Henry K, Jacob SA | J Hosp Med | 2022 |
| Expression, functional mechanism and therapy application of long noncoding RNA in thalassemia. | Pan Y, Xu L, Huang H | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2022 |
| The Unique Magnetic Signature of Sickle Red Blood Cells: A Comparison Between the Red Blood Cells of Transfused and Non-Transfused Sickle Cell Disease Patients and Healthy Donors. | Weigand M, Gomez-Pastora J, Strayer J, Wu X, Choe H, Lu S, Plencner E, Landes K, Palmer A, Zborowski M, Desai P, Chalmers J | IEEE Trans Biomed Eng | 2022 |
| Diagnostic challenges posed by a rare unstable hemoglobin variant Hb Southampton [HBB: c.320T → C] with pyrimidine 5' nucleotidase deficiency and the response to HU therapy. | Gorivale M, Hariharan P, Kargutkar N, Mehta P, Sawant P, Nadkarni A | Blood Cells Mol Dis | 2022 |
| Analysis of circRNAs and circRNA-associated competing endogenous RNA networks in β-thalassemia. | Yang F, Ruan H, Li S, Hou W, Qiu Y, Deng L, Su S, Chen P, Pang L, Lai K | Sci Rep | 2022 |
| A Phase 1 Dose Escalation Study of the Pyruvate Kinase Activator Mitapivat (AG-348) in Sickle Cell Disease. | Xu JZ, Conrey AK, Frey IC, Gwaabe E, Menapace LA, Tumburu L, Lundt M, Lequang T, Li Q, Glass KE, Dunkelberger EB, Iyer V, Mangus H, Kung C, Dang L, Kosinski PA, Hawkins P, Jeffries N, Eaton WA, Thein SL | Blood | 2022 |
| Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance. | Johnson KM, Jiao B, Ramsey SD, Bender MA, Devine B, Basu A | Blood Adv | 2022 |
| A Triple-Heterozygous β-Thalassemia Patient Demonstrated an Unusual Electrophoresis Pattern Due to a Novel β Mutation [an IVS-II-654 (C>T) mutation with a Hb Zürich-Langstrasse (: c.151A>T) mutation ]. | Liao J, Li Q, Ling LQ, Liu CN, Huang XB, Zhou J | Hemoglobin | 2022 |
| Development and Validation of The Sickle Cell Stress Scale-Adult. | Smith WR, McClish DK, Bovbjerg VE, Singh HK | Eur J Haematol | 2022 |
| Sickle cell disease: an update. | Conway O'Brien E, Ali S, Chevassut T | Clin Med (Lond) | 2022 |
| How to approach haemolysis: Haemolytic anaemia for the general physician. | Palmer D, Seviar D | Clin Med (Lond) | 2022 |
| Polymorphisms and avascular necrosis in patients with sickle cell disease - A systematic review. | Leandro MP, Almeida ND, Hocevar LS, Sá CKC, Souza AJ, Matos MA | Rev Paul Pediatr | 2022 |
| Identification of a Novel Hb H Disease with Glucose-6-Phosphate Dehydrogenase Deficiency Using Whole Genome Sequencing. | Ren ZM, Xing ZH, Chen SL, Fu XY, Chen YS, Li DF | Hemoglobin | 2022 |
| Iron Chelation Therapy With Deferasirox in Sickle Cell Disease With End-Stage Renal Disease. | Raj A, McGowan K, Knapp E, Zhao J, Shah S | Cureus | 2022 |
| Stroke in sickle cell disease in association with bilateral absence of the internal carotid arteries. Case report. | Markovic I, Milenkovic Z, Jocic-Jakubi B, Futaisi AA, Kakaria KA, Walli Y | BMC Neurol | 2022 |
| Rare paediatric case of agenesis of the vermiform appendix, ileal duplication and sickle cell disease. | Laezza N, Gião N, Borges C, Knoblich M | BMJ Case Rep | 2022 |
| Hb Westport [β121 (GH4) Glu>Asp; HBB:c.366A>C]: A novel β-globin variant interfering with HbA1c measurement. | Moore JA, Li BV, Wang D, Chan B, King RI, Florkowski CM | Clin Biochem | 2022 |
| Procalcitonin as a diagnostic marker for infection in sickle cell disease. | Maharaj S, Chang S | Expert Rev Hematol | 2022 |
| Polisomographic Investigation of Sleep Disorders in Patients with Sickle Cell Anemia and Evaluation of the Effect on the Prognosis. | Dikmen N, Okuyucu EE, Güntel M, Uçar E, İlhan G, Babayiğit C, Karadağ M | Turk Thorac J | 2022 |
| IVS I-5 (G > C) is associated with changes to the RBC membrane lipidome in response to hydroxyurea treatment in β-thalassemia patients. | Khan MBN, Iftikhar F, Khan T, Danish A, Shamsi T, Musharraf SG, Siddiqui AJ | Mol Omics | 2022 |
| Hematological Parameters in Individuals with Beta Thalassemia Trait in South Sumatra, Indonesia. | Sari DP, Wahidiyat PA, Setianingsih I, Timan IS, Gatot D, Kekalih A | Anemia | 2022 |
| HLA-E*01:01 allele is associated with better response to anti-HCV therapy while homozygous status for HLA-E*01:03 allele increases the resistance to anti-HCV treatments in frequently transfused thalassemia patients. | Hosseini E, Sarraf Kazerooni E, Azarkeivan A, Sharifi Z, Shahabi M, Ghasemzadeh M | Hum Immunol | 2022 |
| Validation of Patient-reported Vaso-occlusive Crisis Day as an Endpoint in Sickle Cell Disease Studies. | Coyne KS, Currie BM, Callaghan M, Wyrwich KW, Pease S, Baker CL, Arkin S, Pittman DD | Eur J Haematol | 2022 |
| L-glutamine for sickle cell disease: more than reducing redox. | Jafri F, Seong G, Jang T, Cimpeanu E, Poplawska M, Dutta D, Lim SH | Ann Hematol | 2022 |
| Hepato-splenic abscesses in a sickle cell disease patient. | Le Monnier O, Joseph L, Bodard S, Boudhabhay I | Am J Hematol | 2022 |
| Fertility after Curative Therapy for Sickle Cell Disease: A Comprehensive Review to Guide Care. | Nickel RS, Maher JY, Hsieh MH, Davis MF, Hsieh MM, Pecker LH | J Clin Med | 2022 |
| Epidemiologic Trends of Thalassemia, 2006-2018: A Nationwide Population-Based Study. | Lee JS, Rhee TM, Jeon K, Cho Y, Lee SW, Han KD, Seong MW, Park SS, Lee YK | J Clin Med | 2022 |
| Prime Editor 3 Mediated Beta-Thalassemia Mutations of the Gene in Human Erythroid Progenitor Cells. | Zhang H, Zhou Q, Chen H, Lu D | Int J Mol Sci | 2022 |
| Translation, cross-cultural adaptation and validation of the sickle cell self-efficacy scale (SCSES). | de Sousa IA, Reis IA, Pagano AS, Telfair J, Torres HC | Hematol Transfus Cell Ther | 2022 |
| Unstable hemoglobin Bicêtre, NM_000518.4(HBB):C.191A>C (p.His64Pro), with slightly decreased P50 and no polycythemia after splenectomy. | Sakamoto A, Nakadate H, Iguchi A, Tsumura Y, Tsuruta T, Yamashiro Y, Hattori Y, Ishiguro A | Pediatr Blood Cancer | 2022 |
| Limited value of the D-dimer based YEARS algorithm to rule out pulmonary embolism in sickle cell disease and sickle cell trait. | Gaartman AE, Strijdhorst A, van Es N, Tang MW, Heijmans J, Biemond BJ, Nur E, | Br J Haematol | 2022 |
| Manifestations of Sickle Cell Disorder at Abdominal and Pelvic Imaging. | Solomon N, Segaran N, Badawy M, Elsayes KM, Pellerito JS, Katz DS, Moshiri M, Revzin MV | Radiographics | 2022 |
| High-Throughput Assay to Screen Small Molecules for Their Ability to Prevent Sickling of Red Blood Cells. | Nakagawa A, Cooper MK, Kost-Alimova M, Berstler J, Yu B, Berra L, Klings ES, Huang MS, Heeney MM, Bloch DB, Zapol WM | ACS Omega | 2022 |
| Evaluation of Individualized Pain Plans for Children With Sickle Cell Disease Admitted for Vaso-occlusive Crisis at Riley Hospital for Children. | Arends AM, Perez A, Wilder C, Jacob SA | J Pediatr Pharmacol Ther | 2022 |
| First Experience in Living Liver Donation From Donors With Sickle Cell Trait. | Schulze M, Zidan A, Sturdevant M, Aljudaibi S, Shagrani M, Bzeizi K, Alqahtani S, Broering DC | Transplant Direct | 2022 |
| The Sickle Cell Pain Action Plan: A low health literacy, pictographic tool to enhance self-management, and guideline concordance. | Reeves PT, Rogers PL, Hipp SJ, Zanetti RC, Echelmeyer S, Rees DJ, Parekh DS | Pediatr Blood Cancer | 2022 |
| Korean clinical practice guidelines for the diagnosis of hereditary hemolytic anemia. | Chueh HW, Hwang SM, Shim YJ, Lee JM, Park HS, Lee JH, Nam Y, Kim N, Jung HL, Choi HS, | Blood Res | 2022 |
| Testosterone Deficiency in Sickle Cell Disease: Recognition and Remediation. | Musicki B, Burnett AL | Front Endocrinol (Lausanne) | 2022 |
| A Case of Congenital Methemoglobinemia: Rare but Real. | Paudel S, Adhikari N, Mandal S, Srivatana P | Cureus | 2022 |
| Individual Watershed Areas in Sickle Cell Anemia: An Arterial Spin Labeling Study. | Stotesbury H, Hales PW, Hood AM, Koelbel M, Kawadler JM, Saunders DE, Sahota S, Rees DC, Wilkey O, Layton M, Pelidis M, Inusa BPD, Howard J, Chakravorty S, Clark CA, Kirkham FJ | Front Physiol | 2022 |
| A rapid evidence assessment of sickle cell disease educational interventions. | Oti AE, Heyes K, Bruce F, Wilmott D | J Clin Nurs | 2022 |
| Sickle cell disorder-it's time to level up. | Gbangbola K | Med (N Y) | 2022 |
| Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab. | Fuja C, Kothary V, Carll TC, Singh S, Mansfield P, Wool GD | Transfusion | 2022 |
| Revisiting anemia in sickle cell disease and finding the balance with therapeutic approaches. | Xu JZ, Thein SL | Blood | 2022 |
| From Mendel to a Mendelian disorder: towards a cure for sickle cell disease. | Makani J, Nkya S, Collins F, Luzzatto L | Nat Rev Genet | 2022 |
| Influence of hydroxyurea on the severity of acute chest syndrome in patients with sickle cell disease. | González-Pérez C, Gómez-Carpintero García A, Cervera Bravo Á | An Pediatr (Engl Ed) | 2022 |
| Rapid degradation of protein tyrosine phosphatase 1B in sickle cells: Possible contribution to sickle cell membrane weakening. | Noomuna P, Hausman JM, Sansoya R, Kalfa T, Risinger M, Low PS | FASEB J | 2022 |
| Emotional reaction to pain as predictor of depression among selected Nigerians living with sickle cell disease in Ile-Ife. | Olasupo MO, Fagbenro DA, Oluwagbamila B, Olasupo MG | Psychol Health Med | 2022 |
| Prevalence and characteristics of inflammatory rheumatic diseases in patients with thalassemia. | Piriyakhuntorn P, Tantiworawit A, Kasitanon N, Louthrenoo W | Ann Hematol | 2022 |
| Value of a cure for sickle cell disease in reducing economic disparities. | Graf M, Tuly R, Gallagher M, Sullivan J, Jena AB | Am J Hematol | 2022 |
| A New Case of Hb Headington (: c.217A>C) Due to a New DNA Transversion, Found in a Patient with Type 2 Diabetes Mellitus. | Liu Y, Liu B, Qiao YC, Niu WY | Hemoglobin | 2022 |
| Kidney Transplantation in Sickle Cell Disease Patients: Case Series and Experience from a Nigerian Kidney Transplant Center. | Igbokwe M, Olatise O, Faponle A, Aremu A, Revanur V, Jiwoh H, Obajolowo O, Ameh I | Indian J Nephrol | 2022 |
| Acute chest syndrome and COVID-19 in hydroxyurea naïve sickle cell disease patient in a low resource setting. | Mawalla WF, Nasser A, Jingu JS, Joseph H, Mmbaga LG, Shija E, Kakumbula H, Lubuva NB, Meda C, Chamba C | EJHaem | 2022 |
| A Smart Chatbot for Interactive Management in Beta Thalassemia Patients. | Alturaiki AM, Banjar HR, Barefah AS, Alnajjar SA, Hindawi S | Int J Telemed Appl | 2022 |
| Case Report: Abnormally Low Glycosylated Hemoglobin A1c Caused by Clinically Silent Rare β-Thalassemia in a Tujia Chinese Woman. | Gao W, Jin Y, Wang M, Huang Y, Tang H | Front Endocrinol (Lausanne) | 2022 |
| Cerebral Vasculopathy in Children With Sickle Cell Disease in an Amazonian Population. | Alcolumbre Tobelem FL, de Andrade GALR, Paschoal JKSF, de Oliveira Cardoso MDS, Sarmento Trindade SM, Paschoal EHA, Paschoal-Jr FM, Bor-Seng-Shu E | J Child Neurol | 2022 |
| A feasibility study of risk prediction modelling for vasoocclusive crisis in children with sickle cell disease. | Şengül MT, Taşdelen B, Ünal S, Akbey V | Turk J Pediatr | 2022 |
| Effects of Senegal haplotype (-rs7412844), alpha-thalassemia (3.7kb deletion), -rs11248850 and -rs4671393 variants on sickle cell nephropathy. | Ndour EHM, Mnika K, Guèye Tall F, Seck M, Dème Ly I, Nembaware V, Sagna-Bassène HAT, Dione R, Ndongo AA, Diop JPD, Barry NOK, Djité M, Ndiaye Diallo R, Guèye PM, Diop S, Diagne I, Cissé A, Wonkam A, Lopez Sall P | Int J Biochem Mol Biol | 2022 |
| Induction of Fetal Hemoglobin by Introducing Natural Hereditary Persistence of Fetal Hemoglobin Mutations in the γ-Globin Gene Promoters for Genome Editing Therapies for β-Thalassemia. | Lu D, Xu Z, Peng Z, Yang Y, Song B, Xiong Z, Ma Z, Guan H, Chen B, Nakamura Y, Zeng J, Liu N, Sun X, Chen D | Front Genet | 2022 |
| An overview of sickle cell disease from the socio-demographic triangle - a Nigerian single-institution retrospective study. | Nwabuko OC, Onwuchekwa U, Iheji O | Pan Afr Med J | 2022 |
| Sickle cell disease: a year in review. | The Lancet Haematology | Lancet Haematol | 2022 |
| The successful strategy of comprehensive pre-implantation genetic testing for beta-thalassaemia-haemoglobin E disease and chromosome balance using karyomapping. | Piyamongkol S, Mongkolchaipak S, Charoenkwan P, Sirapat R, Suriya W, Pantasri T, Tongsong T, Piyamongkol W | J Obstet Gynaecol | 2022 |
| Resveratrol-nitric oxide donor hybrid effect on priapism in sickle cell and nitric oxide-deficient mouse. | Pinheiro AK, Pereira DA, Dos Santos JL, Calmasini FB, Alexandre EC, Reis LO, Burnett AL, Costa FF, Silva FH | PLoS One | 2022 |
| Bone mineral density in primarily preadolescent children with hemoglobin E/β-thalassemia with different severities and transfusion requirements. | Nakavachara P, Weerakulwattana P, Pooliam J, Viprakasit V | Pediatr Blood Cancer | 2022 |
| Optimized Droplet Digital PCR Assay on Cell-Free DNA Samples for Non-Invasive Prenatal Diagnosis: Application to Beta-Thalassemia. | Constantinou CG, Karitzi E, Byrou S, Stephanou C, Michailidou K, Makariou C, Hadjilambi G, Christofides A, Kleanthous M, Papasavva T | Clin Chem | 2022 |
| The mutual crosstalk between iron and erythropoiesis. | Camaschella C, Pagani A, Silvestri L, Nai A | Int J Hematol | 2022 |
| Dual function NFI factors control fetal hemoglobin silencing in adult erythroid cells. | Qin K, Huang P, Feng R, Keller CA, Peslak SA, Khandros E, Saari MS, Lan X, Mayuranathan T, Doerfler PA, Abdulmalik O, Giardine B, Chou ST, Shi J, Hardison RC, Weiss MJ, Blobel GA | Nat Genet | 2022 |
| Tenofovir disoproxil fumarate-mediated γ-globin induction is correlated with the suppression of trans-acting factors in CD34 progenitor cells: A role in the reactivation of fetal hemoglobin. | Khan F, Ali H, Musharraf SG | Eur J Pharmacol | 2022 |
| The effect of sickle cell genotype on the pharmacokinetic properties of artemether-lumefantrine in Tanzanian children. | Sugiarto SR, Bwire GM, Moore BR, Page-Sharp M, Manning L, Batty KT, Minzi OMS, Ngasala B, Davis TME, Makani J, Salman S | Int J Parasitol Drugs Drug Resist | 2022 |
| Does glucose-6-phosphate dehydrogenase deficiency worsen the clinical features of sickle cell disease? A multi-hospital-based cross-sectional study. | Kambale-Kombi P, Marini Djang'eing'a R, Alworong'a Opara JP, Minon JM, Atoba Bokele C, Bours V, Azerad MA, Tonen-Wolyec S, Kayembe Tshilumba C, Batina-Agasa S | Hematology | 2022 |
| Venous thromboembolism prophylaxis in hospitalized sickle cell disease and sickle cell trait patients. | Ionescu F, Anusim N, Zimmer M, Jaiyesimi I | Eur J Haematol | 2022 |
| Hb Laibin [β96(FG3)Leu→Arg; : c.290T>G]: A Novel Hemoglobin Variant Described in a Chinese Family. | Huang YY, Huang J, Ye LH, Liang L, Li YQ | Hemoglobin | 2022 |
| Molecular heterogeneity of β-thalassemia variants in the Eastern region of Morocco. | Belmokhtar I, Lhousni S, Elidrissi Errahhali M, Ghanam A, Elidrissi Errahhali M, Sidqi Z, Ouarzane M, Charif M, Bellaoui M, Boulouiz R, Benajiba N | Mol Genet Genomic Med | 2022 |
| Pain mechanisms in sickle cell disease. Are we closer to a breakthrough? | Conran N | Haematologica | 2022 |
| Inhibition of DAGLβ as a therapeutic target for pain in sickle cell disease. | Khasabova IA, Gable J, Johns M, Khasabov SG, Kalyuzhny AE, Golovko MY, Golovko SA, Kiven S, Gupta K, Seybold VS, Simone DA | Haematologica | 2022 |
| Impact of Superoxide Dismutase Genetic Polymorphism (SOD2 Val16Ala) and Superoxide Dismutase Level on Disease Severity in a Cohort of Egyptian Sickle Cell Disease Patients. | Khorshied MM, Shaheen IA, Selim YMM, Elshahawy AO, Youssry I | Mediterr J Hematol Infect Dis | 2022 |
| The Clinical Significance of the Spectrum of Interactions of the Rare IVS-II-5 G>C () Variation with Other β-Thalassemia Mutations in Southern China. | Liao G, Zhou Y, Yin X, He S, Wu Y, Xiao J, Geng Z, Huang Q, Luo G, Yang K | Mediterr J Hematol Infect Dis | 2022 |
| Mental health assessment of youth with sickle cell disease and their primary caregivers during the COVID-19 pandemic. | Green NS, Manwani D, Smith-Whitley K, Aygun B, Appiah-Kubi A, Smaldone AM | Pediatr Blood Cancer | 2022 |
| Symphysis morphology and mandibular alveolar bone thickness in patients with β-thalassemia major and different growth patterns. | Khojastepour L, Naderi A, Akbarizadeh F, Movahhedian N, Ahrari F | Dental Press J Orthod | 2022 |
| Emergency department visits and hospitalizations among patients with sickle cell disease in illinois, 2016-2020. | Barriteau CM, Feinglass J, Kayle M, VonAchen P, Liem RI, Badawy SM, Kan K | Pediatr Hematol Oncol | 2022 |
| Association of Beta-Thalassaemia and Hypogonadotropic Hypogonadism. | Vidal A, Dhakal C | Case Rep Obstet Gynecol | 2022 |
| Comparative evaluation of efficacy and safety of automated versus manual red cell exchange in sickle cell disease: A systematic review and meta-analysis. | Mukherjee S, Sahu A, Ray GK, Maiti R, Prakash S | Vox Sang | 2022 |
| Genotype and phenotype characteristics of homozygous and compound heterozygous β-thalassemia with 3.4 kb deletion. | Soontornpanawet C, Singha K, Fuchareon S | Int J Lab Hematol | 2022 |
| [Heavy metal! A case of severe iron overload and supraventricular arrhythmias in a thalassemia major patient]. | Marchini F, Fiorio A, Sirugo P, Gamberini MR, Mari E, Bertini M, Malagù M | G Ital Cardiol (Rome) | 2022 |
| Voxelotor for the treatment of sickle cell disease in pediatric patients. | Brown C, Tonda M, Abboud MR | Expert Rev Hematol | 2022 |
| Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease. | Moriconi C, Dzieciatkowska M, Roy M, D'Alessandro A, Roingeard P, Lee JY, Gibb DR, Tredicine M, McGill MA, Qiu A, La Carpia F, Francis RO, Hod EA, Thomas T, Picard M, Akpan IJ, Luckey CJ, Zimring JC, Spitalnik SL, Hudson KE | Br J Haematol | 2022 |
| Sex as an Independent Risk Factor for Venous Thromboembolism in Sickle Cell Disease: A Cross-Sectional Study. | Roe AH, McAllister A, Kete C, Pishko A, Whitworth H, Schreiber CA, Sayani FA | J Womens Health (Larchmt) | 2022 |
| Oxidative stress and associated clinical manifestations in malaria and sickle cell (HbSS) comorbidity. | Aninagyei E, Tettey CO, Kwansa-Bentum H, Boakye AA, Ghartey-Kwansah G, Boye A, Acheampong DO | PLoS One | 2022 |
| In transfusion-dependent thalassemia children, increased iron overload is associated with lower serum alpha-klotho, which is strongly associated with lower total and ionized calcium concentrations. | Moustafa SR, Al-Hakeim HK, Alhillawi ZH, Maes M | Curr Mol Med | 2022 |
| Epicatechin exerts dual action to shield sickling and hydroxyurea-induced myelosuppression: Implication in sickle cell anemia management. | Gour A, Kour D, Dogra A, Manhas D, Wazir P, Digra SK, Kumar A, Nandi U | Toxicol Appl Pharmacol | 2022 |
| Ulcerative colitis in patients with sickle cell disease: a rare but important co-morbidity. | Rankine-Mullings AE | Paediatr Int Child Health | 2022 |
| Thalassaemia. | Kattamis A, Kwiatkowski JL, Aydinok Y | Lancet | 2022 |
| Suboptimal vancomycin levels in critically ill children with sickle cell disease and acute chest syndrome. | Al-Eyadhy A, Al-Jelaify MR | J Infect Chemother | 2022 |
| [Gallstone complications in sickle cell patients]. | Rambaud E, Ranque B, Pouchot J, Arlet JB | Rev Med Interne | 2022 |
| Extramedullary haematopoiesis presenting as an adnexal mass in a patient with β-thalassaemia. | Filippi V, Reina H, Monod C, Manegold-Brauer G | BMJ Case Rep | 2022 |
| Prevalence of venous thromboembolism and its associations in a large racially homogenous population of sickle cell disease patients. | Okoye HC, Ezekekwu C, Nwagha TU, Korubo K, Omunakwe HE, Nnachi OC, Madu AJ, Nwogoh B, Efobi CC, Muoghalu EA, Nonyelu C, Okoye Ae AE, Obodo OI, Ugwu CS, Egolum MC, Nnachi OA, Okpala I | Eur J Haematol | 2022 |
| New therapeutics for children with sickle cell disease: A time for celebration, caution, or both? | Quinn CT, Ware RE | Pediatr Blood Cancer | 2022 |
| Relationship between pancreatic iron overload, glucose metabolism and cardiac complications in sickle cell disease: an Italian multicenter study. | Pistoia L, Meloni A, Allò M, Spasiano A, Messina G, Sorrentino F, Gamberini MR, Ermini A, Renne S, Fina P, Peritore G, Positano V, Pepe A, Cademartiri F | Eur J Haematol | 2022 |
| Promoting Adherence to Iron Chelation Treatment in Beta-Thalassemia Patients. | Eziefula C, Shah FT, Anie KA | Patient Prefer Adherence | 2022 |
| Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectives. | Aramayo-Singelmann C, Halimeh S, Proske P, Vignalingarajah A, Cario H, Christensen MO, Yamamoto R, Röth A, Reinhardt D, Reinhardt HC, Alashkar F | Sci Rep | 2022 |
| The association between sleep disturbances and neurocognitive function in pediatric sickle cell disease. | Tucker T, Alishlash AS, Lebensburger JD, Clay OJ, Oates GR, Nourani A, Bhatia S, Murdaugh DL | Sleep Med | 2022 |
| Longitudinal Study of Glomerular Hyperfiltration in Adults with Sickle Cell Anemia: A Multicenter Pooled Analysis. | Ataga KI, Zhou Q, Saraf SL, Hankins JS, Ciccone EJ, Loehr LR, Ashley-Koch AE, Garrett M, Cai J, Telen MJ, Derebail VK | Blood Adv | 2022 |
| A case of G6PD Utrecht associated with β-thalassemia responding to splenectomy. | Yang K, Liu X, Chen K, Luo S, Kong W, Huang W, Xiao J | Pediatr Blood Cancer | 2022 |
| Pulmonary Functions in Transfusion-Dependent Thalassemia. | Chandra J, Rohatgi S | Indian Pediatr | 2022 |
| Multi-organ Dysfunction Secondary to Abrupt Discontinuation of Voxelotor in a Patient with Severe Sickle Cell Disease. | Nagalapuram V, Kanter J | Am J Hematol | 2022 |
| SARS-CoV-2 omicron variant may present with severe sickle cell painful crisis: A report of two cases. | Ali E, Hatim A, Yassin M | Clin Case Rep | 2022 |
| Analysis of rare thalassemia genetic variants based on third-generation sequencing. | Peng C, Zhang H, Ren J, Chen H, Du Z, Zhao T, Mao A, Xu R, Lu Y, Wang H, Chen X, Liu S | Sci Rep | 2022 |
| One-step genotyping of α-thalassaemia by multiplex symmetric PCR melting curve. | Qin J, He J, Li Y, Liu N, Tao F, Zhang P, Guo W, Qin Q, Zhou W | J Clin Pathol | 2022 |
| Transitioning Adolescents With Sickle Cell Disease From Pediatric to Adult Care: Results From a New Survey of Health Care Professionals. | Shah NR, Treadwell MJ, Vichinsky E | J Pediatr Hematol Oncol | 2022 |
| Primary Prevention of Stroke in Children With Sickle Cell Anemia in Nigeria: Protocol for a Mixed Methods Implementation Study in a Community Hospital. | Bello-Manga H, Haliru L, Ahmed KA, Tabari AM, Farouk BU, Bahago GY, Kazaure AS, Muhammad AS, Gwarzo SA, Baumann AA, DeBaun MR, King AA | JMIR Res Protoc | 2022 |
| Iron overload disorders. | Hsu CC, Senussi NH, Fertrin KY, Kowdley KV | Hepatol Commun | 2022 |
| Novel Bis-phosphoglycerate Mutase Modulators for Treating Sickle Cell Disease. | Sabnis RW | ACS Med Chem Lett | 2022 |
| The Efficacy of Marijuana Use for Pain Relief in Adults With Sickle Cell Disease: A Systematic Review. | Paulsingh CN, Mohamed MB, Elhaj MS, Mohamed N, Ahmed TH, Singh T, Mohammed Z, Khan S | Cureus | 2022 |
| Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review. | Dick MH, Abdelgadir A, Kulkarni VV, Akram H, Chatterjee A, Pokhrel S, Khan S | Cureus | 2022 |
| Assessment of iron overload in a cohort of Sri Lankan patients with transfusion dependent beta thalassaemia and its correlation with pathogenic variants in HBB, HFE, SLC40A1, and TFR2 genes. | Dissanayake R, Samarasinghe N, Waidyanatha S, Pathirana S, Neththikumara N, Dissanayake VHW, Wetthasinghe K, Gooneratne L, Wickramasinghe P | BMC Pediatr | 2022 |
| Sickle cell disease in children: an update of the evidence for WHO guideline development. | Odame I | Arch Dis Child | 2022 |
| Aortic Intima Media Thickness is Increased and Closely Related to Elevated Oxidative Stress Increases in Beta Thalassemia Minor. | Tumer C, Saler T, Aslan MZ, Koc AS, Koc M, Erel O, Neselioglu S, Gulumsek E, Avci BS, Avci A, Sumbul HE | Arq Bras Cardiol | 2022 |
| Economic burden of sickle cell disease in Brazil. | Silva-Pinto AC, Costa FF, Gualandro SFM, Fonseca PBB, Grindler CM, Souza Filho HCR, Bueno CT, Cançado RD | PLoS One | 2022 |
| Uptake and usage of proguanil as malaria chemoprophylaxis and the socio-economic determinants of proguanil usage in children with sickle cell anemia in Benin City. | Enato IG, Odunvbun ME | Niger J Clin Pract | 2022 |
| Hyperkalemia and Metabolic Acidosis Occur at a Higher eGFR in Sickle Cell Disease. | Saraf SL, Derebail VK, Zhang X, Machado RF, Gordeuk VR, Lash JP, Little J | Kidney360 | 2022 |
| Evaluation of thyroid hormones and ferritin level in patients with β-thalassemia. | Hussein SZ | Med Pharm Rep | 2022 |
| Sickle cell trait and multisystem trauma: an unaddressed urgent knowledge gap. | Tessema FA, Lapping-Carr G, Affini MI, Selkridge IK, Oppong AY, Jones TA, Zakrison T | Trauma Surg Acute Care Open | 2022 |
| Reduction in seroprevalence of viral transfusion-transmitted infections in southwest Nigeria in children with sickle cell disease using an enhanced screening strategy. | Ogbenna AA, Akinsete AM, Kalejaiye OO, Matthew OK, Sharma D, Andrews J, Kassim AA | Br J Haematol | 2022 |
| Bcl11a and the Correlated Key Genes Ascribable to Globin Switching: An In-silico Study. | Motlagh FM, Soleimanpour-Lichaei HR, Emami A, Kadkhoda S, Shamsara M, Rasti A, Modarresi MH | Cardiovasc Hematol Disord Drug Targets | 2022 |
| Neutrophil gelatinase-associated lipocalin is elevated in children with acute kidney injury and sickle cell anemia, and predicts mortality. | Batte A, Menon S, Ssenkusu JM, Kiguli S, Kalyesubula R, Lubega J, Berrens Z, Mutebi EI, Ogwang R, Opoka RO, John CC, Conroy AL | Kidney Int | 2022 |
| High risk and low prevalence diseases: Acute chest syndrome in sickle cell disease. | Koehl JL, Koyfman A, Hayes BD, Long B | Am J Emerg Med | 2022 |
| Examining resilience of individuals living with sickle cell disease in the COVID-19 pandemic. | Buscetta AJ, Abdallah KE, Floyd KJ, Wossenseged FS, Conn CA, Ramirez HC, Bonham VL | BMC Psychol | 2022 |
| Assessment of biochemical bone markers of osteoporosis in children with thalassemia major. | Çelik T, Sangün Ö, Ünal Ş, Balcı A, Motor S | Ital J Pediatr | 2022 |
| Dual gradient echo in-phase and out of phase sequences in assessment of hepatic iron overload in patients with beta-thalassemia, would be better? | Ali Mohamed Aboughonaim A, Naguib Ettaby A, Ibrahim El-Noueum K, Hassab H, Emara DM | Eur J Radiol | 2022 |
| COVID19 vaccination in adults with sickle cell disease is not associated with increases in rates of pain crisis. | Friedman E, Minniti C, Campbell S, Curtis S | Hematology | 2022 |
| Understanding the EKG changes in methemoglobinemia. | Arun Kumar P, Dasari M, Sahu KK, Al-Seykal I, Mishra AK | Ann Hematol | 2022 |
| Effects of pregnancy on cardiac structure and function in women with sickle cell anemia: a longitudinal comparative study. | Aliyu Z, Kushimo OA, Oluwole AA, Amadi C, Oyeyemi N, Mbakwem A, Afolabi BB | J Matern Fetal Neonatal Med | 2022 |
| Application of validated mapping algorithms between generic PedsQL scores and utility values to individuals with sickle cell disease. | Jiao B, Hankins JS, Devine B, Barton M, Bender M, Basu A | Qual Life Res | 2022 |
| The oral ferroportin inhibitor vamifeport improved hemodynamics in a mouse model of sickle cell disease. | Nyffenegger N, Zennadi R, Kalleda N, Flace A, Ingoglia G, Buzzi RM, Doucerain C, Buehler PW, Schaer DJ, Dürrenberger F, Manolova V | Blood | 2022 |
| The Association Between Plasma MicroRNA-451 Expression Levels and Chronic Kidney Disease in Children with β-Thalassemia Major. | Ahmed HM, Georgy DB, Meabed MH, Abd El Kareem RM, Botrous OE | Iran J Kidney Dis | 2022 |
| Exploring the crosstalk between long non-coding RNAs and microRNAs to unravel potential prognostic and therapeutic biomarkers in β-thalassemia. | Rahaman M, Mukherjee M, Bhattacharya S, Mukherjee B, Shukla PC, Dolai TK, Chakravorty N | Mol Biol Rep | 2022 |
| Neurocognitive screening in sickle cell disease. | Lance EI, Cannon AD, Casella JF, Shapiro BK | Pediatr Blood Cancer | 2022 |
| Clinical management of the acute complications of sickle cell anemia: 11 years of experience in a tertiary hospital. | Reparaz P, Serrano I, Adan-Pedroso R, Astigarraga I, de Pedro Olabarri J, Echebarria-Barona A, Garcia-Ariza M, Lopez-Almaraz R, Del Orbe-Barreto RA, Vara-Pampliega M, Gonzalez-Urdiales P | An Pediatr (Engl Ed) | 2022 |
| Sickle cell disease in pediatric intensive care. | Cieza-Asenjo R, García-Morín M, Escobar-Fernández L, Cela-de Julián E, Slöcker-Barrio M, Herrera-Castillo L | An Pediatr (Engl Ed) | 2022 |
| Direct Oral Anticoagulants in Sickle Cell Disease: A Systematic Review and Meta-Analysis. | Rozi WM, Rahhal A, Ali EA, Al-Mashdali AF, Hilan Y, Khamees I, Fernyhough LJ, Yassin MA | Blood Adv | 2022 |
| Provider Communication and Fever Protocol for Children With Sickle Cell Disease in the Emergency Department. | Awe M, Robbins A, Chandi M, Cortright L, Tumin D, Whitfield A | Pediatr Emerg Care | 2022 |
| Patient perception of voxelotor treatment benefit in sickle cell disease. | Idowu M, Haque A, Williams EM, Sridhar A | J Investig Med | 2022 |
| New agents for sickle cell disease: patient perceptions of benefit in the real world. | Means RT | J Investig Med | 2022 |
| Transition for Adolescents and Young Adults With Sickle Cell Disease in a US Midwest Urban Center: A Multilevel Perspective on Barriers, Facilitators, and Future Directions. | Calhoun C, Luo L, Baumann AA, Bauer A, Shen E, McKay V, Hooley C, James A, King AA | J Pediatr Hematol Oncol | 2022 |
| First Trimester Noninvasive Prenatal Diagnosis of Maternally Inherited Beta-Thalassemia Mutations. | Madgett TE | Clin Chem | 2022 |
| Innate Variability in Physiological and Omics Aspects of the Beta Thalassemia Trait-Specific Donor Variation Effects. | Anastasiadi AT, Tzounakas VL, Dzieciatkowska M, Arvaniti VZ, Papageorgiou EG, Papassideri IS, Stamoulis K, D'Alessandro A, Kriebardis AG, Antonelou MH | Front Physiol | 2022 |
| Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin). | Zuccato C, Cosenza LC, Zurlo M, Gasparello J, Papi C, D'Aversa E, Breveglieri G, Lampronti I, Finotti A, Borgatti M, Scapoli C, Stievano A, Fortini M, Ramazzotti E, Marchetti N, Prosdocimi M, Gamberini MR, Gambari R | Ther Adv Hematol | 2022 |
| Exploring the relationship of sleep, cognition, and cortisol in sickle cell disease. | Kölbel M, Kirkham FJ, Iles RK, Stotesbury H, Halstead E, Brenchley C, Sahota S, Dimitriou D | Compr Psychoneuroendocrinol | 2022 |
| Stroke propensity in the Th3+/ mouse model of β-thalassemia intermedia. | Sun YY, Yao HW, Chen HR, Chen CW, Kinkaid MM, Kuan CY | Neurobiol Dis | 2022 |
| Contribution of ADAMTS13-independent VWF regulation in sickle cell disease. | Hunt RC, Katneni U, Yalamanoglu A, Indig FE, Ibla JC, Kimchi-Sarfaty C | J Thromb Haemost | 2022 |
| Sickle cell disease: challenging the past, looking to the future. | Cela E | An Pediatr (Engl Ed) | 2022 |
| A case of congenital methaemoglobinaemia with secondary polycythemia. | Kanwal S, Aamir M, Irum S, Haroon Z, Munir MU, Bibi A | J Pak Med Assoc | 2022 |
| Optical coherence tomography findings in patients with transfusion-dependent β-thalassemia. | Haghpanah S, Zekavat OR, Safaei S, Ashraf MA, Parand S, Ashraf H | BMC Ophthalmol | 2022 |
| Determinants of severity in sickle cell disease. | Rees DC, Brousse VAM, Brewin JN | Blood Rev | 2022 |
| Comprehensive assessment of cognitive function in adults with moderate and severe sickle cell disease. | Portela GT, Butters MA, Brooks MM, Candra L, Rosano C, Novelli EM | Am J Hematol | 2022 |
| Beta Thalassemia Carrier rate: Problem Burden Among High School Children. | El-Shanshory MR, Sherief LM, Yahia S, Ragab SM, Mansour AK, Hassab HM, Hesham MA, Ahmed AS, Beshir MR, El Fotoh WMA, El Naby SAA, Alllah AMG, Khalifa NA, Soliman MA, El-Dahtory F, El-Farahaty RM, Osman E, Elhabyan A, El-Lateef AEA, Kamal NM, Kabbash IA, Saied SM, Eid AR | Curr Pediatr Rev | 2022 |
| Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine is not influenced by AB0 blood group in subjects with transfusion-dependent thalassemia. | Sgherza N, Zucano S, Vitucci A, Palma A, Campanale D, Larocca AMV, Visceglie D, Acquafredda A, Musto P | Acta Biomed | 2022 |
| The The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network. | De Sanctis V, Soliman A, Tzoulis P, Daar S, Kattamis A, Delaporta P, Karimi M, Yassin MA, Zarei T, Saki F, Sapunarova K, Banchev A, Galati MC, Raiola G, Messina G, Campisi S, Kattamis C | Acta Biomed | 2022 |
| Cardio-protective effect of regular transfusion in children with non-transfusion dependent thalassemia (NTDT): A cohort study. | Al Senaidi K, Maveda S, Joshi N, Nazir H, Elshinawy M, Al Zadjali S, Al Rawas A, Elghamry I, Wali Y, Khater D | Acta Biomed | 2022 |
| Pharmacogenomics of hydroxyurea therapy and fetal hemoglobin levels in sickle cell anemia. | Sales RR, Nogueira BL, Luizon MR | Pharmacogenomics | 2022 |
| Expanding a Regional Sickle Cell Disease Project ECHO to Rapidly Disseminate COVID-19 Education. | Shook LM, Farrell CB, Mosley C | Adv Med Educ Pract | 2022 |
| Quality by design approach for green HPLC method development for simultaneous analysis of two thalassemia drugs in biological fluid with pharmacokinetic study. | Fares MY, Hegazy MA, El-Sayed GM, Abdelrahman MM, Abdelwahab NS | RSC Adv | 2022 |
| Assessment of functional shunting in patients with sickle cell disease. | Afzali-Hashemi L, Václavů L, Wood JC, Biemond BJ, Nederveen AJ, Mutsaerts HJMM, Schrantee A | Haematologica | 2022 |
| Characterization of a novel HBB:c.194dup variant of the -globin gene combined with six alpha genes. | Huang J, Ding L, Chen J, Chen S, Tian P, Xie J, Huang X, Xin X | J Int Med Res | 2022 |
| Revisiting Arginine Therapy for Sickle Cell Acute Vasoocclusive Painful Crisis. | Hopper RK, Gladwin MT | Am J Respir Crit Care Med | 2022 |
| Dysregulated Serum Cytokine Production in Pediatric Patients with β-Thalassemia Major. | Zhang L, Bao LJ, Hong ZD, Yan MX, Zhang ZH, Li YM, Ye Q, Wang YQ | Hemoglobin | 2022 |
| Bringing Sickle Cell Disease Care Closer to Home: Feasibility and Efficacy of a Quality Improvement Initiative at a Community Hospital. | Binding A | Hemoglobin | 2022 |
| Association of Sickle Cell Pain & Symptoms on Health-Related Quality of Life Among Pediatric Patients. | Moody KL | J Pain Symptom Manage | 2022 |
| BACTERIAL MENINGITIS IN CHILDREN WITH SICKLE-CELL DISEASE IN ANGOLA. | Pelkonen T, Roine I, Bernardino L, Jahnukainen K, Peltola H | Pediatr Infect Dis J | 2022 |
| Targeting Genetic Modifiers of HBG Gene Expression in Sickle Cell Disease: The miRNA Option. | Starlard-Davenport A, Gu Q, Pace BS | Mol Diagn Ther | 2022 |
| Sickle Cell Disease: A Review. | Kavanagh PL, Fasipe TA, Wun T | JAMA | 2022 |
| Is Severity Score Associated with Indication for Hematopoietic Stem Cell Transplantation in Individuals with Sickle Cell Anemia? | Flor-Park MV, Ozahata MC, Moura ICG, Blatyta P, Kelly S, Oliveira CDL, Capuani L, Belisário AR, Carneiro-Proietti ABF, Araujo AS, Loureiro P, Maximo C, Rodrigues DOW, Mota RA, Sabino E, Custer B, Rocha V, On Behalf Of The Recipient Epidemiology And Donor Evaluation Study-Iii Reds-Iii International Component Brazil | Transplant Cell Ther | 2022 |
| Health status of patients with β-thalassemia in the West Bank: a retrospective study. | Dwaik RK, Mohor TIA, Ithyabi II, Warasna SS, Abdeen SM, Karmi B, Seir RA. | Lancet | 2022 |
| Interplay between sickle cell anaemia and Plasmodium falciparum malaria. | Talisuna AO, D'Alessandro U | Lancet Child Adolesc Health | 2022 |
| Sickle cell anaemia and severe Plasmodium falciparum malaria: a secondary analysis of the Transfusion and Treatment of African Children Trial (TRACT). | Uyoga S, Olupot-Olupot P, Connon R, Kiguli S, Opoka RO, Alaroker F, Muhindo R, Macharia AW, Dondorp AM, Gibb DM, Walker AS, George EC, Maitland K, Williams TN | Lancet Child Adolesc Health | 2022 |
| Genetic Manipulation Strategies for β-Thalassemia: A Review. | Zakaria NA, Bahar R, Abdullah WZ, Mohamed Yusoff AA, Shamsuddin S, Abdul Wahab R, Johan MF | Front Pediatr | 2022 |
| Molecular Spectrum, Ethnic and Geographical Distribution of Thalassemia in the Southern Area of Hainan, China. | Yu Y, Lu C, Gao Y, Li C, Li D, Wang J, Wei H, Lu Z, You G | Front Pediatr | 2022 |
| Subclinical Left Ventricular Dysfunction in Children and Adolescence With Thalassemia Intermedia. | Isa Tafreshi R, Radgoodarzi M, Arjmandi Rafsanjani K, Soheilipour F | Front Pediatr | 2022 |
| Prevalence and Genetic Analysis of Thalassemia and Hemoglobinopathy in Different Ethnic Groups and Regions in Hainan Island, Southeast China. | Wang M, Zhang X, Zhang Y, Xiao M | Front Genet | 2022 |
| Skills Capacity Building For Health Care Services and Research Through the Sickle Pan African Research Consortium. | Nnodu OE, Osei-Akoto A, Nembaware V, Kent J, Nwegbu M, Minja I, Mazandu GK, Makani J, Wonkam A | Front Genet | 2022 |
| Spontaneous bilateral intraorbital hematoma: A particular form of sickle cell disease complications in children. | Andriamiarintsoa H, Ramanandafy H, Andriamiadanalisoa OA, Randriantianarisoa K, Randrianarivelo PH, Andrianah EPG, Rajaonarison LHNON, Raobela L, Rakotoson JL, Vololontiana HMD, Ahmad A | Clin Case Rep | 2022 |
| Busulfan and cyclophosphamide-based conditioning regimen still holds the promise of being a safe and efficacious regimen for allogeneic transplantation in patients with transfusion-dependent thalassemia, even in high risk. | Mehta P, Kapoor J, Singh A, Yadav N, Singh R, Halder R, Verma M, Agrawal N, Ahmed R, Bhurani D | Eur J Haematol | 2022 |
| Does TGFBR3 Polymorphism Increase the Risk of Silent Cerebral Infarction in Egyptian Children with Sickle Cell Disease? | Hassab H, Hanafi M, Elbeheiry A, Hassan M, Chazli YE | Indian J Pediatr | 2022 |
| Integrating artificial intelligence into haematology training and practice: Opportunities, threats and proposed solutions. | Chai SY, Hayat A, Flaherty GT | Br J Haematol | 2022 |
| Unmasking delayed hemolytic transfusion reactions in patients with sickle-cell disease: Challenges and opportunities for improvement. | Covington ML, Cone-Sullivan JK, Andrzejewski C, Lu W, Thomasson RR, O'Brien K, Brunker PAR, Stowell SR | Transfusion | 2022 |
| Resveratrol plus low-dose hydroxyurea compared to high-dose hydroxyurea alone is more effective in gene expression and ROS reduction in K562 cells. | Alipour M, Nasiri N, Kazemi F, Zare F, Sharifzadeh S | Nat Prod Res | 2022 |
| Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania. | Christopher H, Josephat E, Kaywanga F, Saul S, Mshana I, Kunambi P, Nasser A, Chamba C, Makani J, Nkya S | Int J Lab Hematol | 2022 |
| The evolution of glucose-insulin homeostasis in children with β-thalassemia major (β -TM): A twenty-year retrospective ICET- A observational analysis from early childhood to young adulthood. | De Sanctis V, Daar S, Soliman AT, Tzoulis P, Karimi M, Kattamis C | Acta Biomed | 2022 |
| Evolution of Combined Impaired Fasting Glucose and Impaired Glucose Tolerance in β-Thalassemia Major: Results in 58 Patients with a Mean 7.7- year Follow-Up. | De Sanctis V, Daar S, Soliman AT, Tzoulis P, Yassin MA, Kattamis C | Acta Biomed | 2022 |
| Dilemma in approach to stroke in sickle cell disease patient: A case report. | Okar L, Ali Alzoubi H, Shukur Mahmud S, Elyas A, Yassin MA | Medicine (Baltimore) | 2022 |
| Assessment of depression in children and adolescents with sickle cell anemia in a low-resource setting: a comparative study. | Ezenwosu OU, Chukwu BF, Uwaezuoke NA, Ezenwosu IL, Urom KO, Udorah MI, Ikefuna AN, Emodi IJ | Pediatr Hematol Oncol | 2022 |
| Low Stroke Risk in Children With Sickle Cell Disease in French Guiana: A Retrospective Cohort Study. | Gargot J, Parriault MC, Adenis A, Clouzeau J, Dinh Van KA, Ntab B, Defo A, Nacher M, Elenga N | Front Med (Lausanne) | 2022 |
| Early hydroxyurea use is neuroprotective in children with sickle cell anemia. | Karkoska K, Pfeiffer A, Beebe DW, Quinn CT, Niss O, McGann PT | Am J Hematol | 2022 |
| Phenotypes of sickle cell intensive care admissions: an unsupervised machine learning approach in a single-center retrospective cohort. | Padrão EMH, Bustos B, Mahesh A, Fonseca GHH, Taniguchi LU | Ann Hematol | 2022 |
| Chronic inflammation persistence after regular blood transfusion therapy in sickle cell anemia. | Dembélé AK, Hermand P, Missud F, Lesprit E, Holvoet L, Brousse V, Ithier G, Odievre MH, Benkerrou M, Le Van Kim C, Koehl B | Blood Adv | 2022 |
| Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso-occlusive episodes during the randomized, open-label HELPS study. | Conran N, de Alvarenga Maximo C, Oliveira T, Fertrin KY, Lobo C, Costa FF | Br J Haematol | 2022 |
| Does Fetal Hemoglobin inhibit the malarial parasite Plasmodium falciparum? | Archer NM, Pasvol G, Wilson I, Duraisingh MT | Am J Hematol | 2022 |
| Sickle cell trait results in a high leukoreduction quality control failure rate for whole blood donations. | Gehrie EA, Petran L, Young PP | Transfusion | 2022 |
| Elevated Selenoprotein P Levels in Thalassemia Major Patients. | Talibova G, Ozturk Z, Parlak M, Kupesiz A | Arch Med Res | 2022 |
| IOX1 fails to reduce α-globin and mediates γ-globin silencing in adult β-thalassemia/HbE erythroid progenitor cells. | Khamphikham P, Wongborisuth C, Pornprasert S, Tantiworawit A, Tangprasittipap A, Songdej D, Hongeng S | Exp Hematol | 2022 |
| Temporal resolution of gene derepression and proteome changes upon PROTAC-mediated degradation of BCL11A protein in erythroid cells. | Mehta S, Buyanbat A, Kai Y, Karayel O, Goldman SR, Seruggia D, Zhang K, Fujiwara Y, Donovan KA, Zhu Q, Yang H, Nabet B, Gray NS, Mann M, Fischer ES, Adelman K, Orkin SH | Cell Chem Biol | 2022 |
| Correlation between Myocardial Iron Overload Detected by CMRT2* and Left Ventricular Function Assessed by Tissue Doppler Imaging in Patients with Thalassemia Major. | Najimi M, Ghandi Y, Mehrabi S, Eghbali A, Habibi D | J Cardiovasc Echogr | 2022 |
| PUM1 mediates the posttranscriptional regulation of human fetal hemoglobin. | Elagooz R, Dhara AR, Gott RM, Adams SE, White RA, Ghosh A, Ganguly S, Man Y, Owusu-Ansah A, Mian OY, Gurkan UA, Komar AA, Ramamoorthy M, Gnanapragasam MN | Blood Adv | 2022 |
| Prevalence and molecular characterization of common thalassemia among people of reproductive age in the border area of Guangxi-Yunnan-Guizhou province in Southwestern China. | Xu G, Wang C, Wang J, Lin M, Chang Z, Liang J, Chen X, Zhong S, Nong X, Wei W, Deng Y | Hematology | 2022 |
| Management of acute chest syndrome in patients with sickle cell disease: a systematic review of randomized clinical trials. | Niazi MRK, Chukkalore D, Jahangir A, Sahra S, Macdougall K, Rehan M, Odaimi M | Expert Rev Hematol | 2022 |
| Primary myelofibrosis with thrombophilia as first symptom combined with thalassemia and Gilbert syndrome: A case report. | Wufuer G, Wufuer K, Ba T, Cui T, Tao L, Fu L, Mao M, Duan MH | World J Clin Cases | 2022 |
| Ferroptosis is involved in the benzene-induced hematotoxicity in mice via iron metabolism, oxidative stress and NRF2 signaling pathway. | Sun R, Liu M, Xu K, Pu Y, Huang J, Liu J, Zhang J, Yin L, Pu Y | Chem Biol Interact | 2022 |
| Optical absorbance-based rapid test for the detection of sickle cell trait and sickle cell disease at the point-of-care. | Srinivasan R, Eugene Christo VR, Nambannor Kunnath R, Katare P, Venukumar A, Nambison NKM, Gorthi SS | Spectrochim Acta A Mol Biomol Spectrosc | 2022 |
| Health related quality of life in children with sickle cell disease: A systematic review and meta-analysis. | Stokoe M, Zwicker HM, Forbes C, Abu-Saris NELH, Fay-McClymont TB, Désiré N, Guilcher GMT, Singh G, Leaker M, Yeates KO, Russell KB, Cho S, Carrels T, Rahamatullah I, Henry B, Dunnewold N, Schulte FSM | Blood Rev | 2022 |
| Liver Transplantation After Hematopoietic Stem Cell Transplant for the Treatment of Sickle Cell Disease: A Case Report. | de Sousa Arantes Ferreira G, Ferreira CA, Watanabe ALC, Trevizoli NC, Murta MCB, Figueira AVF, de Fatima Couto C | Transplant Proc | 2022 |
| Grab regulates transferrin receptor recycling and iron uptake in developing erythroblasts. | Chen M, Zhang Y, Jiang K, Wang W, Feng H, Zhen R, Moo C, Zhang Z, Shi J, Chen C | Blood | 2022 |
| Hematologist Encounters Among Medicaid Patients who have Sickle Cell Disease. | Horiuchi SS, Zhou M, Snyder A, Paulukonis S | Blood Adv | 2022 |
| Sickle Cell Disease and Kidney. | Amarapurkar P, Roberts L, Navarrete J, El Rassi F | Adv Chronic Kidney Dis | 2022 |
| Impact of COVID-19 pandemic on access to online therapeutic education programs for children with sickle cell disease. | Sterlin A, de Montalembert M, Taylor M, Mensah S, Vandaele M, Lanzeray A, Poiraud L, Allali S | J Pediatr Nurs | 2022 |
| Sexual violence as a precipitator of chronic pain in young adults with sickle cell disease. | Chopra M, Byrd J, Wuichet K, DeBaun MR | Blood Adv | 2022 |
| Incidence and Predictors of Priapism Events in a Sickle Cell Anemia: A Diary-Based Analysis. | Idris IM, Abba A, Galadanci JA, Aji SA, Jibrilla AU, Rodeghier M, Adetola K, Burnett AL, DeBaun MR | Blood Adv | 2022 |
| Reduced red cell transfusions and hospitalizations in sickle cell patients treated with voxelotor-Experience from a single center. | Bade NA, Giri U, Wang H, Ershler WB | Transfusion | 2022 |
| Practices of sickle cell disease genetic screening and testing in the prenatal population. | Prince A, Cruz-Bendezú A, Gunawansa N, Wade J, Coleman-Cowger VH, Schulkin J, Macri CJ | J Neonatal Perinatal Med | 2022 |
| Ten-year Longitudinal Analysis of Hydroxyurea Implementation in a Pediatric Sickle Cell Program. | Phan V, Park JA, Dulman R, Lewis A, Briere N, Notarangelo B, Yang E | Eur J Haematol | 2022 |
| [Genotypic and hematological characteristics of 83 β-thalassemia mutation carriers and patients from Henan Province]. | Wang W, Zhao X, Bai S, Wang L, Wang C, Yao Q, Li B, Wang D | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2022 |
| [Acute chest syndrome in adult sickle cell patients]. | Cheminet G, Mekontso-Dessap A, Pouchot J, Arlet JB | Rev Med Interne | 2022 |
| Across the Myeloablative Spectrum: Hematopoietic Cell Transplant Conditioning Regimens for Pediatric Patients with Sickle Cell Disease. | Limerick E, Abraham A | J Clin Med | 2022 |
| Gender Differences in Knowledge and Perception of Cardiovascular Disease among Italian Thalassemia Major Patients. | Meloni A, Pistoia L, Maffei S, Marcheschi P, Casini T, Spasiano A, Bitti PP, Cuccia L, Corigliano E, Sanna PMG, Massei F, Positano V, Cademartiri F | J Clin Med | 2022 |
| Metabolic Reprogramming in Sickle Cell Diseases: Pathophysiology and Drug Discovery Opportunities. | Alramadhani D, Aljahdali AS, Abdulmalik O, Pierce BD, Safo MK | Int J Mol Sci | 2022 |
| LRF Promotes Indirectly Advantageous Chromatin Conformation via -lncRNA Expression and Switch from Fetal to Adult Hemoglobin. | Chondrou V, Shaukat AN, Psarias G, Athanasopoulou K, Iliopoulou E, Damanaki A, Stathopoulos C, Sgourou A | Int J Mol Sci | 2022 |
| Temperature-dependent self-assembly of biofilaments during red blood cell sickling. | Behera A, Sharma O, Paul D, Sain A | J Chem Phys | 2022 |
| HLA-matched related donor hematopoietic stem cell transplantation is a suitable treatment in adolescents and adults with sickle cell disease: Comparison of myeloablative and non-myeloablative approaches. | Dhedin N, Chevillon F, Castelle M, Lavoipière V, Vasseur L, Dalle JH, Joseph L, Beckerich F, Buchbinder N, Coman T, Garban F, Ferster A, Nguyen S, Boissel N, Arlet JB, Pondarre C, | Am J Hematol | 2022 |
| The pleiotropic effects of α-thalassemia on HbSS and HbSC sickle cell disease: Reduced erythrocyte cation co-transport activity, serum erythropoietin, and transfusion burden, do not translate into increased survival. | Brewin JN, Nardo-Marino A, Stuart-Smith S, El Hoss S, Hanneman A, Strouboulis J, Menzel S, Gibson JS, Rees DC | Am J Hematol | 2022 |
| Evaluation of coagulation parameters and impact of transfusion on coagulation in patients with beta thalassemia major. | Kurt ZDÇ, Sönmez Ç, Kaçar D, Eker İ, Bayhan T, Yarali N, Özbek NY | Blood Coagul Fibrinolysis | 2022 |
| Inhaled nitric oxide for treating pain crises in people with sickle cell disease. | Aboursheid T, Albaroudi O, Alahdab F | Cochrane Database Syst Rev | 2022 |
| Cerebral hemodynamics in children with sickle cell disease in India: An observational cohort study. | Gajjar B, Sharma S, Khan E, Sharma P, Jain P, Goel V, Neral A, Patel J, Parmar M, Sharma K, Sharma VK, Sharma AK | Medicine (Baltimore) | 2022 |
| Fulminant dengue hepatitis in sickle cell disease: Recovery against the odds. | Shah D, Talwar D, Kumar S, Acharya S, Hulkoti V | J Family Med Prim Care | 2022 |
| Killer hiding under normal oxygen saturation: a case report about methemoglobinemia. | Sun Q, Yue J, Liang P | Transl Pediatr | 2022 |
| Considerations for Selecting Cognitive Endpoints and Psychological Patient-Reported Outcomes for Clinical Trials in Pediatric Patients With Sickle Cell Disease. | Hood AM, Crosby LE, Stotesbury H, Kölbel M, Kirkham FJ | Front Neurol | 2022 |
| CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease. | Rangarajan HG, Crowell SA, Towerman AS, Shenoy SS | Bone Marrow Transplant | 2022 |
| Unusual coexistence of Stewart-Treves syndrome and sickle cell anaemia: a case of dual pathology. | Walke VA, Datar S, Kowe B, Chaurasia JK | BMJ Case Rep | 2022 |
| A novel mutation Hb jiangnan[β3(NA3) Leu→Lys, :c.10-_11delinsAA] causing elevated Hb A level. | Liang L, Ning S, Lu X, Li Y, Tian M, Qin T, Li Y | Hematology | 2022 |
| Limitations of mouse models for sickle cell disease conferred by their human globin transgene configurations. | Woodard KJ, Doerfler PA, Mayberry KD, Sharma A, Levine R, Yen J, Valentine V, Palmer LE, Valentine M, Weiss MJ | Dis Model Mech | 2022 |
| Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study. | Krishnamurti L, Arnold SD, Haight A, Abraham A, Guilcher GM, John T, Bakshi N, Shenoy S, Syrjala K, Martin PL, Chaudhury S, Eames G, Olowoselu OF, Hsieh M, De La Fuente J, Kasow KA, Stenger E, Mertens A, El-Rassi F, Lane P, Shaw BE, Meacham L, Archer D | JMIR Res Protoc | 2022 |
| Mortality attributed to sickle cell disease in children and adolescents in Brazil, 2000-2019. | Nascimento MID, Przibilski ALF, Coelho CSG, Leite KFA, Makenze M, Jesus SB | Rev Saude Publica | 2022 |
| A novel 15.8 kb deletion α-thalassemia confirmed by long-read single-molecule real-time sequencing: Hematological phenotypes and molecular characterization. | Zhong Z, Zhong G, Guan Z, Chen D, Wu Z, Yang K, Chen D, Liu Y, Xu R, Chen J | Clin Biochem | 2022 |
| Platelet volume parameters as a tool in the evaluation of acute ischemic priapism in patients with sickle cell anemia. | Adawi EA, Ghanem MA | Arch Ital Urol Androl | 2022 |
| Voxelotor versus other therapeutic options for sickle cell disease: Are we still lagging behind in treating the disease? | Tayyaba Rehan S, Hussain HU, Malik F, Usama RM, Tahir MJ, Asghar MS | Health Sci Rep | 2022 |
| A Curative DNA Code for Hematopoietic Defects: Novel Cell Therapies for Monogenic Diseases of the Blood and Immune System. | Porteus MH, Pavel-Dinu M, Pai SY | Hematol Oncol Clin North Am | 2022 |
| Gene Therapy for Hemoglobinopathies: Beta-Thalassemia, Sickle Cell Disease. | Leonard A, Tisdale JF, Bonner M | Hematol Oncol Clin North Am | 2022 |
| Outcomes of pregnancies complicated by haemoglobin H-constant spring and deletional haemoglobin H disease: A retrospective cohort study. | Ake-Sittipaisarn S, Sirichotiyakul S, Srisupundit K, Luewan S, Traisrisilp K, Tongsong T | Br J Haematol | 2022 |
| Consideration of Splenectomy in Unstable Hemoglobinopathy: A Case Report of Hb Hammersmith (: c.128T>C). | Pesce MM, Atkinson MM, Sridhar V, Edwards EG | Hemoglobin | 2022 |
| Transcranial doppler as screening method for sickling crises in children with sickle cell anemia: a latin America cohort study. | Modolo GP, Luvizutto GJ, Hamamoto Filho PT, Braga GP, Bazan SGZ, Ferreira NC, de Souza JT, Winckler FC, Macedo de Freitas CC, Hokama NK, Vidal EIO, Bazan R | BMC Pediatr | 2022 |
| Improvement of Hemolytic Anemia with GBT1118 is Reno-protective in Transgenic Sickle Mice. | Ren G, Setty S, Zhang X, Susma A, Ruiz MAD, Minshall RD, Lash JP, Gordeuk VR, Saraf SL | Blood Adv | 2022 |
| Molecular Mechanisms of Hepatic Dysfunction in Sickle Cell Disease: Lessons From The Townes Mouse Model. | Pradhan-Sundd T, Kato GJ, Novelli EM | Am J Physiol Cell Physiol | 2022 |
| Anti-SARS-CoV-19 antibodies in children and adults with sickle cell disease: A single-site analysis in New York City. | Green NS, Van Doren L, Licursi M, Billings DD, Sandoval LA, Feit YMZ, Hod EA | Br J Haematol | 2022 |
| Recurrent spinal cord compression due to extramedullary hematopoiesis in thalassemia patient: Case report. | Abbarh S, Al-Mashdali AF, Abdelrazek M, Gurusamy VM, Yassin MA | Medicine (Baltimore) | 2022 |
| Sickle cell-related fat embolism syndrome and the need for therapeutic plasma exchange. | Nicholls JR, Leonard A, Garcia M, Sadasivam N, Charlesworth M | J Cardiothorac Vasc Anesth | 2022 |
| The effects of glutamine supplementation on markers of apoptosis and autophagy in sickle cell disease peripheral blood mononuclear cells. | Walter PB, Hohman LS, Rokeby A, Lum JJ, Hagar R, Lavrisha L, Saulys A, Kuypers FA, Vichinsky E, Morris CR | Complement Ther Med | 2022 |
| Hydroxyurea decouples persistent F-cell elevation and induction of γ-globin. | Walker AL, Crosby D, Miller V, Weidert F, Ofori-Acquah S | Exp Hematol | 2022 |
| Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study. | Heeney MM, Abboud MR, Githanga J, Inusa BP, Kanter J, Michelson AD, Nduba V, Musiime V, Apte M, Inati A, Taksande AM, Andersson M, Åstrand M, Maklad N, Niazi M, Himmelmann A, Berggren AR | Blood | 2022 |
| Influenza Vaccine Booster Stimulates Antibody Response in Beta Thalassemia Major Patients. | Sheikh M, Ahmadi-Vasmehjani A, Atashzar MR, Karbalaie Niya MH, Ebrahimian A, Baharlou R | Lab Med | 2022 |
| Urgent use of voxelotor in sickle cell disease when immediate transfusion is not safe. | Ferlis M, Lipato T, Roseff SD, Smith WR | Eur J Haematol | 2022 |
| From the investigation of RHD-CE hybrid genes to the recognition of RHCE variants and RHD zygosity. Expanding the analysis by QMPSF in Brazilian donors and in patients with sickle cell disease. | de Paula Vendrame TA, Arnoni CP, Latini FRM, Pereira Cortez AJ, Bénech C, Fichou Y, Castilho L | Blood Transfus | 2022 |
| Quantification of Silent Cerebral Infarction on High-Resolution FLAIR and Cognition in Sickle Cell Anemia. | Stotesbury H, Kawadler JM, Clayden JD, Saunders DE, Hood AM, Koelbel M, Sahota S, Rees DC, Wilkey O, Layton M, Pelidis M, Inusa BPD, Howard J, Chakravorty S, Clark CA, Kirkham FJ | Front Neurol | 2022 |
| GDF-15 is associated with atherosclerosis in adults with transfusion-dependent beta-thalassemia. | Efat A, Wahb R, Shoeib SAA, Dawod AAE, Abd ElHafez MA, Abd ElMohsen EA, Elkholy A | EJHaem | 2022 |
| Sickle Cell Disease in Children: Knowledge and Home-Based Management Strategies among Caregivers at a Tertiary Facility in Northern Ghana. | Ajinkpang S, Anim-Boamah O, Bimpong KA, Kanton FJ, Pwavra JBP, Abdul-Mumin A | Biomed Res Int | 2022 |
| Current landscape of gene-editing technology in biomedicine: Applications, advantages, challenges, and perspectives. | Zhou W, Yang J, Zhang Y, Hu X, Wang W | MedComm (2020) | 2022 |
| RANK/RANKL/OPG axis genes relation to cognitive impairment in children with transfusion-dependent thalassemia: a cross-sectional study. | Mousa SO, Abd El-Hafez AH, Abu El-Ela MA, Mourad MA, Saleh RN, Sayed SZ | BMC Pediatr | 2022 |
| Nursing protocol for children with sickle cell disease in emergency room: a convergent-care approach. | Teixeira JBC, Morais AC, Santos VEP, Santos DVD, Carvalho ESS, Miranda JOF, Brito LS, Martins LA | Rev Bras Enferm | 2022 |
| Early initiation of disease-modifying therapy can impede or prevent diffuse myocardial fibrosis in sickle cell anemia. | Niss O, Detterich JA, Wood JC, Coates TD, Malik P, Taylor M, Quinn CT | Blood | 2022 |
| "Death is as Much Part of Life as Living": Attitudes and Experiences Preparing for Death from Older Adults with Sickle Cell Disease | Oyedeji CI, Strouse JJ, Masese R, Gray N, Oyesanya TO | Omega (Westport) | 2022 |
| Pediatric hematology providers' contraceptive practices for female adolescents and young adults with sickle cell disease: A national survey. | Askew MA, Smaldone AM, Gold MA, Smith-Whitley K, Strouse JJ, Jin Z, Green NS | Pediatr Blood Cancer | 2022 |
| Health-related quality of life of patients with sickle cell disease aged 8-17 years at Kamuzu Central Hospital, Malawi. | Wachepa S, Bvalani R, Namubiru T, Namugerwa S, Kaudha G, Mpasa A, Munube D, Rujumba J, Ozuah N, Kiguli S | Pediatr Blood Cancer | 2022 |
| [Socio-demographic and economic profile of adult patients with sickle cell disease followed up on a regular basis at the University Hospital Center of Libreville]. | Igala M, Helley Ondo GD, Lentombo LEL, Rerambiah LK, Lacombe SD, Ba JI, Boguikouma JB | Pan Afr Med J | 2022 |
| Micronutrient levels and haemato-biochemical status of patients with sickle cell anaemia at a tertiary hospital in Abakaliki, south-eastern Nigeria: a cross-sectional study. | Nnachi OC, Orih MC, Edenya OO, Okoye AE, Ezenwenyi IP | Pan Afr Med J | 2022 |
| An Integrative Review: The Evolution of Provider Knowledge, Attitudes, Perceptions and Perceived Barriers to Caring for Patients with Sickle Cell Disease 1970-Now. | Reich J, Cantrell MA, Smeltzer SC | J Pediatr Hematol Oncol Nurs | 2022 |
| Catastrophic Neurological Complications in 2 Patients With Sickle Cell Disease and COVID-19. | Clarke K, Benameur K, Wiley Z, Shin YM, Moussa M, El Rassi F, McLemore M | J Investig Med High Impact Case Rep | 2022 |
| Hematopoietic Stem Cell Transplantation and Results in Pediatric Patients with Thalassemia Major: Single-Center Study. | Ayçiçek A, Kalkan Ş, I Paslı Uysalol E, Tekgündüz S, Salcıoğlu OZ, Özdemir G, Arslantaş E, Bayram C | Turk Arch Pediatr | 2022 |
| The Correlation Between Ineffective Erythropoiesis Biomarkers and Development of Extramedullary Hematopoiesis in Patients with Thalassemia. | Chansai S, Yamsri S, Fucharoen S, Fucharoen G, Teawtrakul N | Mediterr J Hematol Infect Dis | 2022 |
| Renal Abnormalities among Sickle Cell Disease Patients in a Poor Management Setting: A Survey in the Democratic Republic of the Congo. | Kambale-Kombi P, Djang'eing'a RM, Alworong'a Opara JP, Mbo Mukonkole JP, Bours V, Tonen-Wolyec S, Mbumba Lupaka DM, Bome LB, Tshilumba CK, Batina-Agasa S | Mediterr J Hematol Infect Dis | 2022 |
| Prospective, Case-Control Study of Serological Response after Two Doses of BNT162b2 anti-SARS-CoV-2 mRNA Vaccine in Transfusion-Dependent Thalassemic Patients. | Sgherza N, Zucano S, Vitucci A, Palma A, Tarantini F, Campanale D, Vimercati L, Larocca AMV, Visceglie D, Acquafredda A, Ostuni A, Di Gennaro D, Vitucci C, Tafuri S, Musto P | Mediterr J Hematol Infect Dis | 2022 |
| Identification of Alpha Thalassemia, p.R4810K and p.R189W among Children with Moyamoya Disease/Syndrome. | Thampratankul L, Okuno Y, Komvilaisak P, Wattanasirichaigoon D, Sirachainan N | Mediterr J Hematol Infect Dis | 2022 |
| Role of Radiotherapy in Spinal Cord Compression Due to Extramedullary Hematopoiesis in Thalassemia Intermedia. | Pandey A, Mishra H, Mishra R | Neurol India | 2022 |
| NGS4THAL, a One-Stop Molecular Diagnosis and Carrier Screening Tool for Thalassemia and Other Hemoglobinopathies by Next-Generation Sequencing. | Cao Y, Yin Ha S, So CC, For TM, Sze-Man Tang C, Zhang H, Liang R, Yang J, Hon-Yin Chung B, Chi-Fung Chan G, Lau YL, Garcia-Barcelo MM, Shiu-Kwan Ma E, Sucharitchan P, Hirankarn N, Yang W | J Mol Diagn | 2022 |
| Expansion and differentiation of ex vivo cultured erythroblasts in scalable stirred bioreactors. | Gallego-Murillo JS, Iacono G, van der Wielen LAM, van den Akker E, von Lindern M, Wahl SA | Biotechnol Bioeng | 2022 |
| MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease. | Belcher JD, Nguyen J, Chen C, Abdulla F, Conglin R, Ivy ZK, Cummings J, Dudler T, Vercellotti GM | Transl Res | 2022 |
| No difference in myocardial iron concentration and serum ferritin with deferasirox and deferiprone in pediatric patients with hemoglobinopathies: A systematic review and meta-analysis. | Saleem A, Waqar E, Shuja SH, Naeem U, Moeed A, Rais H, Ahmed J | Transfus Clin Biol | 2022 |
| Fetal Hemoglobin and Cerebral Tissue Oxygenation during Immediate Postnatal Transition. | Suppan E, Urlesberger B, Schwaberger B, Höller N, Wolfsberger CH, Avian A, Pichler G | Neonatology | 2022 |
| The altered expression of homing factors in CD34 hematopoietic stem cells following G-CSF injection and its effects on transplantation quality in ALL patients. | Shafiei SL, Movassaghpour A, Hosseini SF, Talebi M, Edalati M, Torabi Goudarzi S, Soltani-Zangbar MS, Mehdizadeh A, Yousefi M | Cell Biol Int | 2022 |
| Emerging drugs for the treatment of sickle cell disease: a review of phase II/III trials. | Ross JM, Forté S, Soulières D | Expert Opin Emerg Drugs | 2022 |
| Analysis of Common Beta-Thalassemia (β-Thalassemia) Mutations in East Java, Indonesia. | Hernaningsih Y, Syafitri Y, Indrasari YN, Rahmawan PA, Andarsini MR, Lesmana I, Moses EJ, Abdul Rahim NA, Yusoff NM | Front Pediatr | 2022 |
| Plasma Levels of Acyl-Carnitines and Carboxylic Acids Correlate With Cardiovascular and Kidney Function in Subjects With Sickle Cell Trait. | Nemkov T, Skinner S, Diaw M, Diop S, Samb A, Connes P, D'Alessandro A | Front Physiol | 2022 |
| Oxygen Saturation in Primary Teeth of Individuals With Sickle Cell Disease and Sickle Cell Trait. | Wilson EM, Minja IK, Machibya FM, Jonathan A, Makani J, Ruggajo P, Balandya E | J Blood Med | 2022 |
| Research knowledge transfer to improve the care and support of adolescents with sickle cell disease in Ghana. | Poku BA, Pilnick A | Health Expect | 2022 |
| Empowering children and adolescents with sickle cell disease: a transition journey to adult care. | Badawy SM | Lancet Haematol | 2022 |
| Hemoglobin I-Toulouse: A rare hemoglobinopathy presenting with low oxygen saturations. | Xu Z, Masters IB, Barbaro P, Miller S, Kapur N | Clin Case Rep | 2022 |
| Health-Related Quality of Life and Adherence to Hydroxyurea and Other Disease-Modifying Therapies among Individuals with Sickle Cell Disease: A Systematic Review. | Yang M, Elmuti L, Badawy SM | Biomed Res Int | 2022 |
| Inflammasomes-New Contributors to Blood Diseases. | Tomasik J, Basak GW | Int J Mol Sci | 2022 |
| A Stress and Pain Self-management mHealth App for Adult Outpatients With Sickle Cell Disease: Protocol for a Randomized Controlled Study. | Ezenwa MO, Yao Y, Mandernach MW, Fedele DA, Lucero RJ, Corless I, Dyal BW, Belkin MH, Rohatgi A, Wilkie DJ | JMIR Res Protoc | 2022 |
| Sickle cell bone disease and response to intravenous bisphosphonates in children. | Grimbly C, Escagedo PD, Jaremko JL, Bruce A, Alos N, Robinson ME, Konji VN, Page M, Scharke M, Simpson E, Pastore YD, Girgis R, Alexander RT, Ward LM | Osteoporos Int | 2022 |
| Frequency of Hereditary Hemochromatosis Gene Variants in Sri Lankan Transfusion-Dependent Beta-Thalassemia Patients and Their Association With the Serum Ferritin Level. | Padeniya P, Goonasekara H, Abeysekera G, Jayasekara R, Dissanayake V | Front Pediatr | 2022 |
| ADaPTS | Bruce AAK, Guilcher GMT, Desai S, Truong TH, Leaker M, Alaazi DA, Pedersen SJV, Salami B | Health Qual Life Outcomes | 2022 |
| Two large novel alpha-globin gene cluster deletions causing alpha(0)-thalassemia in two Chinese families. | Jiwu L, Manna S, Ying Z, Youqing F, Haiyang C, Wanfang X, Yanhui L | Gene | 2022 |
| Meteorological parameters and hospitalizations of patients with sickle cell anemia: a 20-year retrospective study in Campinas, São Paulo, Brazil. | Alagbe AE, Corozolla W, Samejima Teixeira L, Peres Coelho R, Heuminski de Avila AM, Paro Costa PD, Fatima Sonati M, de Faria EC, Nunes Dos Santos MN | Int J Environ Health Res | 2022 |
| Incidence of Acute Chest Syndrome in Children With Sickle Cell Disease Following Implementation of the 13-Valent Pneumococcal Conjugate Vaccine in France. | Assad Z, Michel M, Valtuille Z, Lazzati A, Boizeau P, Madhi F, Gaschignard J, Pham LL, Caseris M, Cohen R, Kaguelidou F, Varon E, Alberti C, Faye A, Angoulvant F, Koehl B, Ouldali N | JAMA Netw Open | 2022 |
| Sickle Cell Trait Associated With Kidney Failure and COVID-19 Death. | Slomski A | JAMA | 2022 |
| Comparative effectiveness of adding Omega-3 or Vitamin D to standard therapy in preventing and treating episodes of painful crisis in pediatric sickle cell patients. | Abdelhalim SM, Murphy JE, Meabed MH, Elberry AA, Gamaleldin MM, Shaalan MS, Hussein RRS | Eur Rev Med Pharmacol Sci | 2022 |
| The -α subtype of α-thalassemia was identified in China. | Bao X, Wang J, Qin D, Zhang R, Yao C, Liang J, Liang K, Du L | Hematology | 2022 |
| Iron status of blood donors. | Spencer BR, Mast AE | Curr Opin Hematol | 2022 |
| Measurement of post-transfusion red blood cell survival kinetics in sickle cell disease and β-Thalassemia: A biotin label approach. | Gerritsma JJ, van der Bolt N, van Bruggen R, Ten Brinke A, van Dam J, Guerrero G, Vermeulen C, de Bruin S, Vlaar APJ, Biemond BJ, Nur E, van der Schoot E, Fijnvandraat K, | Transfusion | 2022 |
| CRISPR-Cas9-mediated gene editing of the BCL11A enhancer for pediatric β/β transfusion-dependent β-thalassemia. | Fu B, Liao J, Chen S, Li W, Wang Q, Hu J, Yang F, Hsiao S, Jiang Y, Wang L, Chen F, Zhang Y, Wang X, Li D, Liu M, Wu Y | Nat Med | 2022 |
| Hb Kalundborg [β79(EF3)Asp→Glu; : c.240C>a], a Possible Low-affinity Hemoglobin Variant Detected during Hb A Measurement. | Ahmad-Nielsen EB, Szecsi PB, Bratholm PS, Petersen J, Glenthøj A | Hemoglobin | 2022 |
| Haploidentical Hematopoietic Stem Cell Transplantation in Thalassemia. | Anurathapan U, Pakakasama S, Songdej D, Pongphitcha P, Chuansumrit A, Andersson BS, Hongeng S | Hemoglobin | 2022 |
| Myocardial Iron Overload Causes Subclinical Myocardial Dysfunction in Sickle Cell Disease. | Fujikura K, Cheng AL, Suriany S, Detterich J, Arai AE, Wood JC | JACC Cardiovasc Imaging | 2022 |
| Splenectomy in sickle cell disease: do benefits outweigh risks? | Nardo-Marino A, Brousse V | Haematologica | 2022 |
| [Renal infarction in an adolescent carrier of the sickle cell trait]. | Guffens A, Lombet J, Pirotte I | Rev Med Liege | 2022 |
| Tailored Parenting Plans of Young Adults With Sickle Cell Disease or Sickle Cell Trait. | Oguntoye AO, Eades NT, Aldossary D, Kuenzli G, Gehling G, Ezenwa MO, Johnson-Mallard V, Yao Y, Gallo AM, Wilkie DJ | Comput Inform Nurs | 2022 |
| A New Mutation, Hb A-Canakkale [δ10(A7)Ala→Val; : c.32C>T], and Other Well-Known δ Variants Identified in a Selected Cohort with Low Hb A Levels. | Karakaya T, Silan F, Ozdemir O | Hemoglobin | 2022 |
| Hepcidin-to-Ferritin Ratio as an Early Diagnostic Index of Iron Overload in β-Thalassemia Major Patients. | Zaman BA, Ibrahim SA | Hemoglobin | 2022 |
| Adherence to Iron Chelation Therapy among Adults with Thalassemia: A Systematic Review. | Locke M, Reddy PS, Badawy SM | Hemoglobin | 2022 |
| Bringing Sickle-Cell Treatments to Children in Sub-Saharan Africa. | Zhou AE, Travassos MA | N Engl J Med | 2022 |
| The effect of intensity of conditioning regimen on the outcome of HSCT in children with sickle cell disease. | Alsultan A, Abujoub R, Elbashir E, Essa MF | Clin Transplant | 2022 |
| 2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia. | Farmakis D, Porter J, Taher A, Domenica Cappellini M, Angastiniotis M, Eleftheriou A | Hemasphere | 2022 |
| Clinical characteristics and risk factors of relative systemic hypertension and hypertension among sickle cell patients in Cameroon. | Nguweneza A, Ngo Bitoungui VJ, Mnika K, Mazandu G, Nembaware V, Kengne AP, Wonkam A | Front Med (Lausanne) | 2022 |
| Pulmonary function in children and adolescents with sickle cell disease after nonmyeloablative hematopoietic cell transplantation. | Monagel DA, Guilcher GMT, Nettel-Aguirre A, Bendiak GN | Pediatr Blood Cancer | 2022 |
| Advances in screening of thalassaemia. | Gao J, Liu W | Clin Chim Acta | 2022 |
| Impact of IFN-β1a in treatment of a COVID-19 patient with beta thalassemia and diabetes mellitus: A case report. | Gholinataj Jelodar M, Mirzaei S, Dehghan Chenari H | Clin Case Rep | 2022 |
| The Evaluation of Results of Twenty Common Equations for Differentiation of Beta Thalassemia Trait from Iron Deficiency Anemia: A Cross-Sectional Study. | Ebrahimpour Sadagheyani H, Sharafkhani R, Sakhaei S, Jafaralilou H, Shahmirzalou P | Iran J Public Health | 2022 |
| Hemoglobin Wayne: A Rare Variant That Can Cause Falsely Elevated Hemoglobin A1c. | Ao X, Ganta N, Choe S, Patel P, Turro J, Cheriyath P | Cureus | 2022 |
| Bioinformatic Tools for the Identification of MicroRNAs Regulating the Transcription Factors in Patients with β-Thalassemia. | Kalaigar SS, Rajashekar RB, Nataraj SM, Vishwanath P, Prashant A | Bioinform Biol Insights | 2022 |
| Sickle cell disease patients with COVID-19 in Guadeloupe: Surprisingly favorable outcomes. | Bernit E, Romana M, Alexis-Fardini S, Tarer V, Roger PM, Doumdo L, Petras E, Charneau C, Tressières B, Dessources MDH, Etienne-Julan M | EJHaem | 2022 |
| Newborn screening for abnormal haemoglobins in Jamaica: Practical issues in an island programme. | Serjeant GR, Serjeant BE, Mason KP, Gibson F, Gardner RA, Warren L, Hambleton IR, Thein SL, Happich M, Kulozik AE | J Med Screen | 2022 |
| Effective therapies for sickle cell disease: are we there yet? | Crossley M, Christakopoulos GE, Weiss MJ | Trends Genet | 2022 |
| What is the effectiveness of surgical and non-surgical therapies in the treatment of ischemic priapism in patients with sickle cell disease? A systematic review by the EAU Sexual and Reproductive Health Guidelines Panel. | Gül M, Luca B, Dimitropoulos K, Capogrosso P, Milenkovic U, Cocci A, Veeratterapillay R, Hatzichristodoulou G, Modgil V, Russo GI, Tharakan T, Kalkanli A, Omar MI, Bettocchi C, Carvalho J, Corona G, Jones TH, Kadioglu A, Martinez-Salamanca JI, Serefoglu EC, Verze P, Minhas S, Salonia A, | Int J Impot Res | 2022 |
| HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription. | Huang P, Peslak SA, Ren R, Khandros E, Qin K, Keller CA, Giardine B, Bell HW, Lan X, Sharma M, Horton JR, Abdulmalik O, Chou ST, Shi J, Crossley M, Hardison RC, Cheng X, Blobel GA | Nat Genet | 2022 |
| [The Management of Endocrine Complications in Patients with Haemoglobinopathies: Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE).] | Casale M, Baldini M, Del Monte P, Gigante A, Grandone A, Origa R, Poggi M, Gadda F, Lai R, Marchetti M, Forni GL | Recenti Prog Med | 2022 |
| First-in-human phase 1 trial of artificial red blood cells and hemoglobin vesicles developed as a transfusion alternative. | Azuma H, Amano T, Kamiyama N, Takehara N, Jingu M, Takagi H, Sugita O, Kobayashi N, Kure T, Shimizu T, Ishida T, Matsumoto M, Sakai H | Blood Adv | 2022 |
| A novel, effective, and efficient strategy for treating sickle cell vaso-occlusive events in the infusion center setting. | Peslak SA, Akins-Msn Crnp AB, Foxwell AM, Iannelli M, Grande C, Breen D, Russell JE, Uritsky TJ, Sayani F | Blood Adv | 2022 |
| Contributions of von Willebrand factor to clinical severity of sickle cell disease: a systematic review and metanalysis. | Nwagha TU, Nweke M, Ezigbo ED | Hematology | 2022 |
| First study to describe a novel : c.400A > C mutation and Hb Dongguan heterozygote in two unrelated Chinese families. | Yao C, Qin D, Wang J, Bao X, Liang J, Du L | Hematology | 2022 |
| Pairing parents and offspring's HemoTypeSC Test to validate results and confirm sickle cell pedigree: a case study in Kisangani, the Democratic Republic of the Congo. | Kasai ET, Kadima JN, Alworong'a Opara JP, Boemer F, Dresse MF, Makani J, Bours V, Marini Djang'eing'a R, Paul KK, Batina Agasa S | Hematology | 2022 |
| The incidence and prevalence of unruptured intracranial aneurysms in sickle cell disease patients: a systematic review. | Essiet E, Shapey J, Kailaya-Vasan A | Br J Neurosurg | 2022 |
| Anticoagulation strategies and recurrence of venous thromboembolic events in patients with sickle cell disease: a systematic review and meta-analysis. | El-Amin N, Iness A, Cyrus JW, Sisler I, Karam O | Ann Hematol | 2022 |
| Exercise Capacity and Biomarkers Among Children and Adolescents With Sickle Cell Disease. | Silva LBPD, Mercês de Jesus G, Bessa Junior J, Silva VAPD, Mattos IG, Jenerette CM, Carvalho ESS | Pediatr Exerc Sci | 2022 |
| High-Priced Sickle Cell Gene Therapies Threaten to Exacerbate US Health Disparities and Establish New Pricing Precedents for Molecular Medicine. | Tessema FA, Sarpatwari A, Rand LZ, Kesselheim AS | J Law Med Ethics | 2022 |
| Underutilized legumes, Cajanus cajan and Glycine max may bring about antisickling effect in sickle cell disease by modulation of redox homeostasis in sickled erythrocytes and alteration of its functional chemistry. | Elemo GN, Erukainure OL, Okafor JNC, Banerjee P, Preissner R, Nwachukwu Nicholas-Okpara VA, Atolani O, Omowunmi O, Ezeanyanaso CS, Awosika A, Shode F | J Food Biochem | 2022 |
| Extended Spectrum β-Lactamase Producing Lactose Fermenting Bacteria Colonizing Children with Human Immunodeficiency Virus, Sickle Cell Disease and Diabetes Mellitus in Mwanza City, Tanzania: A Cross-Sectional Study. | Said MM, Msanga DR, Mtemisika CI, Silago V, Mirambo MM, Mshana SE | Trop Med Infect Dis | 2022 |
| Acute Hyperhemolysis Syndrome in a Patient with Known Sickle Cell Anemia Refractory to Steroids and IVIG Treated with Tocilizumab and Erythropoietin: A Case Report and Review of Literature. | Menakuru SR, Priscu A, Dhillon V, Salih A | Hematol Rep | 2022 |
| Neuropsychological, behavioral, and quality-of-life outcomes in children and adolescents with sickle cell disease treated with nonmyeloablative matched sibling donor hematopoietic cell transplantation: A case series. | Fay-McClymont TB, Monagel DA, Singh G, Schulte F, Brooks BL, MacAllister WS, Désiré N, Mineyko A, Vasserman M, Leaker MT, Truong TH, Shah R, Lewis VA, Yeates KO, Guilcher GMT | Pediatr Blood Cancer | 2022 |
| Risks and Benefits of Prophylactic Transfusion before Cholecystectomy in Sickle Cell Disease. | Rambaud E, Ranque B, Tsiakyroudi S, Joseph L, Bouly N, Douard R, François A, Pouchot J, Arlet JB | J Clin Med | 2022 |
| Transition in Sickle Cell Disease (SCD): A German Consensus Recommendation. | Alashkar F, Aramayo-Singelmann C, Böll J, Hoferer A, Jarisch A, Kamal H, Oevermann L, Schwarz M, Cario H | J Pers Med | 2022 |
| A Simple, Cost-Effective, and Extraction-Free Molecular Diagnostic Test for Sickle Cell Disease Using a Noninvasive Buccal Swab Specimen for a Limited-Resource Setting. | Thakur P, Gupta P, Bhargava N, Soni R, Varma Gottumukkala N, Goswami SG, Kharya G, Saravanakumar V, Gunda P, Jain S, Dass J, Aggarwal M, Ramalingam S | Diagnostics (Basel) | 2022 |
| Acupuncture for Pain Management in Pediatric Patients with Sickle Cell Disease. | Plonski KS | Children (Basel) | 2022 |
| Deep venous thrombosis and acute pericarditis associated with severe acute respiratory syndrome coronavirus 2 infection in a Congolese infant with sickle cell disease: a case report. | Lubala TK, Kayembe-Kitenge T, Makinko P, Kalenga L, Kachil H, Kayembe A, Mutombo A, Shongo M | J Med Case Rep | 2022 |
| Detection of maternal carriers of common α-thalassemia deletions from cell-free DNA. | Doan PL, Nguyen DA, Le QT, Hoang DT, Nguyen HD, Nguyen CC, Doan KPT, Tran NT, Ha TMT, Trinh THN, Nguyen VT, Bui CT, Lai NT, Duong TH, Mai HL, Huynh PV, Huynh TTT, Le QV, Vo TB, Dao TH, Vo PA, Le DN, Tran NNT, Tran QNT, Van YT, Tran HT, Nguyen HT, Nguyen PU, Do TT, Truong DK, Tang HS, Cao NT, Lam TT, Tran LS, Nguyen HN, Giang H, Phan MD | Sci Rep | 2022 |
| A novel rearrangement of the α-globin gene cluster containing both the -α and αααα crossover junctions in a Chinese family. | Ning S, Luo Y, Liang Y, Xie Y, Lu Y, Meng B, Pan J, Xu R, Liu Y, Qin Y | Clin Chim Acta | 2022 |
| Fluorescence Lifetime Measurement of Prefibrillar Sickle Hemoglobin Oligomers as a Platform for Drug Discovery in Sickle Cell Disease. | Vunnam N, Hansen S, Williams DC, Been MO, Lo CH, Pandey AK, Paulson CN, Rohde JA, Thomas DD, Sachs JN, Wood DK | Biomacromolecules | 2022 |
| Blood Donors with Thalassemic Trait, Glucose-6-Phosphate Dehydrogenase Deficiency Trait, and Sickle Cell Trait and Their Blood Products: Current Status and Future Perspective. | Noulsri E, Lerdwana S | Lab Med | 2022 |
| Hb Narges Lab, a Novel Hemoglobin Variant of the β-Globin Gene. | Hamid M, Shahbazi Z, Keikhaei B, Galehdari H, Saberi A, Sedaghat A, Shariati G, Mohammadi-Anaei M | Arch Iran Med | 2022 |
| Transmembrane Protein ANTXR1 Regulates -Globin Expression by Targeting the Wnt/-Catenin Signaling Pathway. | Jin T, Zhang Z, Han Y, Li D, Liu J, Jiang M, Zhu J, Kurita R, Nakamura Y, Hu F, Xu Y, Fang X, Huang S, Sun Z | J Immunol Res | 2022 |
| Global longitudinal strain for detection of cardiac iron overload in patients with thalassemia: a meta-analysis of observational studies with individual-level participant data. | Attar A, Hosseinpour A, Hosseinpour H, Rezaeian N, Abtahi F, Mehdizadeh F, Parsaee M, Akiash N, Behjati M, Meloni A, Pepe A | Cardiovasc Ultrasound | 2022 |
| Electrocardiographic findings in Nigerian athletes with the sickle cell trait. | Ilodibia TF, Odigwe CO, Anugweje KC | J Electrocardiol | 2022 |
| Hb Wanjiang: A New β-Globin Chain Variant with Two Amino Acid Substitutions (: c.255_264delinsTTTTTCTCAG). | Wu SM, Jiang F, Li C, Guo ZT, Huang SR, Li DZ | Hemoglobin | 2022 |
| Thalassemia in Thailand. | Paiboonsukwong K, Jopang Y, Winichagoon P, Fucharoen S | Hemoglobin | 2022 |
| Thalassemia in Asia 2021 Thalassemia in Brunei Darussalam. | Chong SC, Metassan S, Yusof N, Idros R, Johari N, Zulkipli IN, Ghani H, Lim MA, Taib S, Lu ZH, Abdul-Hamid MRW | Hemoglobin | 2022 |
| Clinical Severity of β-Thalassemia Pediatric Patients in Myanmar. | Khaing AA, Myint PP, Paiboonsukwong K, Win N, Fucharoen S, Sripichai O | Hemoglobin | 2022 |
| Thalassemia in India. | Colah RB, Seth T | Hemoglobin | 2022 |
| Thalassemia in Sri Lanka. | Premawardhena AP, Madushanka HDP | Hemoglobin | 2022 |
| Thalassemia in Asia 2021 Overview of Thalassemia and Hemoglobinopathies in Bangladesh. | Chowdhury MA, Sultana R, Das D | Hemoglobin | 2022 |
| Thalassemia Status in Cambodia. | Sophâl C | Hemoglobin | 2022 |
| Introduction to the Special Issue. | Fucharoen S, Ping C, Paiboonsukwong K | Hemoglobin | 2022 |
| Thalassemia in Pakistan. | Khaliq S | Hemoglobin | 2022 |
| Thalassemia in the Philippines. | Yuson ED, Naranjo MLT | Hemoglobin | 2022 |
| Thalassemia in Indonesia. | Wahidiyat PA, Sari TT, Rahmartani LD, Iskandar SD, Pratanata AM, Yapiy I, Setianingsih I, Atmakusuma TD, Lubis AM | Hemoglobin | 2022 |
| Current Status of Thalassemia in Lao People's Democratic Republic. | Phengsavanh A, Sengchanh S, Souksakhone C, Souvanlasy B, Sychareun V | Hemoglobin | 2022 |
| Thalassemia in Viet Nam. | Bach KQ, Nguyen HTT, Nguyen TH, Nguyen MB, Nguyen TA | Hemoglobin | 2022 |
| Thalassemia in Malaysia. | Alwi ZB, Syed-Hassan SR | Hemoglobin | 2022 |
| THALASSEMIA in ASIA 2021: Thalassemia in Guangxi Province, People's Republic of China. | Chen P, Lin WX, Li SQ | Hemoglobin | 2022 |
| Pregnancy in the Sickle Cell Disease and Fetomaternal Outcomes in Different Sickle cell Genotypes: A Systematic Review and Meta-Analysis. | Aghamolaei T, Pormehr-Yabandeh A, Hosseini Z, Roozbeh N, Arian M, Ghanbarnezhad A | Ethiop J Health Sci | 2022 |
| A model of painful vaso-occlusive crisis in mice with sickle cell disease. | Khasabova I, Juliette J, Rogness VM, Khasabov SG, Golovko MY, Golovko SA, Kiven SB, Gupta K, Belcher JD, Vercellotti GM, Seybold V, Simone DA | Blood | 2022 |
| Efficacy and Safety of Hydroxyurea as Adjuvant Therapy in Pediatric Patients of Transfusion-Dependent Beta-Thalassemia Major at Zhob, Balochistan. | Akram S, Khan Khattak SA, Khan MA | Cureus | 2022 |
| Bone Mineral Density, Serum Calcium, and Vitamin D Levels in Adult Thalassemia Major Patients: Experience From a Single Center in Eastern India. | Santra S, Sharma K, Dash I, Mondal S, Mondal H | Cureus | 2022 |
| Phosphatidylserine-exposed red blood cells and ineffective erythropoiesis biomarkers in patients with thalassemia. | Chansai S, Yamsri S, Fucharoen S, Fucharoen G, Teawtrakul N | Am J Transl Res | 2022 |
| Hb Kirikiriroa [α57(E6)Gly→Cys; : c.172G>T]: A Novel Unstable α-Globin Variant with Oxidized Derivatives Interfering with Hb A. | Moore JA, Pullon BM, Wang D, Monaghan J, Moore H | Hemoglobin | 2022 |
| Relationship between Serum Ferritin and Outcomes in β-Thalassemia: A Systematic Literature Review. | Shah F, Huey K, Deshpande S, Turner M, Chitnis M, Schiller E, Yucel A, Moro Bueno L, Oliva EN | J Clin Med | 2022 |
| Does G6PD deficiency cause further damage to red blood cells of patients with sickle cell anaemia? | Esperti S, Boisson C, Robert M, Nader E, Cibiel A, Renoux C, Horrand F, Gauthier A, Poutrel S, Joly P, Connes P | Br J Haematol | 2022 |
| Inpatient palliative care use by patients with sickle cell disease: a retrospective cross-sectional study. | Nwogu-Onyemkpa E, Dongarwar D, Salihu HM, Akpati L, Marroquin M, Abadom M, Naik AD | BMJ Open | 2022 |
| High incidence of suicidal ideation in a series of sickle cell patients after hematopoietic stem cell transplantation. | Mishkin AD, Cheung SG, Hoffman A, Leimbach EJ, Dosovitz SM, Mapara MY | Blood Adv | 2022 |
| Reassessing the Need for Preoperative Transfusions in Sickle Cell Disease Patients with an Elevated Baseline Hemoglobin-a Retrospective Study. | Yan A, Tole S, Bair L, Wagner A, Tang K, Kirby-Allen M, Simpson E, Williams S | J Pediatr Hematol Oncol | 2022 |
| Evaluation of Glutamine Utilization in Patients With Sickle Cell Disease. | Wu HW, Gannon M, Hsu LL | J Pediatr Hematol Oncol | 2022 |
| Preoperative Transfusion and Surgical Outcomes for Children with Sickle Cell Disease. | Salvi PS, Solomon DG, Cowles RA | J Am Coll Surg | 2022 |
| The use of pluripotent stem cells to generate diagnostic tools for transfusion medicine. | An HH, Gagne AL, Maguire JA, Pavani G, Abdulmalik O, Gadue P, French DL, Westhoff CM, Chou ST | Blood | 2022 |
| Elucidating Parasite and Host Cell Factors Enabling Babesia Infection in Sickle Red Cells under Hypoxic/Hyperoxic Conditions. | Beri D, Singh M, Rodriguez MA, Barbu-Stevanovic M, Rasquinha G, Mendelson A, An X, Manwani D, Yazdanbakhsh K, Lobo CA | Blood Adv | 2022 |
| High incidence of malaria in patients with sickle cell disease. | Mkombachepa M, Khamis B, Rwegasira G, Urio F, Makani J, Luzzatto L | Am J Hematol | 2022 |
| Sleep quality and pain in adolescents and young adults with sickle cell disease. | Schlenz AM, Thomas SJ, Gloston G, Lebensburger J, Maxwell SL, Kanter J | J Clin Sleep Med | 2022 |
| Prognosis and Overall Survival of Thalassemia Patients using Semi-Parametric Mixture Cure-Rate Model: a 30-Year Retrospective Cohort Study. | Zekavat OR, Bozorgi H, Bordbar M, Shakibazad N, Ebrahimi V | Clin Lab | 2022 |
| study of the effect of high temperature on erythrocytes in sickle cell trait. | Aljohani MM | Niger J Clin Pract | 2022 |
| Depression among patient with sickle cell disease: Prevalence and prediction. | Alsalman M, Alhabrati A, Alkuwaiti A, Alramadhan N, AlMurayhil N, Althafar A, Alsaad A | Niger J Clin Pract | 2022 |
| Red Blood Cell Immunization and Contributing Factors in 685 Thalassemia Patients. | Shaiegan M, Moghaddam M, Maghsudlu M, Azarkeivan A, Zolfaghari S, Pourfatollah AA, Soleimanzadeh P, Shahverdi E | Int J Hematol Oncol Stem Cell Res | 2022 |
| RS12574989 and haplotype associated with α/β-chain imbalance and population HbA2 reduction. | Lin Q, Xie Y, Zhong X, Sun X, Wang D | BMC Med Genomics | 2022 |
| Endothelial VWF is critical for the pathogenesis of vaso-occlusive episode in a mouse model of sickle cell disease. | Shi H, Shao B, Gao L, Venkatesan T, McDaniel JM, Zhou M, McGee S, Yu P, Ahamed J, Journeycake J, George JN, Xia L | Proc Natl Acad Sci U S A | 2022 |
| Life beyond alpha-thalassaemia: We are moving forward. | Torti L | Br J Haematol | 2022 |
| Co-occurrence of oculocutaneous albinism type 2 and mild sickle cell disease explained by HbS/βthal genotype in an individual from the Democratic Republic of Congo. | Aquaron R, Lasseaux E, Kelekele J, Bonello-Palot N, Badens C, Arveiler B, Tshilolo L | Eur J Med Genet | 2022 |
| Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study. | Kuo KHM, Layton DM, Lal A, Al-Samkari H, Bhatia J, Kosinski PA, Tong B, Lynch M, Uhlig K, Vichinsky EP | Lancet | 2022 |
| Characteristics and outcomes of stroke hospitalizations in patients with sickle cell disease and moyamoya syndrome. | Rallo MS, Akel O, Kalakoti P, Sun H | J Stroke Cerebrovasc Dis | 2022 |
| Screening for sickle-cell retinopathy. | Ashwin PT, Sivaraj R | Eye (Lond) | 2022 |
| Simple open-heart surgery protocol for sickle-cell disease patients: a retrospective cohort study comparing patients undergoing mitral valve surgery. | Epis F, Chatenoud L, Somaschini A, Bitetti I, Cantarero F, Salvati AC, Rocchi D, Lentini S, Giovanella E, Portella G, Langer M | Interact Cardiovasc Thorac Surg | 2022 |
| Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years. | Elalfy MS, Hamdy M, El Beshlawy A, Ebeid FSE, Badr M, Kanter J, Inusa BP, Adly A, Williams S, Kilinc Y, Lee D, Fradette C, Rozova A, Toiber Temin N, Tricta F, Kwiatkowski JL | Blood Adv | 2022 |
| A case-control and seven-year longitudinal neurocognitive study of adults with sickle cell disease in Ghana. | Ampomah MA, Drake JA, Anum A, Amponsah B, Dei-Adomakoh Y, Anie K, Mate-Kole CC, Jonassaint CR, Kirkham FJ | Br J Haematol | 2022 |
| Hypothesis: Low Vitamin A and D Levels Worsen Clinical Outcomes When Children with Sickle Cell Disease Encounter Parvovirus B19. | Penkert RR, Azul M, Sealy RE, Jones BG, Dowdy J, Hayden RT, Tang L, Ross AC, Hankins JS, Hurwitz JL | Nutrients | 2022 |
| Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy. | Kassim AA, Leonard A | J Clin Med | 2022 |
| How Hydroxyurea Alters the Gut Microbiome: A Longitudinal Study Involving Angolan Children with Sickle Cell Anemia. | Delgadinho M, Ginete C, Santos B, Fernandes C, Silva C, Miranda A, Vasconcelos JN, Brito M | Int J Mol Sci | 2022 |
| Genetic Background Studies of Eight Common Beta Thalassemia Mutations in Thailand Using β-Globin Gene Haplotype and Phylogenetic Analysis. | Karnpean R, Tepakhan W, Suankul P, Thingphom S, Poonsawat A, Thanunchaikunlanun N, Ruangsanngamsiri R, Jomoui W | Genes (Basel) | 2022 |
| Feasibility and Quality Validation of a Mobile Application for Enhancing Adherence to Opioids in Sickle Cell Disease. | Sop DM, Crouch T, Zhang Y, Lipato T, Wilson J, Smith WR | Healthcare (Basel) | 2022 |
| New Entity-Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement. | Carsote M, Vasiliu C, Trandafir AI, Albu SE, Dumitrascu MC, Popa A, Mehedintu C, Petca RC, Petca A, Sandru F | Diagnostics (Basel) | 2022 |
| Significance of Cardiac Magnetic Resonance Feature Tracking of the Right Ventricle in Predicting Subclinical Dysfunction in Patients with Thalassemia Major. | Das KM, Baskaki UMA, Pulinchani A, Ali HM, Almanssori TM, Gorkom KV, Das A, Dewedar H, Sharma S | Diagnostics (Basel) | 2022 |
| Quantification of human embryonic ζ-globin chains in Southeast Asian deletion (--) carriers. | Ye Y, Sun G, Ren Z, Liang Y, Luo H, Lin P, Wang X, Dong Z, Huang L, Qin L, Yu W, Wang G, Zhou Y, Tang J, Lou J, Liu Y, Zeng X, Chen Y, Li Y, Zhang Q, Huang J, Zhu P, Lin L, Zhang X, Xu X | J Clin Pathol | 2022 |
| Luspatercept in patients with non-transfusion dependent β-thalassaemia. | Platzbecker U, Morison JK | Lancet Haematol | 2022 |
| Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial. | Taher AT, Cappellini MD, Kattamis A, Voskaridou E, Perrotta S, Piga AG, Filosa A, Porter JB, Coates TD, Forni GL, Thompson AA, Tartaglione I, Musallam KM, Backstrom JT, Esposito O, Giuseppi AC, Kuo WL, Miteva D, Lord-Bessen J, Yucel A, Zinger T, Shetty JK, Viprakasit V, | Lancet Haematol | 2022 |
| Paracentral Acute Middle Maculopathy with Sickle Cell Trait. | Baker M, Neuhouser A, Nazari H | Retin Cases Brief Rep | 2022 |
| In vivo base editing by a single intravenous vector injection for treatment of hemoglobinopathies. | Li C, Georgakopoulou A, Newby GA, Everette KA, Nizamis E, Paschoudi K, Vlachaki E, Gil S, Anderson AK, Koob T, Huang L, Wang H, Kiem HP, Liu DR, Yannaki E, Lieber A | JCI Insight | 2022 |
| Haptoglobin 1 Allele Predicts Higher Serum Haptoglobin and Lower Multiorgan Failure Risk in Sickle Cell Disease. | Ruiz MAD, Shah BN, Ren G, Hussain F, Njoku F, Machado RF, Gordeuk VR, Saraf SL | Blood Adv | 2022 |
| Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-Thalassemia: additional dose role. | Carsetti R, Agrati C, Pinto VM, Gianesin B, Gamberini MR, Fortini M, Barella S, Denotti AR, Perrotta S, Casale M, Maggio A, Pitrolo L, Tartaglia E, Piano Mortari E, Colavita F, Puro V, Francalancia M, Marini V, Caminati M, Mazzi F, De Franceschi L, Forni GL, Locatelli F | Blood | 2022 |
| Identification of a rare compound heterozygous hemoglobin variant β0-thal [β17(A14) Lys>Stop, HBB: c.52A>T] and Hb J-Lome [β59(E3) Lys>Asn, HBB: c.180G>C]. | Chen Z, Shao L, Jiang M, Ma R, Ping H, Wang Z, Ba X, Ma B, Zhou T | Hematology | 2022 |
| Survival and late effects of hematopoietic cell transplantation in patients with thalassemia major. | Santarone S, Angelini S, Natale A, Vaddinelli D, Spadano R, Casciani P, Papola F, Di Lembo E, Iannetti G, Di Bartolomeo P | Bone Marrow Transplant | 2022 |
| PATTERN DYSTROPHY-LIKE CHANGES ASSOCIATED WITH A VERY HIGH SERUM FERRITIN LEVEL IN β-THALASSEMIA MAJOR. | Kurnia KH, Elvioza E, Sidik M, Sari TT, Sitorus RS | Retin Cases Brief Rep | 2022 |
| Thalassaemia Registries: A Call for Action. A Position Statement from the Thalassaemia International Federation. | Farmakis D, Angastiniotis M, El Ghoul MM, Cannon L, Eleftheriou A | Hemoglobin | 2022 |
| Rare Pathogenic β-Thalassemia Mutation, Codon 7 (AG>AG) (: c.22G>T). Report of the First Two Cases in Albanian Immigrants of Northern Greece. | Zarkada E, Yfanti E, Teli A, Balassopoulou A, Sinopoulou K, Theodoridou S | Hemoglobin | 2022 |
| Effect of deletions in the α-globin gene on the phenotype severity of β-thalassemia. | Saha D, Chowdhury PK, Panja A, Pal D, Nayek K, Chakraborty G, Sharma P, Das R, Basu S, Chatterjee R, Basu A | Hemoglobin | 2022 |
| A New Hemoglobin Variant, Hb Natal (: c.423C>A), Found in a Greek Family. | Efstathiou A, Boutou E, Teli A, Drikos I, Balassopoulou A, Theodoridou S | Hemoglobin | 2022 |
| The role of opportunistic quantitative computed tomography in the evaluation of bone disease and risk of fracture in thalassemia major. | Carnevale A, Pellegrino F, Bravi B, Gamberini MR, Gagliardi I, Reverberi R, Zatelli MC, Giganti M, Ambrosio MR | Eur J Haematol | 2022 |
| Sickle Cell Disease Presenting as Extradural Hematoma: An Extremely Rare Fatal Crisis. | Shah D, Reddy H, Kumar S, Acharya S | Cureus | 2022 |
| Precision Medicine and Sickle Cell Disease. | El Hoss S, El Nemer W, Rees DC | Hemasphere | 2022 |
| Hyperbilirubinemia Following Retroperitoneal Mass Resection in a Patient with Sickle Cell Anemia. | de la Calle CM, Young ED, Singla N | Urology | 2022 |
| Economic burden and catastrophic cost among people living with sickle cell disease, attending a tertiary health institution in south-east zone, Nigeria. | Amarachukwu CN, Okoronkwo IL, Nweke MC, Ukwuoma MK | PLoS One | 2022 |
| Identifying Chronic Pain Subgroups in Pediatric Sickle Cell Disease: A Cluster-Analytic Approach. | Sil S, Manikowski A, Schneider M, Cohen LL, Dampier C | Clin J Pain | 2022 |
| Age- and sex-specific rates of gall bladder disease in children with sickle cell disease. | Agawu A, Shults J, Smith-Whitley K, Feudtner C | Pediatr Blood Cancer | 2022 |
| Conservative and medical treatments of non-sickle cell disease-related ischemic priapism: a systematic review by the EAU Sexual and Reproductive Health Panel. | Capogrosso P, Dimitropolous K, Russo GI, Tharakan T, Milenkovic U, Cocci A, Boeri L, Gül M, Bettocchi C, Carvalho J, Kalkanlı A, Corona G, Hatzichristodoulou G, Jones HT, Kadioglu A, Martinez-Salamanca JI, Modgil V, Serefoglu EC, Verze P, Salonia A, Minhas S, | Int J Impot Res | 2022 |
| Comparison of anti-Mullerian hormone levels pre- and post-hematopoietic cell therapy in pediatric and adolescent females with sickle cell disease. | George SA, Lai KW, Lewis RW, Bryson EW, Haight AE, Meacham LR | Transplant Cell Ther | 2022 |
| Sickle cell disease and the incidence and etiology of preterm birth. | Fashakin V, Weber JM, Truong T, Craig A, Wheeler SM, James AH | Am J Obstet Gynecol MFM | 2022 |
| Essential strategies and tactics for managing sickle cell disease. | Perkins RA, Payne-Johnson A, Jefferson R | J Fam Pract | 2022 |
| Combined Gap-Polymerase Chain Reaction and Targeted Next-Generation Sequencing Improve α- and β-Thalassemia Carrier Screening in Pregnant Women in Vietnam. | Lam TT, Nguyen DT, Le QT, Nguyen DA, Hoang DT, Nguyen HD, Nguyen CC, Doan KPT, Tran NT, Ha TMT, Trinh THN, Nguyen VT, Lam DT, Le MT, Nguyen XT, Ho TT, Tran TH, Ho VT, Bui TV, Nguyen VT, Hoang PB, Nguyen HT, Nguyen MH, Vo TB, Le DN, Truong TN, Dao HT, Vo PN, Nguyen TV, Tran NT, Tran QT, Van YT, Nguyen TT, Huynh BT, Nguyen TT, Tran KT, Nguyen CT, Doan PL, Nguyen TD, Do TT, Truong DK, Tang HS, Cao NT, Phan MD, Giang H, Nguyen HN | Hemoglobin | 2022 |
| Severe cases of COVID-19 in children with sickle cell disease during the Omicron wave in France: a plea for vaccination. | Eyssette-Guerreau S, Khimoud D, Michaux K, Odièvre MH, Allali S, Pertuisel S, Guillaumat C, Monfort M, Guitton C, Miquel A, Runel C, Gauthier A, Arlet JB | Br J Haematol | 2022 |
| Incidence of Deep Venous Thrombosis and Sickle Cell Disease in Patients Undergoing Spinal Surgery in South Gujarat, India: A Prospective Observational Study. | Menon HJ, Khanna AP, Patel YB | Malays Orthop J | 2022 |
| Nasopharyngeal Carriage and Antibiogram of Pneumococcal and Other Bacterial Pathogens from Children with Sickle Cell Disease in Tanzania. | Mutagonda RF, Bwire G, Sangeda RZ, Kilonzi M, Mlyuka H, Ndunguru J, Jonathan A, Makani J, Minja IK, Ruggajo P, Balandya E, Kamuhabwa AAR | Infect Drug Resist | 2022 |
| Lidocaine and Ketamine Infusions as Adjunctive Pain Management Therapy: A Retrospective Analysis of Clinical Outcomes in Hospitalized Patients Admitted for Pain Related to Sickle Cell Disease. | Zavala NA, Knoebel RW, Anitescu M | Front Pain Res (Lausanne) | 2022 |
| Folate levels in children with sickle cell anaemia on folic acid supplementation in steady state and crises at a tertiary hospital in Enugu, Nigeria: a prospective, comparative study. | Nnajekwu UC, Nnajekwu CO, Onukwuli VO, Chukwu BF, Ikefuna AN, Emodi IJ | Malawi Med J | 2022 |
| Identifying Gingival Pigmentation Patterns and Skin Color and Its Co-relation With Serum Ferritin Levels in Thalassemic Patients. | Gajjar S, Kaur H, Girdhar G, Kaur A, Patel C, Mehta R, Bhakkand S, Hirani T, Joshi S, Irfan M, Binti Wan Ahmad Fakuradzi WFS, Sinha S, Haque M, Kumar S | Cureus | 2022 |
| The Day I Relearned the Sickle Cell Crisis. | Hibbs S, Shaniqua M | Hemasphere | 2022 |
| Prevalence of hypogonadism in transfusion-dependent β-thalassemia patients of Bangladesh: investigating the role of serum ferritin level as a diagnostic tool. | Chowdhury R, Iktidar MA, Ahmed MN, Hasan MM, Tapan MMH, Shaheen SSI, Rahman A, Khatun A | Hematol Transfus Cell Ther | 2022 |
| Cervical Joint Position Sense in Individuals With Type 2 Diabetes and Its Correlations With Glycated Hemoglobin Levels: A Cross-Sectional Study. | Reddy RS, Alshahrani MS, Tedla JS, Asiri F, Nambi G, Kakaraparthi VN | J Manipulative Physiol Ther | 2022 |
| Red blood cell alloimmunization and other transfusion-related complications in patients with transfusion-dependent thalassemia: A multi-center study in Thailand. | Teawtrakul N, Songdej D, Hantaweepant C, Tantiworawit A, Lauhasurayotin S, Torcharus K, Sripornsawan P, Sutcharitchan P, Surapolchai P, Komvilaisak P, Saengboon S, Pongtanakul B, Charoenkwan P, | Transfusion | 2022 |
| Doing more with less: Patient blood management meets sickle cell disease management. | Lauridsen L, Campbell-Lee SA | Transfusion | 2022 |
| HbS promotes TLR4-mediated monocyte activation and pro-inflammatory cytokine production in sickle cell disease. | Allali S, Rignault-Bricard R, De Montalembert M, Taylor M, Bouceba T, Hermine O, Maciel TT | Blood | 2022 |
| Retrospective Analysis of Thalassemia Patients in Secondary Care Hospital: Ras Al Khaimah, United Arab Emirates. | Assadi RR, Sadhu S, Fatima F, Bhat R, Shivappa P | Adv Biomed Res | 2022 |
| The Long-Term Efficacy of Deferiprone in Thalassemia Patients With Iron Overload: Real-World Data from the Registry Database. | Kittipoom T, Tantiworawit A, Punnachet T, Hantrakun N, Piriyakhuntorn P, Rattanathammethee T, Hantrakool S, Chai-Adisaksopha C, Rattarittamrong E, Norasetthada L, Fanhchaksai K, Charoenkwan P | Hemoglobin | 2022 |
| A Randomized Clinical Trial of the Efficacy and Safety of Rivipansel for Sickle Cell Vaso-occlusive Crisis (VOC). | Dampier CD, Telen MJ, Wun T, Brown C, Desai PC, El Rassi F, Fuh B, Kanter J, Pastore YD, Rothman J, Taylor JG, Readett D, Sivamurthy KM, Tammara B, Tseng LJ, Lozier JN, Thackray HM, Magnani JL, Hassell K | Blood | 2022 |
| [Molecular Epidemiological Characteristics and Differential Diagnosis of Common δβ-Thalassemia/HPFH]. | Ju AP, Li N, Lin K, Huang HH, Liu SX, Jiang F | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| P-selectin deficiency promotes liver senescence in sickle cell disease mice. | Vats R, Kaminski TW, Ju E-M, et al. | Blood | 2022 |
| Internalizing Symptoms in Adolescents With Sickle Cell Disease. | Heitzer AM, Longoria J, Porter JS, MacArthur E, Potter B, Ding J, Gossett J, Kang G, Hankins JS | J Pediatr Psychol | 2022 |
| β-Thalassemia Intermedia Caused by the β-Globin Gene 3' Untranslated Region: Another Case Report. | Jiang F, Chen GL, Li J, Tang XW, Li DZ | Hemoglobin | 2022 |
| Molecular Epidemiology and Hematologic Characterization of Thalassemia in Guangdong Province, Southern China. | Xian J, Wang Y, He J, Li S, He W, Ma X, Li Q | Clin Appl Thromb Hemost | 2022 |
| Special issue: Pediatric pain and sickle cell disease. | Brown M, Anheyer D, Morris CR | Complement Ther Med | 2022 |
| Amino acid signature during sickle cell pain crisis shows significant alterations related to nitric oxide and energy metabolism. | Zhou Y, Yu X, Nicely A, Cunningham G, Challa C, McKinley K, Nickel R, Campbell A, Darbari D, Summar M, Majumdar S | Mol Genet Metab | 2022 |
| Metabolic Bone Disease in Children with Transfusion-Dependent Thalassemia. | Handattu K, Aroor S, Kini P, Bhat Y R, Shivakumar G, Shastry P, Shetty S | Indian Pediatr | 2022 |
| Parvovirus b19 infection in children with sickle cell disease, watch out for splenomegaly! A case report. | de la Hoz JA, Otones LL, Sáenz MH, Martín MJR | Afr Health Sci | 2022 |
| Clinical Study of Mobile Application- (App-) Based Family-Centered Care (FCC) Model Combined with Comprehensive Iron Removal Treatment in Children with Severe Beta Thalassemia. | Chen Y, Huang X, Lu Q, Lu J, Huang X, Luo Y, Huang F | Appl Bionics Biomech | 2022 |
| Neurocognitive functioning in children with sickle cell anemia and history of abnormal transcranial doppler ultrasonography. | Longoria JN, Wang W, Kang G, Gossett J, Krull K, King AA, Raches D, Schreiber J, Heitzer AM, Hankins JS | Pediatr Blood Cancer | 2022 |
| The NLRP3 inflammasome fires up heme-induced inflammation in hemolytic conditions. | Salgar S, Bolívar BE, Flanagan JM, Anum SJ, Bouchier-Hayes L | Transl Res | 2022 |
| Characterizing User Engagement With a Digital Intervention for Pain Self-management Among Youth With Sickle Cell Disease and Their Caregivers: Subanalysis of a Randomized Controlled Trial. | Lalloo C, Nishat F, Zempsky W, Bakshi N, Badawy S, Ko YJ, Dampier C, Stinson J, Palermo TM | J Med Internet Res | 2022 |
| Normalization of cerebral hemodynamics following hematopoietic stem cell transplant in children with sickle cell disease. | Hulbert ML, Fields ME, Guilliams KP, Bijlani P, Shenoy S, Fellah S, Towerman AS, Binkley MM, McKinstry RC, Shimony JS, Chen Y, Eldeniz C, Ragan DK, Vo KD, An H, Lee JM, Ford AL | Blood | 2022 |
| Blood transfusion and iron overload in patients with Sickle Cell Disease (SCD): Personal experience and a short update of diabetes mellitus occurrence. | Soliman AT, De Sanctis V, Yassin M, Alshurafa A, Ata F, Nashwan A | Acta Biomed | 2022 |
| A Short Review on Growth and Endocrine Long-term Complications in Children and Adolescents with β-Thalassemia Major: Conventional Treatment versus Hematopoietic Stem Cell Transplantation. | Ahmed S, Soliman A, De Sanctis V, Alaaraj N, Alyafei F, Hamed N, Yassin M | Acta Biomed | 2022 |
| The prevalence of sickling abnormality in Oman: A review of relevant publications | Al-Mashaikhi N, Al-Rawas A, Wali Y, Soliman A, Khater D | Acta Biomed | 2022 |
| Novel insights into heme binding to hemoglobin. | Hopp MT, Rathod DC, Winn KH, Ambast S, Imhof D | Biol Chem | 2022 |
| multiscale drug design to discover key structural features of potential JAK2 inhibitors. | Kamsri P, Punkvang A, Taveepanich S, Ketrat S, Saparpakorn P, Hannongbua S, Suttisintong K, Pangjit K, Pungpo P | Future Med Chem | 2022 |
| NETs in sickle cell disease, quo vadis? | Torres LS, Hidalgo A | Blood | 2022 |
| Advanced clinical parameters: A complementary hydroxyurea adherence evaluation in sickle cell anemia treatment. | Moreira ID, Lessa CLM, Rocha GLG, Schmitz LD, Jahnke VS, Fogliatto LM, Werlang MC, Rotta LN | Eur J Haematol | 2022 |
| Hydroxyurea (hydroxycarbamide) for sickle cell disease. | Rankine-Mullings AE, Nevitt SJ | Cochrane Database Syst Rev | 2022 |
| A | Kajihara Y | QJM | 2022 |
| Efficacy of CRISPR-Based Gene Editing in a Sickle Cell Disease Patient as Measured through the Eye. | Pinhas A, Zhou DB, Otero-Marquez O, Castanos Toral MV, Migacz JV, Glassberg J, Rosen RB, Chui TYP | Case Rep Hematol | 2022 |
| The significance of spleen size in children with sickle cell anemia. | Nardo-Marino A, Glenthøj A, Brewin JN, Petersen J, Braunstein TH, Kurtzhals JAL, Williams TN, Rees DC | Am J Hematol | 2022 |
| Adherence to NHLBI guidelines for the emergent management of vaso-occlusive episodes in children with sickle cell disease: A multicenter perspective. | Rees CA, Brousseau DC, Ahmad FA, Bennett J, Bhatt S, Bogie A, Brown KM, Casper TC, Chapman LL, Chumpitazi CE, Cohen DM, Dampier C, Ellison AM, Grasemann H, Hickey RW, Hsu LL, Lane PA, Bakshi N, Leibovich S, Patil P, Powell EC, Richards R, Sarnaik S, Weiner DL, Morris CR, | Am J Hematol | 2022 |
| Algorithm-based selection of automated red blood cell exchange procedure goals reduces blood utilization in chronically transfused adults with sickle cell disease. | Buban KR, Lawrence CE, Zhu XJ, Tobian AAR, Gehrie EA, Vozniak S, Shrestha R, Lokhandwala PM, Bloch EM | J Clin Apher | 2022 |
| Application of the Single-Molecule Real-Time Technology (SMRT) for Identification of HKαα Thalassemia Allele. | Zhang M, Lin Z, Chen M, Pan Y, Zhang Y, Chen L, Lin N, Ren Y, Jia H, Cai M, Xu L, Huang H | Lab Med | 2022 |
| Homozygosity for the hyperunstable hemoglobin variant Hb Agrinio (HBA2:c.89T>C) leads to severe antenatal anemia: Eight new cases in three families. | Szepetowski S, Berger C, Joly P, Baron-Joly S, Huguenin Y, Cantais A, Brun S, Ged C, Badens C, Thuret I, Giansily-Blaizot M, Pissard S, Aguilar-Martinez P | Am J Hematol | 2022 |
| An evaluation of cardiopulmonary endurance and muscular strength in adults living with sickle cell disease. | Ogunsile FJ, Stewart KJ, Kanter J, Lanzkron SM | Br J Haematol | 2022 |
| Targeting TRPV1 activity via high-dose capsaicin in patients with sickle cell disease. | Glaros AK, Callaghan MU, Smith WR, Zaidi AU | EJHaem | 2022 |
| Management of acute sickle cell priapism in an African (Togo) pediatric department includes conservative measures and intracavernous epinephrine which is safe and efficacious. | Guedenon KM, Fiawoo M, Akolly DAE, Akpako E, Esso B, Dossou FC, Gbadoe AD | EJHaem | 2022 |
| Adverse events of red blood cell transfusions in patients with sickle cell disease. | Rollins MR, Chou ST | Transfus Apher Sci | 2022 |
| Early prenatal diagnosis of hemoglobinopathies by celocentesis is ready for use in routine clinical practice. | Giambona A, Leto F, Cassarà F, Tartaglia V, Marchese G, Orlandi E, Cigna V, Picciotto F, Maggio A, Vinciguerra M | Int J Lab Hematol | 2022 |
| Detection of hemoglobin H disease by long molecule sequencing. | Li Y, Liang L, Qin T, Tian M | J Clin Lab Anal | 2022 |
| The role of MRI-R2* in the detection of subclinical pancreatic iron loading among transfusion-dependent sickle cell disease patients and correlation with hepatic and cardiac iron loading. | Raief Mosaad BM, Ibrahim AS, Mansour MG, ElAlfy MS, Ebeid FSE, Abdeldayem EH | Insights Imaging | 2022 |
| Kinetics of lipid radical formation in lipoproteins from β-thalassemia: Implication of cholesteryl esters and α-tocopherol. | Lerksaipheng P, Paiboonsukwong K, Sanvarinda P, Leuchapudiporn R, Yamada KI, Morales NP | Biomed Pharmacother | 2022 |
| Erythrocytic vacuoles that accumulate a fluorescent dye predict spleen size and function in sickle cell disease. | Sissoko A, Fricot-Monsinjon A, Roussel C, Manceau S, Dumas L, Capito C, Allali S, Yekkache N, Dussiot M, Nguyen Y, Lefort Des Ylouses A, Aussilhou B, Tichit M, Hardy D, Maître B, Eckly A, De Montalembert M, Cavazzana M, Joseph L, Buffet P | Am J Hematol | 2022 |
| UK NEQAS Haematology pilot scheme: Reticulocyte haemoglobin content quantitation. | Mordue KE, Hector Y, Thomas DW, De La Salle BJ | Int J Lab Hematol | 2022 |
| A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs. | Prosdocimi M, Zuccato C, Cosenza LC, Borgatti M, Lampronti I, Finotti A, Gambari R | Wellcome Open Res | 2022 |
| Hyperhemolytic Crisis Following Transfusion in Sickle Cell Disease With Acute Hepatic Crisis: A Case Report. | Trivedi K, Abbas A, Kazmi R, Shaaban H, Miller R | Cureus | 2022 |
| Blood pressure in children with sickle cell disease is higher than in the general pediatric population. | Kupferman JC, Rosenbaum JE, Lande MB, Stabouli S, Wang Y, Forman D, Zafeiriou DI, Pavlakis SG | BMC Pediatr | 2022 |
| Hb Alessandria [β37(C3)Trp→Leu; : c.113G>T]: a Novel Variant on the -Globin Chain with Slightly Increased Affinity for Oxygen Detected by Capillary Electrophoresis. | Calcagno L, Ciriello MM, Maccarini M, Mogni M, Maffei M, Barberio G, Maoggi S, Coviello D, Ivaldi G | Hemoglobin | 2022 |
| The protective effect of the spleen in sickle cell patients. A comparative study between patients with asplenia/hyposplenism and hypersplenism. | Peretz S, Livshits L, Pretorius E, Makhro A, Bogdanova A, Gassmann M, Koren A, Levin C | Front Physiol | 2022 |
| A Comparison of MRI Quantitative Susceptibility Mapping and TRUST-Based Measures of Brain Venous Oxygen Saturation in Sickle Cell Anaemia. | Murdoch R, Stotesbury H, Hales PW, Kawadler JM, Kölbel M, Clark CA, Kirkham FJ, Shmueli K | Front Physiol | 2022 |
| Cardiopulmonary testing in adult patients with β-thalassemia major in comparison to healthy subjects. | Piatti G, Giuditta M, Consonni D, Cassinerio E, Cappellini MD | Ann Hematol | 2022 |
| Transfusion support for patients with sickle cell disease. | Wallace LR, Thibodeaux SR | Transfus Apher Sci | 2022 |
| Predictors of Sex-Induced Crisis, Sexual Function and Marital Satisfaction in Women With Sickle Cell Disease. | Adesoye OB, Akhigbe RE | J Sex Med | 2022 |
| Quantitative T2* MRI for bone marrow iron overload: normal reference values and assessment in thalassemia major patients. | Meloni A, Pistoia L, Restaino G, Missere M, Positano V, Spasiano A, Casini T, Cossu A, Cuccia L, Massa A, Massei F, Cademartiri F | Radiol Med | 2022 |
| Decision-making about gene therapy in transfusion dependent thalassemia. | Quarmyne MO, Ross D, Sinha C, Bakshi N, Boudreaux J, Krishnamurti L | BMC Pediatr | 2022 |
| Genetic modulation of anemia severity, hemolysis level, and hospitalization rate in Angolan children with Sickle Cell Anemia. | Germano I, Santos B, Delgadinho M, Ginete C, Lopes P, Arez AP, Brito M, Faustino P | Mol Biol Rep | 2022 |
| Umbilical cord blood as a hematopoietic stem cell source in transplantation for pediatric sickle cell disease: current challenges and strategies. | Malhotra M, Shenoy S | Transfus Apher Sci | 2022 |
| Sickle cell disease in the new era: advances in drug treatment. | Lee MT, Ogu UO | Transfus Apher Sci | 2022 |
| Evaluating Associations between Average Pain Intensity and Genetic Variation in People with Sickle Cell Disease: An Exploratory Study. | Knisely MR, Yang Q, Stauffer N, Kenney M, Ashley-Koch A, Myers J, Walker JKL, Tanabe PJ, Shah NR | Pain Manag Nurs | 2022 |
| Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center. | Hulbert ML, Manwani D, Meier ER, Alvarez OA, Brown RC, Callaghan MU, Campbell AD, Coates TD, Frei-Jones MJ, Hankins JS, Heeney MM, Hsu LL, Lebensburger JD, Quinn CT, Shah N, Smith-Whitley K, Thornburg C, Kanter J | Pediatr Blood Cancer | 2022 |
| Barriers to hydroxyurea use from the perspectives of providers, individuals with sickle cell disease, and families: Report from a U.S. regional collaborative. | Treadwell MJ, Du L, Bhasin N, Marsh AM, Wun T, Bender MA, Wong TE, Crook N, Chung JH, Norman S, Camilo N, Cavazos J, Nugent D | Front Genet | 2022 |
| Health-related quality of life in hemoglobinopathies: A systematic review from a global perspective. | Rodigari F, Brugnera G, Colombatti R | Front Pediatr | 2022 |
| Association of laboratory markers and cerebral blood flow among sickle cell anemia children. | Adanho CSA, Yahouédéhou SCMA, Santana SS, Vieira C, Santiago RP, de Santana JM, Pitanga TN, Aleluia MM, Maffili VV, Leite IPR, Zanette DL, Lyra IM, Goncalves MS | Front Pediatr | 2022 |
| Frequency of serious bacterial infection among febrile sickle cell disease children in the era of the conjugate vaccine: A retrospective study. | Alzomor O, Aljobair F, Al Kasim F, Azmet F, Alorini S, Alshihayb Y, Bahamdan Y | Int J Pediatr Adolesc Med | 2022 |
| An Urgent Need for Local Guidelines to Address Phosphate Homeostasis in Children with Transfusion-dependent β-thalassemia Major. | Jafri L, Farooqui AJ, Khan AH | J Coll Physicians Surg Pak | 2022 |
| Prevalence of people with sickle cell disease and leg ulcers in Brazil: Socioeconomic and clinical overview. | Spira JAO, Borges EL, Guedes ACM, Andrade PGR, Lima VLAN | PLoS One | 2022 |
| Special Issue: | Ricchi P, Forni GL | J Clin Med | 2022 |
| Does Hepcidin Tuning Have a Role among Emerging Treatments for Thalassemia? | Longo F, Piga A | J Clin Med | 2022 |
| Thalassemia Intermedia: Chelator or Not? | Lee YC, Yen CT, Lee YL, Chen RJ | Int J Mol Sci | 2022 |
| Haploidentical stem cell transplantation for patients with sickle cell disease: current status. | Pawlowska AB, Sun V, Rosenthal J | Transfus Apher Sci | 2022 |
| Diverse Approaches to Gene Therapy of Sickle Cell Disease. | White SL, Hart K, Kohn DB | Annu Rev Med | 2022 |
| Increased myocardial extracellular volume is associated with myocardial iron overload and heart failure in thalassemia major. | Meloni A, Pistoia L, Positano V, De Luca A, Martini N, Spasiano A, Fotzi I, Bitti PP, Visceglie D, Alberini G, Sinagra G, Pepe A, Cademartiri F | Eur Radiol | 2022 |
| The population incidence of thalassemia gene variants in Baise, Guangxi, P. R. China, based on random samples. | Wei B, Zhou W, Peng M, Long J, Wen W | Hematology | 2022 |
| Intravascular hemolysis leads to exaggerated corpus cavernosum relaxation: Implication for priapism in sickle cell disease. | Iacopucci APM, da Silva Pereira P, Pereira DA, Calmasini FB, Pittalà V, Reis LO, Burnett AL, Costa FF, Silva FH | FASEB J | 2022 |
| Antioxidant-Rich Nutraceutical as a Therapeutic Strategy for Sickle Cell Disease. | Ibrahim A, Muhammad SA | J Am Nutr Assoc | 2022 |
| Pulmonary hypertension screening in children with sickle cell disease. | Chan KH, Rizvi SH, De Jesus-Rojas W, Stark JM, Mosquera RA, Prada-Ruiz AC, Gonzales T, Brown DL, Menon NM, Nguyen TT, Jon CK, Yadav A | Pediatr Blood Cancer | 2022 |
| An unusual myositis presentation in a pediatric patient with sickle cell disease. | Ribersani M, Testi AM, Palumbo G, Giordano C, Alfieri G, Filipponi V, Angi A, Moleti ML, Giona F | Pediatr Blood Cancer | 2022 |
| Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion Therapy. | Manganas K, Delicou S, Xydaki A, Koskinas J | Hemoglobin | 2022 |
| The hemoglobinopathies, molecular disease mechanisms and diagnostics. | Harteveld CL, Achour A, Arkesteijn SJG, Ter Huurne J, Verschuren M, Bhagwandien-Bisoen S, Schaap R, Vijfhuizen L, El Idrissi H, Koopmann TT | Int J Lab Hematol | 2022 |
| Understanding pulse oximetry in hematology patients: Hemoglobinopathies, racial differences, and beyond. | Patterson S, Sandercock N, Verhovsek M | Am J Hematol | 2022 |
| Role of Oxidative Stress and the Protective Effect of Fermented Papaya Preparation in Sickle Cell Disease. | Warang PP, Shinde NS, Umare VD, Deshmukh PV, Ghosh K, Madkaikar MR, Colah RB, Mukherjee MB | Hemoglobin | 2022 |
| The Effect of Happiness Training on Psychological Well-Being in Patients with Thalassaemia Major: A quasi-experimental study. | Sargolzaei MS, Shirsavar MG, Allahyari J, Bazi A, Nasirabady AP | Sultan Qaboos Univ Med J | 2022 |
| Evaluating the Effect of Peer Education on the Hope of Patients with Thalassaemia Major: A quasi-experimental study. | Seyedoshohadaee M, Khachian A, Haghani H, Sargolzaei MS | Sultan Qaboos Univ Med J | 2022 |
| Psychological distress and coping strategies among the caretakers of children with transfusion-dependent thalassemia. | Othman A, Abdul Ghani MSA, Taib F, Mohamad N | Front Pediatr | 2022 |
| Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion-independent a murine model of transfusion-dependent β-thalassemia. | Di Modica SM, Tanzi E, Olivari V, Lidonnici MR, Pettinato M, Pagani A, Tiboni F, Furiosi V, Silvestri L, Ferrari G, Rivella S, Nai A | Am J Hematol | 2022 |
| Risk of Premature Atherosclerosis in Children With Transfusion - Dependent Thalassemia: A Twin-Center Study. | Kumaravel KS, Sampathkumar D, Punitha P, Anurekha V, Hema M, Rameshbabu B | Indian Pediatr | 2022 |
| Development and characterization of a preclinical total marrow irradiation conditioning-based bone marrow transplant model for sickle cell disease. | Sargur Madabushi S, Fouda R, Ghimire H, Abdelhamid AMH, Lim JE, Vishwasrao P, Kiven S, Brooks J, Zuro D, Rosenthal J, Guha C, Gupta K, Hui SK | Front Oncol | 2022 |
| Rheumatological picture of a patient having multifocal osteonecrosis associated with sickle cell anemia: a case study. | Hussein AH, Jan AA, Alharbi LK, Khalil KA, Abdelrahman AI, El Sayed SM | Am J Blood Res | 2022 |
| Al-hijamah (the triple S treatment of prophetic medicine) significantly increases CD4/CD8 ratio in thalassemic patients via increasing TAC/MDA ratio: a clinical trial. | El-Shanshory M, Hablas NM, El-Tahlawi R, Awny S, Aboonq MS, Al Jaouni SK, Abdel-Latif TM, Abdel-Gawad AR, Okashah AM, Fakhreldin AR, Baghdadi H, El-Allaf H, Shebel Y, El-Sawy SA, Albeihany A, Mahmoud HS, Sayed AA, Abu-Elnaga MA, Nabo MMH, El-Dardear A, Abdel-Rahman IM, El Sayed SM, Mahmoud AA | Am J Blood Res | 2022 |
| Clinical pathology aspect on diagnosis cholelithiasis in β-Thalassemia patient: A case report. | Maulana MB, Fuadi MR | Ann Med Surg (Lond) | 2022 |
| First and Second Level Haemoglobinopathies Diagnosis: Best Practices of the Italian Society of Thalassemia and Haemoglobinopathies (SITE). | Mandrile G, Barella S, Giambona A, Gigante A, Grosso M, Perrotta S, Scianguetta S, Forni GL | J Clin Med | 2022 |
| Study of Ineffective Erythropoiesis in Thalassemia: Diverse Intrinsic Pathophysiological Features of Erythroid Cells Derived from Various Thalassemia Syndromes. | Kaewsakulthong W, Suriyun T, Chumchuen S, Anurathapan U, Hongeng S, Fucharoen S, Sripichai O | J Clin Med | 2022 |
| Transdermal Maltose-Based Microneedle Patch as Adjunct to Enhance Topical Anesthetic before Intravenous Cannulation of Pediatric Thalassemic Patients Receiving Blood Transfusion: A Randomized Controlled Trial Protocol. | Abdul Jalal MI, Ooi KS, Foo KC, Hamzah AA, Goh CS, Dee CF, Ooi PC, Buyong MR, Low TY, Chua XY, Lau DSC, Abdul Latiff Z, Cheah FC | J Clin Med | 2022 |
| The Roles of Mitophagy and Autophagy in Ineffective Erythropoiesis in β-Thalassemia. | Chaichompoo P, Svasti S, Smith DR | Int J Mol Sci | 2022 |
| A New Model of Hemoglobin Oxygenation. | Lavrinenko IA, Vashanov GA, Hernández Cáceres JL, Buchelnikov AS, Nechipurenko YD | Entropy (Basel) | 2022 |
| Common Single Nucleotide Polymorphism of , an Iron Regulation Gene, Associated with Variable Red Blood Cell Indices in Deletional α-Globin Genotypes. | Suksangpleng T, Glomglao W, Viprakasit V | Genes (Basel) | 2022 |
| Erythropoietin-driven dynamic proteome adaptations during erythropoiesis prevent iron overload in the developing embryo. | Chakraborty S, Andrieux G, Kastl P, Adlung L, Altamura S, Boehm ME, Schwarzmüller LE, Abdullah Y, Wagner MC, Helm B, Gröne HJ, Lehmann WD, Boerries M, Busch H, Muckenthaler MU, Schilling M, Klingmüller U | Cell Rep | 2022 |
| Assessment of coagulation markers, serum zinc and copper in children with beta-thalassemia major in Egypt. | El Sehmawy AA, Hassan DA, Elamir RY, Eldesoky NA, Al Anany MGED, El-Fattah DAA, El Attar S, Abdelbadea A | J Trop Pediatr | 2022 |
| Fetal hemoglobin regulating genetic variants identified in homozygous (HbSS) and heterozygous (HbSA) subjects from South Mexico. | Rizo-de la Torre LC, Borrayo-López FJ, Perea-Díaz FJ, Aquino E, Venegas M, Hernández-Carbajal C, Espinoza-Mata LL, Ibarra-Cortés B | J Trop Pediatr | 2022 |
| Epigenetic analysis in placentas from sickle cell disease patients reveals a hypermethylation profile. | Gil GP, Ananina G, Maschietto M, Lima SCS, da Silva Costa SM, Baptista LC, Ito MT, Costa FF, Costa ML, de Melo MB | PLoS One | 2022 |
| Spontaneous Acute Mesenteric Thrombosis in a Patient With Hemoglobin E Thalassemia. | Asemota J, Ojo AS, Ojukwu SG, Saleh M, Sarma R | J Med Cases | 2022 |
| Impact of sickle cell disease on work activity. | Pires RP, Oliveira MC, Araújo LB, Oliveira JC, Alcântara TM | Rev Bras Med Trab | 2022 |
| [The broad spectrum of sickle cell disease: HbSC in everyday clinical practice]. | Dickerhoff R | Dtsch Med Wochenschr | 2022 |
| Prioritizing Sickle Cell Disease. | Hsu LL, Hooper WC, Schieve LA | Pediatrics | 2022 |
| New Gene Therapy for β-Thalassemia. | Rubin R | JAMA | 2022 |
| Hydroxyurea for Secondary Stroke Prevention in Children with Sickle Cell Anemia in Nigeria:a Randomized Controlled Trial. | Abdullahi S, Sunusi SM, Abba MS, Sani S, Inuwa HA, Gambo S, Gambo A, Musa BS, Covert Greene BV, Kassim A, Rodeghier M, Hussaini N, Ciobanu M, Aliyu MH, Jordan LC, DeBaun MR | Blood | 2022 |
| Regulation of iron homeostasis by hepatocyte TFR1 requires HFE and contributes to hepcidin suppression in β-thalassemia. | Xiao X, Moschetta GA, Xu Y, Fisher AL, Alfaro-Magallanes VM, Dev S, Wang CY, Babitt JL | Blood | 2022 |
| Patient reported outcomes in children with sickle cell disease at presentation for an acute pain episode. | Bakshi N, Liu Z, Gillespie S, Keesari R, Leake D, Khemani K, Kumari P, Rees CA, Dampier CD, Morris CR | Blood Adv | 2022 |
| Opportunity for pharmacogenetics testing in patients with sickle cell anemia. | Gallaway KA, Sakon C, Ongeri J, Patel KS, Oliver J, Patacca H, O'Brien AR, Skaar TC, Tillman EM | Pharmacogenomics | 2022 |
| Major histocompatibility complex (MHC) antigens polymorphism and alloimmunization study in thalassemia patients with febrile non-hemolytic transfusion reaction (FNHTR). | Dadashi M, Ostadali M, Mohammadi S, Azarkeivan A, Zadsar M | Transfus Clin Biol | 2022 |
| Investigation of the mechanism of copy number variations involving the α-globin gene cluster on chromosome 16: two case reports and literature review. | Zhu D, Xu L, Zhang Y, Liang G, Wei X, Li L, Jin W, Shang X | Mol Genet Genomics | 2022 |
| Sickle cell inflammation: is HbS the answer? | Gibb DR, Hudson KE | Blood | 2022 |
| Standardizing elements of care in pediatric sickle cell disease centers: The road toward health equity. | Raffaella C | Pediatr Blood Cancer | 2022 |
| Relationship between Iron deposition and T lymphocytes in children with β-thalassemia with haematopoietic stem cell transplantation. | Zhou Y, Luo J | Front Pediatr | 2022 |
| Alteration of monocyte subsets and their functions in thalassemia patients. | Piyajaroenkij T, Tantiworawit A, Khikhuntod J, Piriyakhuntorn P, Rattanathammethee T, Hantrakool S, Chai-Adisaksopha C, Rattarittamrong E, Norasetthada L, Fanhchaksai K, Charoenkwan P, Thananchai H | Int J Hematol | 2022 |
| Prospective changes of pancreatic iron in patients with thalassemia major and association with chelation therapy. | Meloni A, Pistoia L, Ricchi P, Allò M, Rosso R, Cuccia L, Casini T, Cecinati V, Serra M, Rossi V, Righi R, Renne S, Vallone A, Positano V, Cademartiri F | Blood Adv | 2022 |
| Magnesium homeostasis in deoxygenated sickle erythrocytes is modulated by endothelin-1 via Na /Mg exchange. | Romero JR, Inostroza-Nieves Y, Pulido-Perez P, Lopez P, Wohlgemuth JG, Dlott JS, Snyder LM, Alper SL, Rivera A | FASEB J | 2022 |
| A case of Hb Rothschild (: c.112T>A) with low pulse oximetry: a first familial presentation in China. | Li D, Wan Q, Li C, Ma H, Wang G | Hematology | 2022 |
| The prevalence and genetic disorders spectrum of thalassemia among breast cancer patients in Jiangxi province, China. | Ding J, Huang Z, Jiang X, Li Q, Cao Y, Guo Y | Front Genet | 2022 |
| Brain volume in Tanzanian children with sickle cell anaemia: A neuroimaging study. | Jacob M, Kawadler JM, Murdoch R, Ahmed M, Tutuba H, Masamu U, Shmueli K, Saunders DE, Clark CA, Kim J, Hamdule S, Makani J, Stotesbury H, Kirkham FJ | Br J Haematol | 2022 |
| Increased autophagy leads to decreased apoptosis during β-thalassaemic mouse and patient erythropoiesis. | Chaichompoo P, Nithipongvanitch R, Kheansaard W, Tubsuwan A, Srinoun K, Vadolas J, Fucharoen S, Smith DR, Winichagoon P, Svasti S | Sci Rep | 2022 |
| PGT pregnancies have a similar risk for post-partum complications as naturally conceived pregnancies. | Srebnik N, Sverdlik Kislasi Y, Amosi-Victor D, Rotshenker-Olshinka K, Eldar-Geva T, Ben-Ami I, Shonberger O, Michaeli J, Grisaru-Granovsky S, Rotem R | Reprod Biomed Online | 2022 |
| Sleep and fatigue among youth with sickle cell disease: A daily diary study. | Johnston JD, Reinman LC, Bills SE, Schatz JC | J Behav Med | 2022 |
| Anemia, iron deficiency, and thalassemia among the Thai population inhabiting at the Thailand-Lao PDR-Cambodia triangle. | Karnpean R, Vanichakulthada N, Suwannaloet W, Thongrung R, Singsanan S, Prakobkaew N, Fucharoen G, Fucharoen S | Sci Rep | 2022 |
| Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression. | Antoniou P, Hardouin G, Martinucci P, Frati G, Felix T, Chalumeau A, Fontana L, Martin J, Masson C, Brusson M, Maule G, Rosello M, Giovannangeli C, Abramowski V, de Villartay JP, Concordet JP, Del Bene F, El Nemer W, Amendola M, Cavazzana M, Cereseto A, Romano O, Miccio A | Nat Commun | 2022 |
| Glomerular filtration rate abnormalities in sickle cell disease. | Afangbedji N, Jerebtsova M | Front Med (Lausanne) | 2022 |
| Quantitative susceptibility mapping (QSM) and R2 of silent cerebral infarcts in sickle cell anemia. | Murdoch R, Stotesbury H, Kawadler JM, Saunders DE, Kirkham FJ, Shmueli K | Front Neurol | 2022 |
| Peer Mediated Groups:: Nonpharmacologic Management of Pain for and By Those with Sickle Cell Disease. | Guarino S, Wright CS, Pachter LM, Lanzkron SM | Dela J Public Health | 2022 |
| Targeting the Second Transferrin Receptor as Emerging Therapeutic Option for β-Thalassemia Major. | Vinchi F, Ali MS | Hemasphere | 2022 |
| Opioid Use in Vaso-Occlusive Crisis During Intravenous Opioid Drug Shortage. | Katsivalis KV, Kosacz J, Austin Szwak J | Hosp Pharm | 2022 |
| Nasopharyngeal Carriage and Antimicrobial Resistance among Adults with Sickle Cell Disease at the Korle Bu Teaching Hospital in Accra, Ghana. | Dayie NT, Sekoh DN, Tetteh-Quarcoo PB, Dayie AD, Osei MM, Kotey FC, Donkor ES | Microbiol Insights | 2022 |
| Profile of Hemoglobin D (HbD) Disease in Eastern Uttar Pradesh: A Single-Center Experience. | Gupta V, Aggarwal P | Cureus | 2022 |
| Dietary iron restriction protects against vaso-occlusion and organ damage in sickle cell disease. | Li H, Kazmi JS, Lee SK, Zhang D, Gao X, Maryanovich M, Torres LS, Verma D, Kelly L, Ginzburg YZ, Frenette PS, Manwani D | Blood | 2022 |
| Cost-effectiveness analysis of adding omega-3 or vitamin D supplementation to standard therapy in treating painful crises of pediatric sickle cell disease patients. | Abdelhalima SM, Murphy JE, Meabed MH, Elberry AA, Gamaleldin MM, Alshaeri HK, Mohammad BA, Hussein RRS | Eur Rev Med Pharmacol Sci | 2022 |
| Sickle Cell Disease Association with Premature Suture Fusion in Young Children. | Manrique M, Toro-Tobon S, Bade Y, Paredes-Gutierrez J, Mantilla-Rivas E, Rana MS, Oh AK, Rogers GF | Plast Reconstr Surg Glob Open | 2022 |
| A Quality Improvement Initiative to Decrease Time to Analgesia in Patients With Sickle Cell and Vaso-Occlusive Crisis: A Population With Disparities in Treatment. | Arnold T, Coffee RL, Rosenberg L, Jacob SA, Thompson S, Saavedra H, Cico SJ, Wagers B | Cureus | 2022 |
| Myeloproliferative neoplasms complicated with β-thalassemia: Two case report. | Xu NW, Li LJ | World J Clin Cases | 2022 |
| Red Blood Cell Alloimmunization in Pediatric group with Beta Thalassemia: A Five-Year Experience. | Minhas K, Ejaz MS, Tukruna A, Haider M, Arif A, Saleem Tebha S | Glob Pediatr Health | 2022 |
| Hypoxic storage of donor red cells preserves deformability after exposure to plasma from adults with sickle cell disease. | Karafin MS, Field JJ, Ilich A, Li L, Qaquish BF, Shevkoplyas SS, Yoshida T | Transfusion | 2022 |
| Neonatal hemochromatosis with εγδβ-thalassemia: a case report and analysis of serum iron regulators. | Tsuge M, Kodera A, Sumitomo H, Araki T, Yoshida R, Yasui K, Sato H, Washio Y, Washio K, Shigehara K, Yashiro M, Yagi T, Tsukahara H | BMC Pediatr | 2022 |
| Apohemoglobin-haptoglobin complex alleviates iron toxicity in mice with β-thalassemia via scavenging of cell-free hemoglobin and heme. | Munoz CJ, Pires IS, Jani V, Gopal S, Palmer AF, Cabrales P | Biomed Pharmacother | 2022 |
| Role of regional anesthesia in patients with acute sickle cell pain: A scoping review. | Rizvi MB, Kessler DO, Rabiner JE | Pediatr Blood Cancer | 2022 |
| HIF1α reboots fetal haemoglobin production. | Eccleston A | Nat Rev Drug Discov | 2022 |
| The impact of in utero transfusions on perinatal outcomes in patients with alpha thalassemia major: the UCSF registry. | MacKenzie TC, Schwab ME, Lianoglou BR, Gano D, Gonzalez J, Arvon RL, Baschat AA, Bianchi DW, Bitanga M, Bourguignon A, Brown RN, Chen B, Chien M, Davis-Nelson S, de Laat MWM, Ekwattanakit S, Gollin Y, Hirata G, Jelin A, Jolley J, Meyer P, Miller J, Norton ME, Ogasawara KK, Panchalee T, Schindewolf E, Shaw SW, Stumbaugh TL, Thompson AA, Towner D, Tsai PS, Viprakasit V, Volanakis E, Vichinsky E, Allen IE, Zhang L | Blood Adv | 2022 |
| Gastrointestinal vaso-occlusive crisis in sickle cell disease. | Gautam G, Harmon R, Foley R | Proc (Bayl Univ Med Cent) | 2022 |
| Endothelial alpha globin is a nitrite reductase. | Keller TCS, Lechauve C, Keller AS, Broseghini-Filho GB, Butcher JT, Askew Page HR, Islam A, Tan ZY, DeLalio LJ, Brooks S, Sharma P, Hong K, Xu W, Padilha AS, Ruddiman CA, Best AK, Macal E, Kim-Shapiro DB, Christ G, Yan Z, Cortese-Krott MM, Ricart K, Patel R, Bender TP, Sonkusare SK, Weiss MJ, Ackerman H, Columbus L, Isakson BE | Nat Commun | 2022 |
| Sickle cell disease among Latinx in California. | Valle J, Baker JR, Madrigal D, Ferrerosa J, Paulukonis S | PLoS One | 2022 |
| National Audit of Criteria For Pre-Operative Sickle Cell Screening in Children. | Sweeney R, O'Sullivan M | Ir Med J | 2022 |
| Approach to the management of β thalassemia major associated osteoporosis - A long-standing relationship revisited. | Yavropoulou MP, Anastasilakis AD, Tzoulis P, Tournis S, Rigatou E, Kassi E, Kattamis A, Makras P | Acta Biomed | 2022 |
| Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Aromatic Aldehydes as Drug Candidates for the Treatment of Sickle Cell Disease. | Huang B, Ghatge MS, Donkor AK, Musayev FN, Deshpande TM, Al-Awadh M, Alhashimi RT, Zhu H, Omar AM, Telen MJ, Zhang Y, McMahon TJ, Abdulmalik O, Safo MK | Molecules | 2022 |
| Non-Transfusion-Dependent Thalassemia: A Panoramic Review. | Shash H | Medicina (Kaunas) | 2022 |
| miRNA Expression Associated with HbF in Saudi Sickle Cell Anemia. | Cyrus C, Vatte C, Al-Nafie A, Chathoth S, Akhtar MS, Darwish M, Almohazey D, AlDubayan SH, Steinberg MH, Al-Ali A | Medicina (Kaunas) | 2022 |
| Rate of Dental Extractions in Patients with Sickle Cell Disease. | Ahmad A, Mihalca D, Stacey B, Samaee S, Mehta D, Hibbs S, Freeman T, Chatterjee B, Ali E, Cheng L, Tsitsikas DA | J Clin Med | 2022 |
| Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β039-Globin Gene Editing and Induction of Fetal Hemoglobin. | Cosenza LC, Zuccato C, Zurlo M, Gambari R, Finotti A | Genes (Basel) | 2022 |
| Deep Learning Assisted Automated Assessment of Thalassaemia from Haemoglobin Electrophoresis Images. | Salman Khan M, Ullah A, Khan KN, Riaz H, Yousafzai YM, Rahman T, Chowdhury MEH, Abul Kashem SB | Diagnostics (Basel) | 2022 |
| Environmental Factors in Northern Italy and Sickle Cell Disease Acute Complications: A Multicentric Study. | Guerzoni ME, Marchesi S, Palazzi G, Lodi M, Pinelli M, Venturelli D, Bigi E, Quaglia N, Corti P, Serra R, Colombatti R, Sainati L, Masera N, Colombo F, Barone A, Iughetti L | Children (Basel) | 2022 |
| Effect of Blood Transfusion on Cerebral Hemodynamics and Vascular Topology Described by Computational Fluid Dynamics in Sickle Cell Disease Patients. | Sawyer RP, Pun S, Karkoska KA, Clendinen CA, DeBaun MR, Gutmark E, Barrile R, Hyacinth HI | Brain Sci | 2022 |
| The Value of SIRT1/FOXO1 Signaling Pathway in Early Detection of Cardiovascular Risk in Children with β-Thalassemia Major. | Ibrahim HA, Zakaria SS, El-Batch MM, El-Shanshory MR, Alrayes ZR, Kabel AM, Eldardiry SA | Biomedicines | 2022 |
| Ferritin thresholds for cardiac and liver hemosiderosis in β-thalassemia patients: a diagnostic accuracy study. | Darvishi-Khezri H, Aliasgharian A, Naderisorki M, Kosaryan M, Ghazaiean M, Fallah H, Zahedi M, Karami H | Sci Rep | 2022 |
| Prevalence and molecular characterization of alpha and beta-Thalassemia mutations among Hakka people in southern China. | Zeng X, Liu Z, He C, Wang J, Yan L | Genet Mol Biol | 2022 |
| Exposing Racial Bias to Confront Care Chasms: Innovations in the Sickle Cell Disease Curriculum at Rush Medical College. | Burgess AE, Morrison O, Kent P | Acad Med | 2022 |
| Recent Advances in Sickle-Cell Disease Therapies: A Review of Voxelotor, Crizanlizumab, and L-glutamine. | Migotsky M, Beestrum M, Badawy SM | Pharmacy (Basel) | 2022 |
| Management of Salter-Harris Type 1 Fracture Complicated with Osteomyelitis in a Sickle Cell Disease Patient: A Case Report and Review of Literature. | Opara NU, Osuala EC, Nwagbara UI | Medicines (Basel) | 2022 |
| Massive single lesion in a patient with sickle cell disease. | Salles-Silva E, Caroli-Bottino A, Parente DB | Gastroenterology | 2022 |
| Sickle Cell Disease in Children and Adolescents: A Review of the Historical, Clinical, and Public Health Perspective of Sub-Saharan Africa and Beyond. | Egesa WI, Nakalema G, Waibi WM, Turyasiima M, Amuje E, Kiconco G, Odoch S, Kumbakulu PK, Abdirashid S, Asiimwe D | Int J Pediatr | 2022 |
| Enrollment Lessons from a Biological Assignment Study of Marrow Transplantation versus Standard Care for Adolescents and Young Adults with Sickle Cell Disease: Considerations for Future Gene and Cellular Therapy Trials. | Krishnamurti L, Neuberg D, Sullivan KM, Smith S, Eapen M, Walters MC | Transplant Cell Ther | 2022 |
| Sickle Cell Disease and Quality of Life: An Evaluation of Reporting of Patient-Reported Outcomes in Randomized Controlled Trials. | Renner A, Love M, Garrett E, Douglas A, Kee M, Heigle B, Wise A, Ottwell R, Hartwell M, Vassar M | Hemoglobin | 2022 |
| Zynteglo: Betibeglogene autotemcel - An innovative therapy for β- thalassemia patients. | Asghar AA, Khabir Y, Hashmi MR | Ann Med Surg (Lond) | 2022 |
| Can HPLC be used as an ideal methodology instead of Hb Electrophoresis for the diagnosis of hemoglobinopathies in a routine clinical laboratory of under-resource country like Nepal? Is the change necessary? | Bhusal A, Bhandari S, Sah RP | Ann Med Surg (Lond) | 2022 |
| The consortium on newborn screening in Africa for sickle cell disease: study rationale and methodology. | Green NS, Zapfel A, Nnodu OE, Franklin P, Tubman VN, Chirande LF, Kiyaga C, Chunda-Liyoka CM, Awuonda B, Ohene-Frempong K, Inusa BP, Ware RE, Odame I, Ambrose EE, Dogara LG, Oron AP, Willett C, Thompson AA, Berliner N, Coetzer TL, Novelli EM | Blood Adv | 2022 |
| Working memory and school readiness in preschool children with sickle cell disease compared to demographically matched controls. | Heitzer AM, Schreiber JE, Yuan X, Wang F, Pan H, Graff JC, Murphy L, Rupff R, Russell K, Wang W, Estepp JH, Hankins JS, Porter JS, Jacola LM | Br J Haematol | 2022 |
| Correction to: CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease. | Rangarajan HG, Crowell SA, Towerman AS, Shenoy SS | Bone Marrow Transplant | 2022 |
| A Novel Measure of Pain Location in Adults with Sickle Cell Disease. | Abudawood K, Yoon SL, Yao Y, Grundmann O, Ezenwa MO, Molokie RE, Wilkie DJ | Pain Manag Nurs | 2022 |
| Right in time: Mitapivat for the treatment of anemia in α- and β-thalassemia. | Musallam KM, Taher AT, Cappellini MD | Cell Rep Med | 2022 |
| Spleen size in homozygous sickle cell disease: TRENDS in a birth cohort using ultrasound. | Walker TM, Hambleton IR, Mason KP, Serjeant G | Br J Radiol | 2022 |
| Complete Neurologic Recovery of Cerebral Fat Embolism Syndrome in Sickle Cell Disease. | Oyedeji O, Anusim N, Alkhoujah M, Dabak V, Otrock ZK | Cureus | 2022 |
| Deep Compartment Syndrome Without Myonecrosis: A Case Report on a Rare Complication of Sickle Cell Disease. | Iversen PO, Hankin A, Horn J, Pedersen TH, Borgersen R, Frøen HM | Cureus | 2022 |
| Renal Dysfunction in Pediatric Patients in Iraq With β-Thalassemia Major and Intermedia. | Shaalan MG, Hassan MK, Al-Shanoof HJ, Al Naama LM | Cureus | 2022 |
| Systematic online academic resources (SOAR) review: Sickle cell disorders. | Alavian S, Asare-Agbo P, Chan TM | AEM Educ Train | 2022 |
| The Effect of Long-Term Iron Chelator Therapy on Serum Levels of Hepcidin and Ferritin in Patients with Thalassemia Major and Intermediate. | Eshagh Hossaini SK, Haeri MR, Seif F | Indian J Hematol Blood Transfus | 2022 |
| Automated sickle cell disease identification in human red blood cells using a lensless single random phase encoding biosensor and convolutional neural networks. | Douglass PM, O'Connor T, Javidi B | Opt Express | 2022 |
| Dizziness, Falls, and Hearing Loss in Adults Living With Sickle Cell Disease. | Nelson MD, Bennett DM, Lehman ME, Okonji AI | Am J Audiol | 2022 |
| Neutrophils as drivers of vascular injury in sickle cell disease. | Torres LS, Hidalgo A | Immunol Rev | 2022 |
| Impact of adherence to hydroxyurea on health outcomes among patients with sickle cell disease. | Kang HA, Barner JC, Lawson KA, Rascati K, Mignacca RC | Am J Hematol | 2022 |
| Using Clustered Regularly Interspaced Short Palindromic Repeats gene editing to induce permanent expression of fetal hemoglobin in β-thalassemia and sickle cell disease: A comparative meta-analysis. | Quagliano A, Acevedo D, Hardigan P, Prasad S | Front Med (Lausanne) | 2022 |
| Simultaneous detection of genomic imbalance in patients receiving preimplantation genetic testing for monogenic diseases (PGT-M). | Yang L, Xu Y, Xia J, Yan H, Ding C, Shi Q, Wu Y, Liu P, Pan J, Zeng Y, Zhang Y, Chen F, Jiang H, Xu Y, Li W, Zhou C, Gao Y | Front Genet | 2022 |
| Molecular prevalence of -associated hemoglobinopathy among reproductive-age adults and the prenatal diagnosis in Jiangxi Province, southern central China. | Luo H, Huang T, Lu Q, Zhang L, Xu Y, Yang Y, Guo Z, Yuan H, Shen Y, Huang S, Yang B, Zou Y, Liu Y | Front Genet | 2022 |
| Infantile-onset Pompe disease complicated by sickle cell anemia: Case report and management considerations. | Starosta RT, Hou YC, Leestma K, Singh P, Viehl L, Manwaring L, Granadillo JL, Schroeder MC, Colombo JN, Whitehead H, Dickson PI, Hulbert ML, Nguyen HT | Front Pediatr | 2022 |
| Activated CD4 + T lymphocyte is a potential biomarker for acute graft-vs.-host disease after hematopoietic stem cell transplantation in children with transfusion-dependent β-thalassemia. | Huang K, Luo J | Front Pediatr | 2022 |
| Applications of next generation sequencing in the screening and diagnosis of thalassemia: A mini-review. | Suhaimi SA, Zulkipli IN, Ghani H, Abdul-Hamid MRW | Front Pediatr | 2022 |
| Reduction in vaso-occlusive events following stem cell transplantation in patients with sickle cell disease. | Leonard AK, Furstenau D, Abraham AA, Darbari D, Nickel RS, Limerick EM, Fitzhugh CD, Hsieh M, Tisdale JF | Blood Adv | 2022 |
| Impact of the COVID-19 Pandemic on the Implementation of Mobile Health to Improve the Uptake of Hydroxyurea in Patients With Sickle Cell Disease: Mixed Methods Study. | Badawy SM, DiMartino L, Brambilla D, Klesges L, Baumann A, Burns E, DeMartino T, Jacobs S, Khan H, Nwosu C, Shah N, Hankins JS, | JMIR Form Res | 2022 |
| Chronic red cell exchange in sickle cell patients with iron overload may not affect mortality. | Zhou YY, Reeves HM, Webb L, Santiago Z, Maitta RW | Front Med (Lausanne) | 2022 |
| Krüppel-Like Factor 1: A Pivotal Gene Regulator in Erythropoiesis. | Caria CA, Faà V, Ristaldi MS | Cells | 2022 |
| Optimum dose of oral folic acid supplementation in transfusion-dependent thalassemia: a randomized controlled trial. | Agrawal T, Dewan P, Gomber S, Agarwal R, Sharma S, Kotru M | J Trop Pediatr | 2022 |
| Sickle cell disease-related knowledge and perceptions of traditional healers in tribal communities in India: implications on sickle cell disease programme. | Babu BV, Sridevi P, Surti SB, Bhat D, Sarmah J, Sudhakar G, Sharma Y | J Community Genet | 2022 |
| Sickle cell disease treatment and management in India: a systematic review of interventional studies. | Sridevi P, Sharma Y, Balakrishna SL, Babu BV | Trans R Soc Trop Med Hyg | 2022 |
| MALDI-TOF-MS for Rapid Screening and Typing of β-Globin Variant and β-Thalassemia through Direct Measurements of Intact Globin Chains. | Zhang Q, Wang G, Sun D, Lin W, Yan T, Wu Y, Wu M, Chen J, Zou S, Xie W, Zhou Y, Wang Y, He L, Liu Y, Qiu Z, Hu L, Lin B, Zhou X, Li Y, Xu X | Clin Chem | 2022 |
| Variation and impact of polygenic hematological traits in monogenic sickle cell disease. | Pincez T, Lo KS, D'Orengiani APHD, Garrett ME, Brugnara C, Ashley-Koch AE, Telen MJ, Galacteros F, Joly P, Bartolucci P, Lettre G | Haematologica | 2022 |
| Temporal macular thinning and vessel density correlation in children and young adults with sickle cell disease. | Monteiro C, Vivas M, Almeida J, Ramalho M, Mota M, Teixeira S, Prieto I | Eur J Ophthalmol | 2022 |
| Kocuria rosea Bacteremia in a Sickle Cell Patient: A Case Report. | Nudelman BG, Ouellette T, Nguyen KQ, Schmaus WH, Chokshi RR | Cureus | 2022 |
| A comprehensive study of immune function and immunophenotyping of white blood cells from β-thalassaemia/HbE patients on hydroxyurea supports the safety of the drug. | Siriworadetkun S, Thiengtavor C, Thubthed R, Paiboonsukwong K, Fucharoen S, Pattanapanyasat K, Vadolas J, Svasti S, Chaichompoo P | Br J Haematol | 2022 |
| Identification of haemolytic anaemia caused by glucose phosphate isomerase deficiency in a thalassaemia-endemic region: Correction of misdiagnosis and consideration of the cause of misdiagnosis. | Zhu D, Liang G, Zhang Y, Wei X, Wu X, Shang X | Br J Haematol | 2022 |
| Prevalence of Substance Use Disorders in Sickle Cell Disease Compared to Other Chronic Conditions: a Population-Based Study of Black American Adults. | Jonassaint CR, O'Brien J, Nardo E, Feldman R, Stanton M, DeCastro L, Abebe KZ | J Gen Intern Med | 2022 |
| Influenza Vaccination Receipt in Pediatric Patients With Cancer or Sickle Cell Disease. | Yarnall JN, Mertens A, Yee M, Orenstein E, Lai KW, Wasilewski-Masker K | J Pediatr Hematol Oncol | 2022 |
| Sickle cell disease in gulf cooperation council countries: a systematic review. | Abu-Shaheen A, Dahan D, Henaa H, Nofal A, Abdelmoety DA, Riaz M, AlSheef M, Almatary A, AlFayyad I | Expert Rev Hematol | 2022 |
| Plasma immune mediators as laboratorial biomarkers for Sickle Cell Disease patients according to the hydroxyurea therapy and disease severity. | de Oliveira Toledo SL, Ladeira VS, Nogueira LS, Ferreira LGR, Oliveira MM, de Oliveira Renó C, Dos Santos HL, Coelho-Dos-Reis JGA, Campi-Azevedo AC, Teixeira-Carvalho A, Martins-Filho OA, Rios DRA, Barros-Pinheiro M | Blood Cells Mol Dis | 2022 |
| Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial. | Taylor SM, Korwa S, Wu A, Green CL, Freedman B, Clapp S, Kirui JK, O'Meara WP, Njuguna FM | PLoS Med | 2022 |
| Molecular characterization of a novel homozygous deletion in β-globin cluster causing (δβ)-Thalassemia among Tunisian family. | Kalai M, Moumni I, Ouragini H, Ben Fraj I, Mellouli F, Ouederni M, Chaouachi D, Boudriga I, Menif S | Ann Clin Biochem | 2022 |
| Reproductive health and knowledge among youth with sickle cell disease. | Khachikyan I, Speller-Brown B, Gomez-Lobo V, Trotman G, Darbari D | J Nurse Pract | 2022 |
| Pediatric-Adult Care Transition: Perceptions of Adolescent and Young Adult Patients with Sickle Cell Disease and Their Healthcare Providers. | Hoegy D, Guilloux R, Bleyzac N, Gauthier-Vasserot A, Cannas G, Bertrand Y, Dussart C, Janoly-Dumenil A | Patient Prefer Adherence | 2022 |
| A Novel 5 kb Deletion in the -Globin Gene Cluster Identified in a Chinese Patient. | Bao XQ, Wang JC, Qin DQ, Yao CZ, Liang J, Du L | Hemoglobin | 2022 |
| An Overview of Solid Organ Transplantation in Patients With Sickle Cell Disease. | Sharpe CC, Suddle A, Stuart-Smith S | Transplantation | 2022 |
| Direct sequencing of β-globin gene reveals a rare combination of two exonic and two intronic variants in a β-thalassemia major patient: a case report. | Chauhan W, Fatma R, Zaka-Ur-Rab Z, Afzal M | J Med Case Rep | 2022 |
| Considerations in the Sickle Cell Patient Undergoing Hip Reconstructive Surgery. | Sustich SJ, Stronach BM, Stambough JB, Barnes CL, Mears SC | Orthop Clin North Am | 2022 |
| [The Clinical Observation with Ruxolitinib as Graft-Versus-Host Disease Prophylaxis for Children with Thalassemia after Unrelated or Haploidentical Allo-Hematopoietic Stem Cell Transplantation]. | Chen YM, Hong XL, Lin JZ, Shi J, Lu QY | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| [Analysis of Gene Detection and Hematological Phenotype of Thalassemia]. | Zhou XP, Liu T, Pang XL, DU HF, Xu Y | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| [Predictors of Hematologic Responses in Patients with Non-Transfusion-Dependent β-Thalassemia Receiving Thalidomide Therapy]. | Yang K, Yin XL, Liu XD, Hua F, Peng W, Li L, Chen K, Zhang J, Luo S, Xiao J | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| Global perspectives on cellular therapy for children with sickle cell disease. | John TD, Namazzi R, Chirande L, Tubman VN | Curr Opin Hematol | 2022 |
| Salvage Intrapartum Splenectomy for the Treatment of Transfusion-refractory Anaemia in a ß-thalassemia Intermedia Patient. | Sivrikoz TS, Ozbalak M, Ozmen A, Tukenmez M, Besisik SK | J Coll Physicians Surg Pak | 2022 |
| Hemorrhagic Stroke in Children and Adults With Sickle Cell Anemia: The Post-STOP Cohort. | Fox CK, Leykina L, Hills NK, Kwiatkowski JL, Kanter J, Strouse JJ, Voeks JH, Fullerton HJ, Adams RJ, | Stroke | 2022 |
| Africa must participate in finding a gene therapy cure for sickle-cell disease. | Moshi G, Sheehan VA, Makani J | Nat Med | 2022 |
| Commentary on A Pediatric Patient with a Complicated History of Sickle Cell Trait. | Campbell ST | Clin Chem | 2022 |
| A Pediatric Patient with a Complicated History of Sickle Cell Trait. | Nedelcu E, Wiencek JR, Pierre CC | Clin Chem | 2022 |
| Sickle cell disease and pregnancy profile of complicated malaria in 982 pregnancies in Kinshasa. | Mikobi TM, Kamuanya NC, Akilimali PZ, Lukusa PT | PLoS One | 2022 |
| Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018. | Snyder AB, Lakshmanan S, Hulihan MM, Paulukonis ST, Zhou M, Horiuchi SS, Abe K, Pope SN, Schieve LA | MMWR Surveill Summ | 2022 |
| The effects of cardio-selective beta blockade on diastolic dysfunction in children with sickle cell disease. | Rai P, Okhomina VI, Kang G, Akil N, Towbin JA, Hankins JS, Beasley G | Haematologica | 2022 |
| Assessment of cerebrovascular function in patients with sickle cell disease using transfer function analysis. | Sayin ES, Sobczyk O, Poublanc J, Mikulis DJ, Fisher JA, Kuo KHM, Duffin J | Physiol Rep | 2022 |
| Transfusion-transmitted infections, its risk factors and impact on quality of life: An epidemiological study among β-thalassemia major children. | Biswas B, Naskar NN, Basu K, Dasgupta A, Basu R, Paul B | Asian J Transfus Sci | 2022 |
| Prevalence and specificity of red blood cell alloantibodies and autoantibodies in transfused Iranian β-thalassemia patients: A systematic review and meta-analysis. | Rostamian H, Javandoost E, Mohammadian M, Alipour A | Asian J Transfus Sci | 2022 |
| A novel deep learning approach for sickle cell anemia detection in human RBCs using an improved wrapper-based feature selection technique in microscopic blood smear images. | S A, Ganesan K, K BB | Biomed Tech (Berl) | 2022 |
| The perception of parents with a child with sickle cell disease in Ghana towards prenatal diagnosis. | Ampomah MO, Atkin K, Flemming K | J Community Genet | 2022 |
| Alpha-fetoprotein and high sensitive C-reactive protein levels in Iraqi patients with liver cirrhosis. | Abbas WAK | J Popul Ther Clin Pharmacol | 2022 |
| The association between steatosis and liver damage in transfusion-dependent beta thalassaemia patients. | Padeniya P, Ediriweera D, De Silva AP, Niriella M, Premawardhena A | Br J Haematol | 2022 |
| Evaluation of Oxidative Stress by Dynamic Thiol/Disulfide Homeostasis and Ischemia-Modified Albumin Levels in Children with β-Thalassemia Major. | Güler Kazancı E, Korkmaz MF, Eren F, Erel Ö | Lab Med | 2022 |
| Evaluation of Liver Function Tests in β-Thalassemia Major Children. | Sultana I, Sultana N, Rabbany MA, Banu M, Begum S, Alam S, Tasnim J, Akter T, Hossain MS, Akter S, Faysal MR | Mymensingh Med J | 2022 |
| Ketamine as an Analgesic Adjunct for Opioid-Induced Hyperalgesia in a Patient With a Sickle Cell Pain Episode. | Martinez MR, Garmon EH, Starling GD, Sheth MA | Ochsner J | 2022 |
| Prevalence and Molecular Evaluation of Hepatitis C Virus Infection among Multi-transfused Thalassemia Patients in South of Iran. | Farshadpour F, Taherkhani R | Oman Med J | 2022 |
| Incidence, kinetics, and risk factors for intra- and extracranial cerebral arteriopathies in a newborn sickle cell disease cohort early assessed by transcranial and cervical color Doppler ultrasound. | Bernaudin F, Arnaud C, Kamdem A, Hau I, Madhi F, Jung C, Epaud R, Verlhac S | Front Neurol | 2022 |
| The need to perform α-thalassemia genetic testing in Italian patients with β-thalassemia trait: A case report. | Santoro G, Cro F, Poma F, Kullmann C, Lapucci C, Ferrari M | Clin Case Rep | 2022 |
| Case report: Safety and efficacy of voxelotor in a patient with sickle cell disease and stage IV chronic kidney disease. | Alshurafa A, Yassin MA | Front Med (Lausanne) | 2022 |
| Sickle Cell Disease and Its Respiratory Complications. | Khan MI, Patel N, Meda RT, Nuguru SP, Rachakonda S, Sripathi S | Cureus | 2022 |
| Sickle Cell Trait and Adverse Pregnancy Outcomes: Is There a Link? | Buhusayyen H, Isa HM, Kamal N | Cureus | 2022 |
| Awareness Among Educated and Uneducated Parents of Beta-Thalassemia Major Patients About Antenatal Screening. | Muhammad L, Wajid KK, Afridi I, Ullah S, Khan A, Muhammad A | Cureus | 2022 |
| Coexistence of sickle cell disease and systemic lupus erythematosus is associated with quantitative and qualitative impairments in circulating regulatory B cells. | Boulassel MR, Al-Naamani A, Al-Zubaidi A, Al-Qarni Z, Khan H, Oukil A, Al-Badi A, Al-Kaabi J, Al-Shekaili J, Al-Hashmi S, Zadjali F, Nabi Qureshi R, Panjwani V, Al-Kindi S | Hum Immunol | 2022 |
| Systemic Steroids and the Risk of Vasoocclusive Events in Patients with Sickle Cell Disease. | Cohen RT, Klings ES | Ann Am Thorac Soc | 2022 |
| Amiodarone improves anemia in a murine model of sickle cell disease and is associated with increased erythrocyte bis(monoacylglycerol) phosphate. | Venugopal J, Wang J, Guo C, Eitzman DT | Sci Rep | 2022 |
| Hemoglobin Beth Israel [HBB:c.308A>G (p.Asn103Ser)]: an ultra-rare, low oxygen-affinity, non-methemoglobinemic hemoglobin diagnosed on targeted resequencing as cause of dominantly inherited benign cyanosis. | Singh N, Jamwal M, Sharma R, Murgai P, Chhabra S, Hira JK, Das R, Sharma P | Ann Hematol | 2022 |
| Oral microbiota analyses of Saudi sickle cell anemics with dental caries. | Alyousef YM, Alonaizan FA, Alsulaiman AA, Aldarwish MI, Alali AA, Almasood NN, Vatte C, Cyrus C, Habara AH, Koeleman BPC | Int Dent J | 2022 |
| MicroRNA-92a-3p-mediated inhibition of BCL11A upregulates γ-globin expression and inhibits oxidative stress and apoptosis in erythroid precursor cells. | Li H, Lin R, Li H, Ou R, Wang K, Lin J, Li C | Hematology | 2022 |
| Treatment Options That Reduce the Duration of Sickle Cell Vaso-Occlusive Crises: A Systematic Review. | Akindele AO, Jalkh AP, Eastmond AK, Shetty C, Rizvi SMHA, Sharaf J, Williams KD, Tariq M, Acharekar MV, Guerrero Saldivia SE, Unnikrishnan SN, Chavarria YY, Balani P | Cureus | 2022 |
| Haptoglobin treatment contributes to regulating nitric oxide signal and reduces oxidative stress in the penis: A preventive treatment for priapism in sickle cell disease. | Pereira PDS, Pereira DA, Calmasini FB, Reis LO, Brinkman N, Burnett AL, Costa FF, Silva FH | Front Physiol | 2022 |
| Knowledge and awareness of sickle cell disease: a cross sectional study amongst unmarried adults in Nigeria's capital city. | Adigwe OP | J Community Genet | 2022 |
| Sickle Cell Disease and Gene Therapy - Patient and Physician Perspectives. | DeBaun M, Heeney M, Jackson T, Longo D, Love M, Love T, Okwo P, Thompson A, Trimnell C, Woolford T | N Engl J Med | 2022 |
| Microbial gut evaluation in an angolan paediatric population with sickle cell disease. | Delgadinho M, Ginete C, Santos B, Mendes J, Miranda A, Vasconcelos J, Brito M | J Cell Mol Med | 2022 |
| Fetal hemoglobin-boosting haplotypes of BCL11A gene and HBS1L-MYB intergenic region in the prediction of clinical and hematological outcomes in a cohort of children with sickle cell anemia. | Sales RR, Nogueira BL, Belisário AR, Faria G, Mendes F, Viana MB, Luizon MR | J Hum Genet | 2022 |
| Using FIB-4 score as a screening tool in the assessment of significant liver fibrosis (F2) in patients with transfusion-dependent beta thalassaemia: a cross-sectional study. | Padeniya P, Ediriweera DS, De Silva AP, Niriella MA, Premawardhena A | BMJ Open | 2022 |
| Systemic thrombolysis for acute central retinal artery occlusion in sickle cell disease: Case report. | Isaac E, Saherwal AA, Alam S | J Natl Med Assoc | 2022 |
| Phenotypic screening of the ReFRAME drug repurposing library to discover new drugs for treating sickle cell disease. | Metaferia B, Cellmer T, Dunkelberger EB, Li Q, Henry ER, Hofrichter J, Staton D, Hsieh MM, Conrey AK, Tisdale JF, Chatterjee AK, Thein SL, Eaton WA | Proc Natl Acad Sci U S A | 2022 |
| Point-of-care testing allows successful simultaneous screening of sickle cell disease, HIV, and tuberculosis for households in rural Guinea-Bissau, West Africa. | Menzato F, Bosa L, Sifna A, Da Silva L, Gasperoni E, Martella M, Mustik A, Da Dalt L, Reggiani G, Munaretto V, Liotta G, Riccardi F, Colombatti R | Pediatr Blood Cancer | 2022 |
| Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 study. | Kanter J, Thompson AA, Pierciey FJ, Hsieh M, Uchida N, Leboulch P, Schmidt M, Bonner M, Guo R, Miller A, Ribeil JA, Davidson D, Asmal M, Walters MC, Tisdale JF | Am J Hematol | 2022 |
| Building research capacity for sickle cell disease in Africa: Lessons and challenges from establishing a birth cohort in Tanzania. | Nkya S, Njiro BJ, Ngowi D, Solomon D, Kaywanger F, Nyangasa S, Ndoje G, Marco E, Moses M, Makani J | Front Pediatr | 2022 |
| Perspectives and challenges to discovering hemoglobin-inducing agents in Sickle Cell Disease. | Pavan AR, Lopes JR, Lima Imperador CH, Man Chin C, Dos Santos JL | Front Med (Lausanne) | 2022 |
| Detection of four rare thalassemia variants using Single-molecule realtime sequencing. | Luo S, Chen X, Zeng D, Tang N, Yuan D, Liu B, Chen L, Zhong Q, Li J, Liu Y, Chen J, Wang X, Yan T | Front Genet | 2022 |
| Oral health-related quality of life and orthodontic treatment need in thalassemia major patients. | Tabesh A, Abbasi F, Shavakhi M, Mahmood M | Dent Res J (Isfahan) | 2022 |
| Drug-induced duodenal perforation in the paediatric patient with thalassemia major, an unreported side effect of iron- chelating agent: A case report. | Shakir FTZ, Sultan R, Siddiqui R, Shah MZ, Javed A, Maryam N | J Pak Med Assoc | 2022 |
| Sickle Cell Disease in Mauritania: epidemiological, clinical and therapeutic aspects about 135 cases. | Laghdaf Sidi M, N'Diaye AM, Cheikh M, Heinhane MM | Tunis Med | 2022 |
| Association between periodontal inflamed surface area and serum acute phase biomarkers in patients with sickle cell anemia. | Sari A, Ilhan G, Akcali A | Arch Oral Biol | 2022 |
| The impact of MCP1-2518A/G and CCR2-V64I genetic polymorphisms in Egyptian sickle cell disease patients. | Ibrahim NS, Makhlouf MM, Shahin GH, Elghamrawy MK, Hussein NM | Exp Mol Pathol | 2022 |
| For hemophilia and thalassemia, a new era of 'one-and-done' gene therapies has arrived. | Sheridan C | Nat Biotechnol | 2022 |
| Gene Therapy for Sickle Cell Disease, β-Thalassemia Enters Regulatory Reviews. | Larkin HD | JAMA | 2022 |
| Creating an Automated Contemporaneous Cohort in Sickle Cell Anemia to Predict Survival After Disease-Modifying Therapy. | Cronin RM, Wuichet K, Ghafuri DL, Hodges B, Chopra M, He J, Niu X, Kassim A, Wilkerson K, Rodeghier M, DeBaun MR | Blood Adv | 2022 |
| Assessment of transition readiness to predict health care utilization during transition to adult care in sickle cell disease. | Howell KE, Heitzer AM, Longoria JN, Potter B, Wang WC, Anderson S, Kang G, Hankins JS, Porter JS | Expert Rev Hematol | 2022 |
| Determinants of hydroxyurea use among doctors, nurses and sickle cell disease patients in Nigeria. | Isa HA, Nnebe-Agumadu U, Nwegbu MM, Okocha EC, Chianumba RI, Brown BJ, Asala SA, Peprah E, Nnodu OE | PLoS One | 2022 |
| Pharmacokinetics, pharmacodynamics, safety and efficacy of crizanlizumab in patients with sickle cell disease. | Kanter J, Brown C, Norris C, Nair SM, Kutlar A, Manwani D, Shah N, Tanaka C, Bodla S, Sanchez-Olle G, Albers U, Liles DK | Blood Adv | 2022 |
| Vascular Effects of the Fetal Hemoglobin Inducer Agent 3-(1,3-Dioxoisoindolin-2-yl) Benzyl Nitrate. | Terroni B, de Moraes LHO, Pavan AR, Rodrigues GJ, Dos Santos JL | Pharmaceuticals (Basel) | 2022 |
| Excess deaths among adults with sickle cell disease in 2020 compared to prior years. | Curtis S, Henny B, Joanna S, Betancourt J, Thomas M, Vattappally L, Crouch A, Caterina M | Ann Hematol | 2022 |
| Deep Vein Thrombosis of the Left Lower Limb in a Sudanese Child with Sickle Cell Disease. | Mustafa AEM, Tahir NM, Ahmed Mohamed NAE, Mohammed AA, Mohammed SI | Medicines (Basel) | 2022 |
| Safety of coronavirus disease 2019 vaccines in 213 adult patients with sickle cell disease. | Joseph L, Corbasson A, Manceau S, Khimoud D, Meunier B, Cheminet G, Lefrere F, Jannot AS, Lu E, Arlet JB | Br J Haematol | 2022 |
| Fertility preservation for pediatric patients with hemoglobinopathies: Multidisciplinary counseling needed to optimize outcomes. | Bedrick BS, Kohn TP, Pecker LH, Christianson MS | Front Endocrinol (Lausanne) | 2022 |
| Thalassemia and Moyamoya Syndrome: Epidemiology and long-term outcome. | Das S, Ray BK, Pandit A, Ghosh R, Chakraborty AP, Dubey S | Eur J Paediatr Neurol | 2022 |
| What does it mean to be affiliated with care?: Delphi consensus on the definition of | Lamont AE, Hsu LL, Jacobs S, Gibson R, Treadwell M, Chen Y, Lottenberg R, Axelrod K, Varughese T, Melvin C, Smith S, Chukwudozie IB, Kanter J, | PLoS One | 2022 |
| Occult ischemic bone lesions in children with sickle cell disease: a study of prevalence. | Voi V, Turrini S, Mattavelli M, Vigliani V, Margarita G, Ferrero GB | Eur J Haematol | 2022 |
| DeepThal: A Deep Learning-Based Framework for the Large-Scale Prediction of the α-Thalassemia Trait Using Red Blood Cell Parameters. | Phirom K, Charoenkwan P, Shoombuatong W, Charoenkwan P, Sirichotiyakul S, Tongsong T | J Clin Med | 2022 |
| Individuals with Sickle Cell Disease Using SBAR as a Communication Tool: A Pilot Study. | Jean-Baptiste DM, Wassef M, Bolyai SS, Jenerette C | Int J Environ Res Public Health | 2022 |
| Barriers and Facilitators of Availability of Hydroxyurea for Sickle Cell Disease in Tanzania; A Qualitative Study of Pharmaceutical Manufacturers, Importers, and Regulators. | Mlyuka HJ, Kilonzi M, Mutagonda RF, Chirande L, Mikomangwa WP, Myemba DT, Sambayi G, Mwakawanga DL, Ndunguru J, Jonathan A, Makani J, Ruggajo P, Minja IK, Balandya E, Kamuhabwa AAR | Healthcare (Basel) | 2022 |
| Knowledge and Attitude toward Hemoglobinopathies in Premarital Screening Program among the General Population in the Western Region of Saudi Arabia. | Almasmoum HA, Tabassum A, Iqbal MS, Abo-Alshamat R, Aqeeli W | Hemoglobin | 2022 |
| Too Few Children, Teens with Sickle Cell Anemia Receive Screening, Medication to Prevent Serious Complications. | Stephenson J | JAMA Health Forum | 2022 |
| High accuracy of single-molecule real-time sequencing in detecting a rare α-globin fusion gene in carrier screening population. | Zhou QM, Jiang F, Xu J, Lin D, Huang RL, Zhou JY, Qu YX, Li DZ | Ann Hum Genet | 2022 |
| Surveillance for the Rare Condition of Sickle Cell Disease in Wisconsin. | Singh A, Dasgupta M, Retherford D, Baker M, Hulihan M, Brandow AM | WMJ | 2022 |
| A dyadic analysis of parent and child pain catastrophizing and health-related quality of life in pediatric sickle cell disease. | Shih S, Donati MR, Cohen LL, Shneider C, Sil S | Pain | 2022 |
| Eteplirsen Use in a Boy with Duchenne Muscular Dystrophy and Sickle Cell Anemia. | Aiello GM, Cartwright MS | Case Rep Neurol | 2022 |
| Comparisons of serum non-transferrin-bound iron levels and fetal cardiac function between fetuses affected with hemoglobin Bart's disease and normal fetuses. | Jatavan P, Sekararithi R, Jaiwongkam T, Kumfu S, Chattipakorn N, Tongsong T | Front Med (Lausanne) | 2022 |
